var title_f40_35_41520="Chemical structure DNA and RNA";
var content_f40_35_41520=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Chemical structure of DNA and RNA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41520=[""].join("\n");
var outline_f40_35_41520=null;
var title_f40_35_41521="Dilated cardiomyopathy four chamber echocardiogram";
var content_f40_35_41521=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/78668/4chdilcm_conv.mp4?title=Dilated+cardiomyopathy+four+chamber+echocardiogram\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dilated cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 242px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Four chamber view from a 2-D echocardiogram shows a very dilated left ventricle which is diffusely hypokinetic. There is also enlargement of the right ventricle and right and left atria.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41521=[""].join("\n");
var outline_f40_35_41521=null;
var title_f40_35_41522="Calfactant: Pediatric drug information";
var content_f40_35_41522=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Calfactant: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2707?source=see_link\">",
"    see \"Calfactant: Drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F144833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Infasurf&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Lung Surfactant",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Endotracheal: 3 mL/kg every 12 hours up to a total of 3 doses in the first 96 hours of life; repeat doses have been administered as frequently as every 6 hours for a total of up to 4 doses (if the neonate was still intubated and required at least 30% inspired oxygen to maintain arterial oxygen saturations &gt;90% or with a PaO",
"     <sub>",
"      2",
"     </sub>",
"     &le;80 torr on &gt;30% inspired oxygen) (Bloom, 2005; Kattwinkel, 2000)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F144823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intratracheal [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infasurf&reg;: 35 mg phospholipids and 0.7 mg protein per mL (3 mL, 6 mL) [production involves products derived from bovine sources]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F144811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intratracheal: Gently swirl to redisperse suspension; do not shake; administer dosage divided into two aliquots of 1.5 mL/kg each into the endotracheal tube; after each instillation, reposition the infant with either the right or left side dependent; administration is made while ventilation is continued over 20-30 breaths for each aliquot, with small bursts timed only during the inspiratory cycles; a pause followed by evaluation of the respiratory status and repositioning should separate the two aliquots; calfactant dosage has also been divided into four equal aliquots and administered with repositioning in four different positions (prone, supine, right and left lateral)",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1057144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate; protect from light; unopened, unused warmed vials of calfactant may be returned to refrigerator within 24 hours for future use; repeated warming to room temperature should be avoided",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of respiratory distress syndrome (RDS) in premature infants",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Prophylactic therapy: Infants &lt;29 weeks at significant risk for RDS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Treatment: Infants &le;72 hours of age with RDS (confirmed by clinical and radiologic findings and requiring endotracheal intubation)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F144844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, cyanosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Airway obstruction, reflux, reintubation, requirement for manual ventilation",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Transient episodes of reflux of calfactant into the endotracheal tube, cyanosis, bradycardia, or airway obstruction have occurred during dosing procedures; such episodes may require stopping administration and taking appropriate measures to alleviate the condition before resuming therapy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rapidly affects oxygenation and lung compliance and should be restricted to a highly supervised use in a clinical setting with immediate availability of clinicians experienced with intubation and ventilatory management of premature infants; if transient episodes of bradycardia and decreased oxygen saturation occur, discontinue the dosing procedure and initiate measures to alleviate the condition; produces rapid improvement in lung oxygenation and compliance that may require immediate reductions in ventilator settings and FiO",
"     <sub>",
"      2",
"     </sub>",
"     ; for intratracheal administration only",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6218819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1057145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Continuous heart rate and transcutaneous O",
"     <sub>",
"      2",
"     </sub>",
"     saturation should be monitored during administration; frequent ABG sampling is necessary to prevent postdosing hyperoxia and hypocarbia",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Replaces deficient or ineffective endogenous lung surfactant in neonates with RDS or in neonates at risk of developing RDS; surfactant prevents the alveoli from collapsing during expiration by lowering surface tension between air and alveolar surfaces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bloom BT, Clark RH, and Infasurf Survanta Clinical Trial Group, \"Comparison of Infasurf (Calfactant) and Survanta (Beractant) in the Prevention and Treatment of Respiratory Distress Syndrome,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2005, 116(2):392-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41522/abstract-text/16061594/pubmed\" id=\"16061594\" target=\"_blank\">",
"        16061594",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bloom BT, Kattwinkel J, Hall RT, et al, &ldquo;Comparison of Infasurf&reg; (Calf Lung Surfactant Extract) to Survanta&reg; (Beractant) in the Treatment and Prevention of Respiratory Distress Syndrome,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1997, 100(1):31-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41522/abstract-text/9200357/pubmed\" id=\"9200357\" target=\"_blank\">",
"        9200357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hudak ML, Martin DJ, Egan EA, et al, &ldquo;A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress Syndrome,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1997, 100(1):39-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41522/abstract-text/9200358/pubmed\" id=\"9200358\" target=\"_blank\">",
"        9200358",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kattwinkel J, Bloom BT, Delmore P, et al, \"High- Versus Low-Threshold Surfactant Retreatment for Neonatal Respiratory Distress Syndrome,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2000, 106(2 Pt 1):282-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41522/abstract-text/10920152/pubmed\" id=\"10920152\" target=\"_blank\">",
"        10920152",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13109 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-2D9DC08A38-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41522=[""].join("\n");
var outline_f40_35_41522=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144833\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057146\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442190\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144823\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144811\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057149\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057144\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057148\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144844\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057141\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057140\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298945\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6218819\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057145\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057139\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13109\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13109|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2707?source=related_link\">",
"      Calfactant: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_35_41523="Middle ear anatomy";
var content_f40_35_41523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomy of the ear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This diagram illustrates the relationship of the middle ear to the external auditory canal and inner ear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Bluestone CD, Klein JO. Otitis Media in Infants and Children. WB Saunders, Philadelphia, 2001.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41523=[""].join("\n");
var outline_f40_35_41523=null;
var title_f40_35_41524="Double balloon endoscopy system";
var content_f40_35_41524=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Double balloon endoscopy system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 407px; height: 573px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Double balloon endoscopy system showing the endoscope, overtube, and balloons (panel A) as well as the pump and controller for balloon inflation and deflation (panel B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Professor Dr. Christian Ell.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41524=[""].join("\n");
var outline_f40_35_41524=null;
var title_f40_35_41525="Spider kukulcania";
var content_f40_35_41525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F64635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F64635&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Kukulcania spider",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 362px; height: 504px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH4AWoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6Ht0jmQELiXPzEDih4FlVoim+Jsbs9+fb3xSWkYgSURIFaRy7YJ6mrglG0RA7VABJHc1q9CNyAr5kuW3BgMFT0NMMMYId+efTJxVmILK7iX5T1BHaoWj+YIHAYYz7D3pANuYoyw8sFR0APUUiW481SBvGfmJbHH5c1LIoZTkkMnBPXI9aS1aWeJXCeWOoz1NILDrtWFuphWNWJwd+Tx36HrUJjBMaI+MKcrjv2we1XWO+ED+JeCMVVuIyZFfcU7EKcE0kNleKKQOVjXaM4G08n14xxWD4ogDabNGcZHXNdO7NGUKfdJ2gZ9O9c14kdvIcKVZW5NG4LRnznrUHlahMuMfN26Gshl+fOO/5V1Pi2JV1F3UcN39650x5z0xUNWOhSuRpGWOAP1rT8OTvY6qkisVGfXFQW0abwWHbFExSKVXzjnrRTetgmtD6F8N3guLaNlkLMBjnnOe9dWq7Y1cncQM56V4n4J1xvOigSQduCcCvbbN828e85IXPOOapprc59HsS7gXGcfMOB2+tPSFZAxYqZAM4HH4ilROEYgjHPJpzEgAkAr1z1NMZAsyqChf5t3Bps+HQsAGOM5zTZxGSjnb0yBinCMjaEZgW7jnimSQXMLXNm3kSNBK64Ekf3lPsDxVxxhUbbtU44oUBDsCkKeallBljPDbVOMgcUXEROwXDFsYHPHWmzQMxHldD8zEngURoRKS5LDkA9xTxKXkKqCgHyk460DIfssbo27rjG3+8aliijYqkkahCuMLVhc4ZAcYGTnr9apPIu1mUkt2H+FINgleOGKVHICngEjOKpEySDCLgZ4PrUtoiFZUOQT85Y84NQS3yW8yxEZQ/xUmND7lnBjRgeBwV5J9q8d+JJjlvQm0AjoMV7JLKNwODgDcPQivDPiHJt1qV0B2c85/pUS2sa0t7nCXEAEh4GPWqzRYdjnjtWpMQ43DpiqcvyLsJJA/vHJrBNtnU9ERRRq0nIGa6bwtbI+rQZAIDZxWJZR5YnFdX4RjzqkaKQD1z6ChL3hTdonuOhFHtYx93jGc1fuIQJAUJzjvWdoKeZbjZnAz1NbcbsVG8DC8dK6UcTKa4VR5oPJwMCnLGHVjkkgEDHStCKJZjl1xjPNVeAZo/f0ouFjLmtDl2LESbSB7V594tDQWsVo8zTSxsSSxyef6V6bJIN6sVYjBHSvLvHYSPUnYsG8xs8t0rnxX8JnRhF+9RlW5AiG/ofbAqvOHkJbecZzg81Xa9VQAuCR2ArIi1CaTVPLfOzqDXg06EpNtH0DaS1PWfhqHnjdptrHdhVrv3j3NsxtK8kCuK+GTn7LJIoQheV4713hkMkRkCFZZFBIPevoqPwI+er/xGMeANCWib5/Qgc0zY3pj2zUiLtkDsSD3x0FIxJYnk5PXFbGJV0iK5S1jF2m2VVy2ehPtVl4yrF8HdjketSieIhAOGI6//AFqbJPsVD8pJPOeuKvUjQfA4klTCgMMFgOoHr7Uy5kCzsSSYgPuYNPt5nkkBOMdh6UXFursZABnv65+tS9wFVVKlxlt9NSVzIUyoXqADk05PLaPbNGoYfMCTRBhbaaV13kdNi0DIpGK7wj5btjiq13cqqgTNgggYPTOanikMu4ONhXofb6dqgvrdFlE2WI75oJ6DZrsWrbRt8snlicc1keLUSXTd9uQSByCDVlbbJlNwSqOeCe3pUl5aFrVow2Uxg56/WjqOLufM/ia9BndG++pI+lY0bGQZxzW98RtJez1uRhuKyHIyK56A7F7E+tazhHlTQqU3dpl2MNjniql7kjg8/WnmY44wKYSXHqfesqaUXc1nK6saXgyeZdatlDEHcBn8a+o9DzNpqSqzFguOSQvoSRXy9oaiK+hfnO4HI619H+Eb9Z4ViDYHAzjt71VWSk7mUIOO504MZjVZGIIHbvUF6lw8qmyZAAMEOMbqlljHmblfj8qltY2SN2IXA5PPIrMso28oY7bpWjkHOGHFXYSgORtPHAHHHrQVS5t2MsQ47tTxgRxiEE+oNFxCvFujJBP+FVHjQzCUqBOo8tXKElQcZHHODU4mUSgyA7M4II6VJNtVj5bApt/IUwepHGhVmIBJPO1utJsbnHA9D/8AqpsXnyoXViVA6A5zRuLzr1TAwaAGT/abcN5wUqcgEdxVNXVSCGBUjnI/zirlxK0sLKxLKpzzVWCBnhl37Iy4OzHJHHejoJ7gixxriTGW96x9dngV/szI3K5Vgvf610DyQxtFGf8AWlevTJ9qoX1kt6Ckq/d6HPSobfQtW6nOQa9/Z6y2GolUlK/uy2ACv1ry/wAUkT3czhldc8HqPzrtvibpiHSDOrEeUBtbuDXmqlP7MBMpdscgmsquiTN6O9jHdcbwBgfzqkY2Mhc8j0q9LjJGce1Qjo1ZJ2OiSJbQHnoM9O36123w405rzVHkk/1aYzt6muQtY9qZ3Y5Fep/CpS2USMvJnk9gKqDVzKrtY9RgtBAMxn5CNo4p7xhYuWJDHqR2p5dzGQRgDjK0gOMLz0rpRyCx5AOyTHGCM5qSQK0IZBlj+NV3hGwyZYMe1S2smxFYg46bT1NAypNGBG7kfMOSQfSvEPHNy0+rFQSAvYele4ajEZEcoegzivBfFLs2sXJkHQ4HfiufEStE68JG87lGzQKoD5JznJI5/KnXcCA7lCg9sdRSwuEyT6Y4pLuUGQEH65rxouXM2j2ntZnd/Di/QSi3VsnHzD1r1hpMeVgZIHbpXiHwyV5NYlZAvyoeAc/j717Za5EUTN0A6YxXuUHeCueFiNKjsTlDyWOPl4HpUJ35PzH8qt20wbzFccdmI4xVJ5QHYbh1rY52QPgiHdgMRxj2pjRu7FiDvUVKoxOCyjI7gd6lhtUiAEBJXuSc5Oeea0uZ2H+UyRJIzgN6461NHMjQncwIHUDt71CzYYA7tnbmo/JSOYn7uR6VIx8zZkC7UeMDv2qFpWbdEDtHU+ppLmEeZE642EfMPQ+tSfZ0PzAfMevpj3pgRwx+Y6hkbg9+Ks3Cr5ClgxKnkAdPbHeoIjJFtZ5A8b/dK9AKlHmkZD7ifVcgfWpGVZmcbFC7sHB/xzRLGzIxJxu4HHT/AD7VYNvJGjSM5wxwMiqz/u9ilssT1pAeSfFjSVNosw52nDfLk143JGVYgHn0r6I+JDxy2c1sq5lK5GR19q8Cu1HmHPUcHIrRPQXUo/e4JqaL359KiPDZyRTY3fzcNt69ulQ9SlozdtP3bK/fr1r2n4YIXtYg7YXAwSckGvGrVh5GWzkdOK9T+FU6G28tt3LZGDjisk7oua1PT7mU2jF/vIBzmo7XUBeQsux8E5BzwKzry4e8lWCI5I+9jnAzVt/3Mawwrhu+PWruRYuwvI58tm4U5HtV1HUHHHA44rNtYpFwr8lhg57ipl/cqAmxYwcAHsKLisAaQpICoBycE1Pbw79pcjknODxWeupQz3UkMU6PJH8pUYzmrlu3lxtu5J65p3FYuwymM7YtpXr06/SqU0kfn8kqTkmpkvFSHeF+ZeORj8MVRW4jmmZZPlLdQx5FLYe4hfY6ojBt3U4q9uCiTa6sgAGPSqMkUSoqr8rDqp6gfh0plykpiU20o8xOVz3ptoFdCajEZbeUx8SoBtPoeoIqnpOqi+jaOY7btOHAGM470PqbSgkLiWM4ljxyR7Vlatam3uYtT07p94gfxCp6lIzviBKP7NeIgbe4AFeLz2hguA4ZhGeQK9L8W6vDfJFFBKWnGPMDAZH1wK4fUlw/DEgdQea56k2pWR1Uo3VzEnHHoQOPaolXC4O0t65qeXGSMmoEXLEgqCOnFZpmr3NG1GVB6L3r2X4WWwXSGmIRQWyCfavG42KxAkYHqO9eyfD2zuLnQ7cSlYrfJK9i1aUjKsegQsrRna+STwc96fFjBLnpVFrhIdkKKWYEBVTn8TVlTsYYBBPaug5R00i7CykBAaqTTSBiUUiMDIyOKsShWX5gcH0qJ9r4GTgHbketMRRuJpTDM2WXC5GPWvDPEEhl1W4ZiT82MdK9x1jdDYOzMCdpzjqOPTvXguqSq97OexY81xYrY9DBbjFfauTyD0pkkm/pwf0xUFw4CDnBA/KoVmyhxzjg4rzoRPUkz0v4PRbr+eRcFgMBT0NexGN9u2TYGPGMnFeR/BYZa4Yg7Qc4r15x8nLFueAeD+de1SVoo8Ou7zZCGjeFXjkVoyDhlIKn8RTfKQ8+X19AKdJEWdAgRe2AMDFPMZz1H5VqYDIypiBVixHBHelEeyMoAVD85HGPeobTDIsoGFLdR0zUkvmLKVziNx696pkjpcLhWQdODmo5EJB29RxmpGmkSAIVUnp71VT95cKGlkAUENGD8h6ckdyMUAy8kBGnkuwBxknPWqcDSmNxGu70PrUlzsih3LOpUHHB4qO3uBAT5RYk8sTmkIkZmMCCQDI7KMAUsUmCQjADHQmh5SxLYyo5yeDSSQhwJEKj09c0DHEs42sxC5yeeBVaaEJKASpAyQwPIPpT5GLJgBTnqG5qGVyCVIx3x6UmBzfi/TVu7NpYGzNHzx/KvnjVY2GoTDA+8Sy+h719Km4iaa4t3kAbHCFcEHvz3rwnx7ai2124EYIB+Yj3qogzi5uOnJoiHzZA5qSYZHP4VEhAbGahvQtLU1rI/uyGOcnI7YFdV4X8RHS5RBCu534A561x9meQMgg9/SrtojfbozHwxIAz71nBpuzNJrTQ950Kd44RjBvHGSR2rpdOiCKdzrIzHOW9faud0RYrXTInicT3TYTIOeTXRKERVJ4OPm46mqMy5ImwIpfzJOuF4Ciue8S6rHY2Mss+I40bBZuK1biZEw3mBQBgknFeVfFnUGvzDZwP8rndnGciqjvqKz6HO+GPFix+JpW2ENNK53euTwK99iuENsJWwW2jH5V8raLpM1vrlpv3FmmXCr1619PRBFgiVwRgAfNzV1nDmvF6GVGNRJqa1JJ2UushZh5ak/eOOfUZwfrXmHiPxNfxXN0unqql2zvJ6j2rp9S8T27QalC0gWaBwjLnHHYivOJplupGd2GD61yVa3I0d1Chzp3GW/jfVrV1gnOxGbLuOWYfX869G8J+JE1i7nP3IlUKgOck+teV3lujguV3Dp0yAfrWv4JuTa3pKMqsBgey9/aq9vGaukJ4dwe567e2hkQXFqwW5TPJ/iHofasKy1eNLs2xKIrsVMX/ADzf0HsetbsG826vE5UEhhnksK4Tx1oczakl3p2RO6k5Xjleat90Yrszk/iHBHBrbSW7BJm5bC4GOlc/NMWiXnLY5NSz6lLqV1I10zPKp28j0qpPjcSMdOa5a03ex2Uoe7cqSNuf0+lGAZBtB46mopZhHJlvujmiCdrhywG1fbrUK9rlPexqRZCoNpOecjoK9i8K6g5020s7ImWfA3MR8sYxXjaMylCE3OWCg9ete+eDbSPTtHieba00ig7AMk+wFdFNWVzCq9To7C18iJmAJJGXc8MfXkdKtui7VkDcHnmm2E5Y7ZYhEW6KT/OpHxhlOdo9xzWyVjnepG6EhWG0gVG4hhVjjaznJPqatMUaBBCCXPcnFY2vSJCtuZWGC+M5xTEUPFbi30a5lLhfkJyee1fO7T+bcM2f4ucdDXr3xQ1JY9GaKJj+8GK8bt4MK7KD1zjP+Nc1drldzvwqaLbAswGenANJEoEbcDHfFR7soeueRnjikSVjtTrk46c158U3sei2j2n4M25ispJMAgtjOK9NaVRGnmncSe/Ari/hvbpBpNuqrglMnsc11N2qv8u77p5z1A9q9emrRR4lWV5Nlh2WVmKbuBgkelQmSQEjHSpo5I4Ywo3eWeSx4GfSmGVSScp+JrQyMjwtfJeaHFICMMQSue9bcwXyMRNh26cZxXlHwt1N5N0BkG3+56e+a9LQCQHOMg4zShK6HOPK7DULBczAkA4ycZ+tOiK5dsYz3pSR5LIfnGPx96rrvMuG+ZGXp0IqmyLDysMyYkTdGe2Pen3eB5aQw8EfepgAiXfE25emOP51YjklVdwH3u+OBRcLCLHkOCFyVwKrys0abQCSeuDTprgl2TkuOc4/zioHJlYbsKUPekIerK0gXnI6EHrSuxSZ3lZTH2JHI+tNMCyYHmsrnneuMr+fFRTujlkLhgTxSGZ1/aQ3RLKQrnOGUdP8a8U8cW80epus77nPXPp/T6V61eXv9mXe1lJtj0ftn09q86+KKi4uYLiE/IysAaCkjzSUZYgqTx94dKp7cyZ/rV2fgkA/lVTOGJJxWPP2NeUv2jBX9vpWjC5Rw3QgjB96xorpC6qowRxWi06LGGkJxjrWPM0zblTR7V4GvVuLKE5YQW8eEViTtHrW/LqkbDe7nywcBR1Y/SvG/CviK7MLWFim4uRmRhwoHtXc6dq1vYnDgXN4nzs0h+U+wx3roTsjBpNnVmKW5HnTqY4UGViB5Pua8s8WXTTeLZHRAoRNo3cAD2rsLvxyDHthgHmkHIznaD2zXCXtpHLdz3Ul20jyjLLjGwZ6VM5PlZdJLmVy34URpfE1tu2yug3KMcD3r2O+ufKt1aVRsU4Yg9K8i8Fy2NjqTXj3KlUyPL3YZV7n3NeptdWepadIbeUSwyIRvB9qVPRahU96Wh454n1K1fU52tJlbzyCy91A7GsoXRYEfMdo7Dj8+9c/JB5Orz7mw24gN2IB71fuWFqhZjuJ+Y+9cmKfvWiehh4WjqaBu5X2xxyExFslM960NDZby6mClVt4gQ0mOSa4WTVgwmMfyOCAM5/Oux8LwMIYoXVlyNwQ88/3mHp7UuRwjdhKSlKyPT/CmvtFp6RXjvLEDhZgv3fQEelXvGMqQaIt3Awk8twVKnIwetZ/heyhvreSOQIrYwGjXkeua47x7p2uaFaXgtrvztNEwDRdDyMjA9K60+aNjg5bSucPqMUrNPdW5aNyxOB3yahtJZJIgJiC9EOpiRVgeCRZOrMBTnT5ztA55rkqSe0jtpwW6GBC7sSBj35qSJR521VxREGH0z3qS3UmUt1PbFSpaD5dbmrpkTSXsUf95wAMY/Wvobw9p8VvaxTxMbh3XiYnt3A9K8H8Mgya1bKiCWQNkKeMmvftPgmCwyX8iFioAiRsKnsPU12UlocVbc0J4Y5HVlbD5yfU0o5VlHfpgUqlctsA3EcYNMXe+1SArA10HM0SGP8AdYR8H+7XnfxT11tMgtXcfdfoO9ei3YWKNXkcbVGMLXgXxf1MajfmGM/JFnr9KE1dXKUW9jmfGHjE61JEFQ+Wn45rOju1eEdST29aw4rMmQkEE1o2xKFRKgIX0HWscRGD0idmHlJLUsiYsu3cOvardiVa/hU9cg4/Gq7i3KBlDAntVTQrae68QQxQ8EuAT6DNZ0KCm2a16vIrn0r4N3xadEu4sCvzbunP8q3VmBkaMoUJbn3qpo9l9nsYY+jBRkir9zF+6Qhh17CuxHmN3JlddjJFjcOT1wB9fWoMHuoz7Hin7FUfKSp6kDjdUBlGTluaYHgfw81BrfWI15+fjnmvco5JCyyRsTCwzgHqa+XLLUHsbqGZCfkO7I7EGvddE8T295pUTpOowPm3dQawpS0udFeF2dzNG627SrgDGBis2EzruYncc9D/AJ/SmWt9HdWgdZwy9Dg8D60scyTRArKjqeQynjH1rS5ztF5pk8va+7kVKt6YoxtXOB+NVHfMYU4yBnOO31qlfXLw7djAL6k0+gral6S4wd/ygdCT3qvdX8KKTK+FHoOB7Vxmp+IFtxKFmDTgnapG7HbIHeuYm16dLgbZG3Z5JwT/AIVnKokawouR6RLrSxzIqDIYHCs1RnU08zLbeeeDzmvKTeSy/O8zkgk8N0qITP1SVs+ueaweJSOhYRtHq+o3sYt2+2QrLaOuGK/wfjXlHjWGS1kCx3BuLJxmLJyQPQ1di1a9P7sztOu3bsk5U1ieJNRWQCOQYI4DDv8AWqjWUnoTOg4LU5iZiW4445qo/wArc96szkFztII9qgdRuBPOetZSlYqMbofHEoYEKM561Ncr5sAVivHoTmox8q7s5PpUqjdFu5J96x52maqGh0ngt/KWVI1OMdMkfjxVu61GOGTYiRPJyrMDgn0yK4GPUbuW7W2sCwcnBb1rptJsDG5N4nnSdcBsVvJtRuzKMU5WRqx3CTKRsYgDDNu4rndb1Vo4zHCvz4IJGSSK2dQnAiYIFjX7vy81xWoEi+BJ/dnuamlWuzWVCyuT6VZ3MhMszuAeig9Peus8O6/eaG0sSuWgk6gnoemaydJdHGwhSOpDdKs30YZdyc/Soni5OWpdPCxjGyKEc5ubpw/zHJYnv1plza+a5EkrbfTNZ9xujkJIJJbmrsLBsHGCR61lNtPmTOinZqzK9pp6Q3Kv/ETkZ5FegaQv+h4hyFHM1w2Dn2FcjZIrSoHzt9j972r1bw9pdvp8drdayNrkAw2oOSD247n27VtG9SzbOeq+RtI6rwpF9hsBcOrKrgDHGAOAK5H4wyuky24Y+XchXf3K8V6LbRlrVxOFV5VxsUcJ/wDXrxj4hXk1/r6wv92GMRlSecjqfzrSfuQMKS5pXOSmh6S/dOOBSqARw/JGc1M4CKuM4HTNRuNwXLHPUen0rgcrnoqNh1vEeTgnjoeKktY2MjbfmHt0qo738bkQIGToWPpWvpsSvEAWHmEdR61e2pB0vgS2Ya7HcrLFC0Y4aX5gM+g7n2r27So0iRp5hNJOSB5ky4OPZR0FcH8JNLDJdXco3TI4VG28KPX616VGiN5hVR65PrXoUlpc82s/eElQKOArA981E0hVPnYKScGnMqhyEJz97aMdfWs7XbkR6ezj5mTkgitk2zDqM8Q3Y0/TriVnJQDuc8mvnfXZjPcyzc/O5Nd74z8RtqNqtlCyhU5bH5151qDKWVRjgdjXLVqe9Y7aFPS5meXjJJxmnICoLY6U+U4AAGRTF3M23tWabZs0kyaNCyD5cntXsHwk8HokX2q4jUzTHcSy52gdK4Twfoz6rqsUeD5S/MxavofSCtokUNmqlQuD6Zrqo3scuIlfQtT2ypuBHyqvQfxcUwhlhRUUM2cE/wBassD54MjbRxuIOM069KoAUYDHUA5OK6LnKVZodsQZ8B/UiqjKAxGe/pSbIzM8xJErgAsT1A6CmeSW580889DTFc+RZnBXO3PatDRtXNo5t3f93/dJ4H4VmIrsuR3rA1ZJY5zsY568GuLCvmdnsehXVlc9R03xPKGktF2zB2DfvGYKfYheorpbbxjqWAsk9tGqjCiKHAB9OTXinh6SeK4zIcnPfmvQEaR7YeRs3EZJPI5ratPkfunNRgpr3tDsZvH13EiqSZLYDLgjbjnqD9KydV8ZNfQiOASiaQ/MvUDHTB7VylzOwXe0rLzgrtIBPTiqGnXKJcmFgkcfLbmU7efWiM+eNxyp8j3Oi8+d0bznUbmycdvx70QQzyTMIomcD05GK2dE0aa/SFlCSKSOeCp/HPFej6F4Yt7WGJpl8uReflIII9DislBy3NHWUFaJ5mmiXZK74z83JUZGPxq6fDFxCEdS8qsNwOcFT3BzXrwgjMIVFG0c8iotiOCFUHjnFaqkkjB1pN7nld9oG7D2bNESBgN7dRn8K5bUYS9rIsygsrYIIwa95ewiaAqUUoW+ZCvf2rgfGvhSWGCW7sG8xAMsjj51Hse9ZOjbVI0VZvRs8da1WJ2255PSkkXAHtV67CMwZWB461WmGVyoOK5aj11OmnHQZs3RcckVIgPlEAnj3qB7yK2RfNzuPGAKmtnSVXaP7pPeueXNvY3ilsJo8Qj1WB3UAGQAjPXmu98T6K9vALxV8yHq4UD5RXnjSR28omdtmCOc4NejWviBNe0gCVJ0soEAZIx88x9/7q+td1Je0Wpy1XyM4W51FQGDgiIcB8cGsHU2Vpi0ZLKDz7Vr63cIl1KIoo4EPSPduHHYGsSaRZSdnDZ4GOfzqYwUZbGjk3Hc1LRpIDG0isFkXKkjAYe1aSzHyyM/K1cnFqF010LaVy0Sj5M/wmtvT7hZsQljuHTHOK58RS5XdHRh6nPHUZqEiQDzHxsPep9LeK4gSSN84bBH1qxqVjE9mZLggqoI2jjJqLQLZUtVVQVYtnGCPlqJSXstdzVR/eaGpZReXdQsY5iwPHlf0Pb616z4T0lVtxd3is2ozLiNDyYV7t6j+teeaPYyXF9ClqzGVm+UKOWI5x7fU16zohibbZWTN5WM3V4Pm3t/dB7n9K6MM7q5x4pWkUbnR9fs7WW407X8pEC+y4iDDjrzXjGo3OrzX095I9tLK53FsYz9K98+IGqQ6Z4VuFGyNpl8lFY4wD1rwZL6K5keNY5FCjKylcBhV4ibWlrk4aHNrexXs57qZ2+07d3VSh4PrVnGVGBhiep60icAbgMrxkdqmJAkTJBXt9a8+Uk3oego2QJ9xQANo78/rWlp5WKJSY42yeM/KPw9apQSQz4ELHIODnjB9q6TwvYf2lrVpaCFSoYMzNyCo61tSV3axjUfKrnrPgoXttY24mtUt7bG4ux+Zs+g7D610wnQo7KzYJNMt4VeIrEdqhQv0psQEcTggfKdpLHjr616sVZWPHk7u5JMmxVfA4A57Gud8W3aWmj3MgIDlTtz0zW5eztFAu9OC20L715L8QNZ+23zWkLsIoOD83U96mpPkjculT55HnJuLmx1DEp81ZM856ZqKVwZGbpnmrl+6vKoOCQPXpVJgMmuGc+d3PQhDkVkVJrhUO1AS56cVcsomEJdx1xxTDEGkUcD/Cui8L6Y+p6rDaqpZcgt6ADua1hrZIiTtds9B+Fvhy4+xi7usRpIeADivUrKBIX2wkAJ1IPf0qhpiQ2tpFDECI1AA5qeSeRM+WCY2bd6c13RVjzpSuy9d3DgMsqKTjp/jTImE1sHZQGYYPHNVrdnaYvNukUnoO1TzfNc7xlBjGOtWQmVLmL5jD94r144FRHgkbD+dTvHI6GQZEi8nHHX2qIwMTktzVCPka5vk8kR26jpWU0YLlnHzHue1WHicEbVxjjjjFR4B5JxjqDXnK60PScr6iW8YWTcP0rctJZCAhYhPX0rMgIKj+tXIX2tjsRzUc0k7hypon1GCd3Kxb5F6rjn9K1fCekR6nKF0wRy6kF/f2N2/wC7uB6xyLyp9mFRWF+ul39tdyJujVsFTx+VexW+meHPEdvFdLYwif7wuISYpgf99SDXfSqJx0OCrCXNqzN8K2mm6TflbaPVtCu3wJbS+xJBL7KwyM+hBrvw4RQAuR2qhpdpPZ2j21xcvcQK37ppvmk2+jHuR61eQAop4JFWQI8jg7YflJH5VznjXWbrQ9M+0W6TYUZkaKIOwHqMkAfjXTkZbOzqKoa3pcWsWTwXBGzHRyQB9duD+tNWT1E720PBU+LHiFZiBciVGY7RLCox9ccV0ll8RNSlhdbqK0dCQnRlJJ9OSPwrlPHPgfVdFvHuorB5YGz++tiXiVfQ5+YH68Vn6ak8en2qXEEzJI4kCfxStjgKccj6Zq8RGPKpU0Z4aUuZxqstahCGlLLt2EkgDsM9KosMjaM/jW1eGMqRtkieE7JV68+mB0PtWUYzt3kswY5UkYNeRXi1qz2qDTdkVo0VgSwBP06U+FQCUVQB9KfDt2nGCPSkZispAIHHSvPk3c7IwMu/sVku97s5BwNvavVtB1m207wSghSNo2iIZVIDqfcHqK8svmMI3MkknYBRyfqaebmV42aZ4reMDGeGf6V3Uarsm9jlrUlfTcp6puljd3XajvuU44B9vQVWtIzJZkCIYX5mMZ+eMnv7jitJFDI72xLuBkxynh/fJqzFpTRRmX7OsRYbmQg8enfFXUxCjF9zOlh5SkuxjG0Dx/MxJz96nW1jLbSl1l257+laDoqZ6KPbvVKYl3ZAwAztGTiuaFaU3oztdOMEWjIyQeWXeZmPQ9q6Oyhkjt7clSOnG3IHvzznFQv4VutN0mHUrlEuY3IxNbsWCZ6AggVr6dBJcWbM8LMDyqoSrnHBO7344rHGxdOKHhZqbdi3a2sMkxS4kkETDH7n77cjIBz6V6r4dSSa3Z4US0UKscMYXcsS46Y7nnk15qg8uSKRz5YI2kk8n2xgfSvUvDt1BFp0aKwCBfM9Dz1q8uqcy5exlj6dtUeefFKK6S/gtv8AQHdFLhkiYMcnvljXnUw1ETjM9uq9WVI+cDqDmuk8bN/aGt3c0mpXm0sVBkmA2gdBwOlZAVSsa7xIqDbkDLDj1orV1zN7r0Lo0moroOt0XzFKn5cbiQOtPtYyWY4Y5Pp2+lLHE4QLkh5M/KeMCpXjBjMJ2EjhgMY+hP8Ak1xqep1OOg63jCTMWUgg5Pt7V6p8J9L8uG6vZ1Z2kOyNnGDjqcfpXl9tbGaQRxx7JXHCFsY9xnqK990eKG10WztIUMaxxglj3OOSf1r1cJHqeZi5WVjTlaaK337cAnjtUlrzZBnYktzhhURkjeGNA+GJy5NUb+9Nu1yWZI/KgMinJPA7+n4da77qx51rnPfEPXZLa1jSCQGbzMHB5FeS3UpIZ3J3nOT71a1PVH1aRrl2yWySc45ye1YtwzGTKsdvQ7uc15terzSsepQp8kSNyHO45HaoHBweyjvipyxZOFOc8Y5pj/O2COvTjk/SsoO7NJIktI0VTJksc8Z71678J9HVY5NTnXy1bKKCO1ebaVp8l/fW9nEMliA3qo969+0u3jtLGG2UfKgABxxXfh43944cTKy5TSKpGoxtIHanxxrIMjco6Ht+VRqz5VgsZRQc8ndnPYdMdaVpHZlyAF7V2o4bjlV1bCjAAPyk5NWmXeMEkOeck9KrGN9qEHPXvVZ5kS6WKR185lLIp67R1x+YpoL2Lb7lZhI2FI/E1W8uTsqke5qWdgIFKyqSRjpzVTGeTjJ9zTJZ4L8Q/CP9lSNdW64hdjkY4FeeTQE54IPtX1X4g06G9097e4i89ZGC7ey+5z2FeH+MvBl3o07ywoXtCeNv8IqJ001dbm0KjTszzxBIkvByP1q/E4xjvmmzwcbgOfqaai555B61yTVzog7FmaFrlIlJ4U9M4rsfCerSaLMjRlhCSN6iuRtXyMN61pxnkYz9ayVRx0NXBS1PdtC1ODU33CcOMbgmcGtkoDJmEEKPXqK8G0PVZdKvEuoedowVHcfSvX9I8Q22oaStxH8xA+dR1B78V2U6qkcdSlyG9u3bGbCjoakYKUYA5fqCelUkf7REqlSyMOCPerMMQij2KclRwTWpiM+aIAFiWPWorpI5VIuFRozxk8kZ/lVgxthmyN3Y/wCNRsozh+TQM8+8daDptpo0Y0qCG3WJuUjXG7Pf6+9eZzwuC6HgYwcH9PrXuOvWv2gTp5TSM8BKIBksy846jsTXjOpxtb3TiYosq5U7yeMfhzXJiFc7cNIxY1IcgnnoRnio50KzBj8ijqfT9KtFHLluAWA/zz3qK5tUkQ4LEn3ya8iTSlqevG7WhUlaOSJnjXzMHgkkc+uKyRbW8aSvJ5bSuQAGOMHP510KxqYQsan5OCp69KpJYotyHLPGhHKrxu+pxmnSrKN1cVWjzLY09D0RVnS5dyCvRV6Z9AeuKvXS+ZI2whQCThfr2z1pdNmja2CIcIp2qMdT681YuDGLdirYVR82RnPvj/GuLEVZTqHRQpKEDl787SVKFjgKdpwT+FTaDYRNfI9wQkQ+8PLDcewI4P4VPHarf3KgBwj8o6sGU88g+xreNrDAfsi/KGUMFPIB74712UHyrzOeunJ26GhL4utZFi0kjdZxPlpsGPhegqk1zDbvIU82ZCy+SnSTn15xx71SvraAwhnVUUt1AzUDTvHcpcPHtYDaGJyD6EU69VVoeaIo0nSl6nRzEmPaT84A+83J9+Kmt9Z/0me3jfAtrNi3Jxknj3rn2vwIiWAPYDHDH3pUhTTPD19qF3MwuLuRYUVQeFByTn07VyYWXI3Y6cRDmsn3Mqawjub6Xz7S0mjbLb/L+fPcY6H61Ygt98Tor+XhcKwzlfT6VJpr+cu52A2kEgn/AD1q+Y/MQ4WQKOiqR8/br6VlVxDbs3sawopalTToJbZF89vOMYx5kmMsf8aVNwm2d+V27h07buauzQ7lHyOGxj5cD/P1qFoJSpkLPvxjlwWb/wDV9KVOpzyuxThZWRv+CbOBru5u3jJit13ghs89B07k5wD717HYpJ9ljEnDhQD3/CvJvAodZGlmeJLGCXdM2cb3xwuO59hzXrVnOl/MjQEm1iG4ydA746D2HXP4V9Hh1aJ4GJ1mJMwhhD4UPJIEx7VwHxD1oxvJp9ociQL52GzgeldR4g1OLTbaKdmBwHkjH949B+HNeOaleyz3M9xI253JLnpn6VGKrqK5UaYWg5e8zHs7hEu7q2bPmqS0YbuKcVL4UH5e+Mj9abNEPOaaPDPgZIO3ipEQlyoyWP8AKvNlUUndHoxhyqwRqJOchVX171JBGVkaV1IRfXqakmtgkSqBiVufbFXtD02TWdRhsBI6wA/vTjBUVtSXMZVPd1Z2vw10+G2LX96yG6nOIkX5nC/QdK9KiUgb5VPljpg8n2rHsLOw0e3SC0jCQAKoCLlz7nHP1rX+0xnbEu0N3HWvXg4xSVzx6l5u5OpR4sR/Kp9e9W5JozaqjEgqMHNUMCXCkke44qSJcFd4GRhTz0Hr9a2i76mL00LQnQAhegXIx3qKBvPZtw56njBpIAQ77QCM7s0hldZsZPvx0/GrQrk94kEMSiNvmPJOelZXmt2BFWrgSDLHasXrVTfnkBT/AMBo2ERXAlaVDGNwO7dz09Kiv7OK+tDb3YBJHIx0rVtEGwmThl6AUjpGcucBs42mmwR8/wDjzwjPod15qRhrWU/Iw/ka4yaBuCO3JFfTGuaZDqltJb3GShHygHpXhXijRpND1FoZVbyj91j0NY1I3VzenNbHMqdiBtwA96v20+5PvexqleQqzc8p1OKkhRUwUzXFUjodcJGnC5JCn7hHWtLTNRn02682GRlXvg8H/wCtWIGLD5cce9WhPHFaO03QAkY7nHSsFNxehu4qSPXPAniA61plwodIrmJyVQHqPT6V2VvcJcQRuqjzCCcDnB6V83+FtSns/LuIcpPu3D1//VXq3hvxSbmR1Hlxtw7pnqTwcfzrvjWV+VnBOi0uZHeCTzFYbSGHUEUxiRIpVeO/NRxXAdeSNxGSSaNmyRdxyT0re5gZniWaSXTHW1Z4LqOUbZk+ZoX/AIW29x6j0zXjHiHUpbqdzNE1rc5+dB0Zu7DjkV7B4qtbmezlksr1bSfyyrM67o2Xr8468dQRgivFtWs9UunO2e0aW0IlZ9xBaJv4xzyKwrpct2zpw7fNYo7JGQZCtj0OQDVqFGYIuxsEHnsD6evNbkOmTRxqJ4A69RJG+4f41LHZIGykEpfHGST+Br5iviLu1j6OlSsjmUtXSQlSAvTYBkH1PtVPxAzQWheKIqeip1Lk+gruvsEjMCkKoP8Aaxx/WqeoWEVvbyOF8y6YFd5PT6VnTm3JSaNeWysjjdHZ2s4pT8jvw0b8cjvTLy8d78W6mVQ3JdCME+hqO1hMM7SZPlyMQqDOFx+pNM1Hel3FIFyu4Env+VaSnH2jsJRly2Zq6XbPYyyCJ2QSZ2sOise2Kvy3Dw3kbSfPNGMhyvX19qLORVUb8gEgjNT3FkLsh9zDHQEVFOu29RSoLoIoF5Gpk+Zu3PrWPr9pL9lKRyskRYMQPQdhW7BbrEGT5ihPGRjBHp61X1KF5baZFJJYg4I6fSlKpKErlKmmrMisZI4Y4RK33mAT5c8msLxFdyanemxjfHljamfu4OSwz61r3EdzDAqhGjGPmb2qlPbr5AkIEYjk8xiADjPTPtU0ayptt9QnSctjQ0PTL21tYzKVuUxw6A5A9x61v28MbEHDDk8Dv+Haq+galBIXjgYuqAFiowu70B7iumiZPvHazHjO3FYVZczbbsy1otDN8mEqoCPuGOcdaWXTJLu3lEaRxIASZpRwK2kZE5JAPeszxBey3FsbGz3bp1IaSIZ8sfj3NTRhaa1JnJ20Q7wTo9rcy2enRW9vqt/ExuLmWd3jSNTyqYAOSRz0+teqatL9itiWVYycRBVbCpkduOg+lcT8O7yDSEkO2KKaY+YIs5Y9iS3c8fhTvH+trPsigfzJCCXAOcHsB719Sq6hS5z590HUq8pz3i/VhqN8yxM32eL5I9x7Dvj8K4u7hu0uFns3Ri2A8Uo+VhnqKt217HfSSoH2TL/rI5AAwPrilfbnao3YAAB5+mK8eriJc7uetClHlVtiJ/Mld22kbwBnOcYqO5tHmiw8hjBH3h8px2NXEjbeI3VSxJLEDpio5JBIoRMxCPqWYZpUW21YdRJLUzreze3KsZJp3BwCzZH4V6n4fsJ9NsYv3TG6nYM7EY2jsCazPh14fOo3rajdQq1tb/cLt95x+leiWUc10ZTJFs2njA4Ir2qcXo3uzx60lrFFTShcNDJ9vWPztxA2fMPY1qw2+5Q3KsOuBziprPSypZ1YxrnJBXrV+CAh1JKqB1NdKpK9zjc3awlvGIyC2SAMAVZikg5kflqeV8wDachu/rVOVC7MPKI2HA9zXUjIuPJF5iNEVCBTwBTJpkII6cdh1NUfKZxh/lwc4FPZ9yrGVw2fTtVom5DdRSYChznqV7ULNCAASMirChXdt4xt6VTYoGOIyeeuBTET25J68seM+1JKNpByC3Xmltn35wu7B4xUMnmRyO8rAjsMdKdguNYYJLHkngDsKxPEGkWur2hhvUySMh8YwfWt9CCG3cDsc96qzWxkkBJwPc0g9D528TaYNHvXhknicE/KQeo96yWxEclgFr6E1fwxYahaTRTW6fOMBtoyD7V4z4i8N3Gg3HlXUQa3Yny2Xofr71hVppq6OmlUfUxTd2yyBElDOegBzUtw5DRqUymc8A9ahitoY5S0cYyP4sVZUf3j35zXl1UovQ9Cm3Jaklq2flWNgVJLE+ntV7S7pCEuMMUycBe1USS8EyHftZcZ9KtWAEFvFEg3KAMAEc/1rm9rym/Jc9K8MeIDMos9Rk2sw2I5x0NdnYzMYtsjZZSUYe44z+PWvnxZll1wrbuwW2GCTkZkI7fQfzr0Xwp4o+zCGG8H7nAUnndkcZ5rto4pRspnJVw3NeUD0JwoO3Hvk15t470CxmV5VRLWYk7J4js2MfXtg967mC8+2Ts0UqSQdsdao+IYEeH5kVkIIIcZXp3rbFP93zRexjhdKlpI820XWJbGRdO1Q7ZkB/ebSFYevpW7FPCqKIiuwDjBrm/EHh8eSGhinvbdeRbGYkp6gAnke3asJ0VLpVU3lksY/dWTczTP2AXkKv1NfN1LSd4s+gg7L3jurzUoYQDLIiMzYAJ+8a5DxJdi7aSzvYpYkcgwyJKUDH0yOn0qO50vydCc31zG11H+/Z9xby3zkAenpV60Nvd2xbaJNyguZB6jPT0rndXl1Wp0KN9DBGiIpijSe7k29f324ZPXn0/GtmKwht8tK2SvJBAPHpzU6RpErLCqIg7KMVDctgHB+Ueo4rOVd9XdlqmlsNluUcjZGFwcAA5qGXVY7ViJZUUDODuzWZeztaW88hJOFJHrXl+qX8TZUFJbpslm+8Iwff1rtwODnipPWyObGYqOFjdnq7eKLaOUIwui5HGUOD+Pr3rUtdQtLv5re9ieRsBY94yx9MV4jHrGoNYGM3BZOMF/vD6U7TtRCti4cxnjbIg7j+9/jXpVMllyt31+88ynnUJSUbfoe+x3CyKyOqMuMe/4/rWbPpNvcSlppZXhP/LuW2pj3xyaNMBntY2mIbegyT34rQEYUoACFj+77V8w60oaXPf5EyK3tjZgLAf3SZKp0wMVFBcanDpIngczTbvMdDydmc4GO+PWrkzFLWb5C3yNj34qHTllhmgtYpXjJtCxIGcOCAcnuRmslN2bG97DHvL+e4jD3sVvZXabre5C5XeOqN6GpdItIpppRb3N3YZIMqO+9Zmz98BhyPp+VVG0TUC22S4sbq1lbdJHNGyq5/vbQcBvcYq3IG02wUXd/LdA5EcUuCgJ6YzkkgdDmuqlUg7KLOepe2qLmpRxyzLLcXEksq/elkcKUA6Y24AHtiqN3OZJzgM2cbVHoT9eadNdLCPKygeeTAI+8x/u/his9ElNxfxXLebAzK6NuyR6qPbPP41rOtfS5EKdugk+n2l1dRTsqmWM7g/ViPQ/4VdRWyuATu+4AuOO5NOQMHRJi4Yg7EP6Z6etOvbKOazkFzKUUkgsJynt2zxmso1HJpNlNKOwyaJ4cxtH8zKpbcOD+dWvDenSazq8VtvVYAQZJBxtX0yO/wBazrS3kjCWdqbmfJ+/I+/HH+16V2mm20unwYtmIYj5wOpPvXq0JQpWcjhq801aJ6PYW9vaotpapGkEa7VAHb8KtxsbWZXQn5TuGelcCusXtsRlFOPvhTyfertn4iudgW7C7hnJx1HtXtUsZSnszyKmFqR6HdC/afIfac9B0FTNsMPbPselctDq1pOqhSu71xnFbFneWkLIHuURJBtG49SewFdanF6pnM4SWjRpJIUcKEYDHDVHdyTJCJkjZy3Q/wBaha5lKEh1ZRwuKIZpmgaNjt2859a0TIaJWkDDpz1GDyKlhCSBtzZdR0xVVXKRg7eX6cdan+Y2+8YXuSe3tVokZeAqPlHzDtjrUan5RkAHHTFRjUIJrhlE2+QDbx2qQq+eDHimS9diEu8Up8jYG4yCSB+FV5ys8wYj5h2NTW0nmyIyHAIPWo7khZzKy455A6GrQnqKqsoJ4+gpGnwQvBPvSXDttCwpye1VlVvPXedz45OMZP0osF7EkzluCD06jtWdqOlW+q2csN3GssZG0hutXrp/Ljbdjk/TFV4JUkXcfu/1pWDmPGfE/hi60bdLFG8tiCQNvJX61gxsqgAKNg5OOTXpet+NLe11f7BPBuRm2lSuciq+t+DYbhPtujKyFvnMIOQT7Vz4nDNq9jpw2KV7XPP0GcGPoMZNTI/lvt8tt3XGc5zTZUubWdleMpOoIVZSf/11DpqukJW4madnILZGBn0AFeFXoSjds9mlVT0NFFXccBkBXkscMTj09as2yyF8j74XcEJ3YPfJPrx+tV48BRtw0Q+XJycj6/0q+se+MeUyvjIKSDp6gegrzZTcTsjFMl0HXHJM8EjIqkorg5DdsgeldpFqqalaIsj+VO3ytzlQSD/gK4RbMW9ssMUeEUFRlfujORjHHtUU169jtlDMjRneDn7v4fj+ldNLG8r5ej6GU8Lze91Ommm2SNvwCpIPcfnVS42yIScAk5JI4FZFz4kS6dI7hEWTORMD9/jpjse+anjnJYnJPcZPJrzcXFQfNHZnXQbas90Zvkxz61qsZwYTDHEwAz8xzx9ah0GIpYW7ZyoTyX3H5gQSOa0orNIh5cSE5YuSSSXb1J9aui3VYSoVFJ5YDp/+vNc0q1lZeRvGFndlGaPO3HYmqrR8kk7iBgg9q19vJBBz6mqc0YKuUU9MZrNTTNEcp4hR1sJlADAgr+deb2ehxS6tNbS5SILuUo2NpNev3sSyKFZQyEYZTxkVw0+hmK8uJEmeNH4Eatxj06V7mV4xUYyje1zzswwf1jl0vY5JtElwWXcUJIBK5yAM1tal4cgtNL0aZZEka6+Z3c4YHOccdhXQR2qJ5cQ/1ag4HY8YNPt9M+0XMUUgc20TjaANwx3A9K75ZtJ6t6HCsohHZHYeGIimlQqSSANoJ9O1bKQhpEPzcDFNtosQqFGUQYAC4xWikahFKvuI5K8ivjasnOTZ9ClZWIFgAYBuwqtd28kc9pPGu4xMVcA9UYYP5da0jEzcgkED15J9PpSSKJF3PjKZGAelZRuncb1KUs2wHB57c9azb27je0hPlg7mLKR6d6brZnhja3gJ8x/lWQ/wA1zUGmX1+fskV7s8lwgdx0x0/WuzDUFa7diJeh0S2kd0FwhchllBBwFIatOVEijM8hDhVZi4AIAHJOOpxTtKs5olWC6X98B8xJ+Vj3rYSxfBPlqenQYLDvmou+az2JlboYC6hYQxWkslwiw3SrsaQ/M4PIOMcY96W9uo42IUStKSdreWGXj3Ocdc8DmrN3oqC1Ft5Ki2TcfKK7upPv65NZmhw2f2p4jdSIIFMQjtYmkkJ6gKADt969bBYaNV6HDiKrhFtm5p+nvYwPdkRyO2FLg55Poa0ZdTisjH9smwM4OMGuo0rSre9SGV7NYLONQYoSoUucfeYfw/Tr3qzcaHaup2RQhuf4ATXuyy+M1oeQsa09TnFvLfyi80jRh+h25p2IJ4mdJoi5GMZHH4GtWXwyXQsq5fGSV7Vnz6TNCArRh8c/MvWuKeXzjsdMMXCQ0WvlqMAqeuVOc8VGGuABIhVi38LjpVO508yKS0U8XPHlORjFacTI6R53Lt6gnnNc/NWo9ze1Oou5BNqF9bIfLVmjB5RTgj6VpaZ4wXeFds54wTytRfIWzt+U8n1qjHpVqs0syRgM/LcYzXRSzKcdJGM8HCWx21rrMFxhFYEg5JODVqa4Etv5cTgqx5we1cEtjgDyHZT9T+VCSX9vkq5YDqp7V3U81g/iOOeXy+yddZ2MEEzvg73OTU7SSZP3fzrlG8Q3EDI0sTYzg5Oas/8JNa90cnv0r0I4ylPXmOSWFnHdGr4Y1CO7s45EOSQD171o3cjSZAVWz2ry/4Z6ttJtpGJGcg57elerFowFUL8x4+ldFOfMjCpDldhkW8MGyNqrjk85+lNlVgPN4JB64pGjKsSXB7YoEgjwJDx6VqZkbvHOf3nJ9KiMag7EwoPQVJIpEvmZBHpUI3Bix+ooAy73QtOnuhcXNsplUdcVeigZUwu0egxjHpVmKXzsrj5uoqLymBZiW49Tx+VJ67iSS2MLXNJt762dL6EO5wEnX/AFiH+o9q8z1fQZtK3SoS8G8jzVG0c9iOSePpXsjg7GCjOe9ZUzxRxyf2jKlvJjbmQDZKn48HHpnIrnrUo1FZnTRrSgzyq2k8wIjMwjI27lJ49j7VDZ6i93BG1lAZQ8wjDXA+VY84LcHJ/GpPEtpa6NeiSS8spLORiIzBOrkZ55Ucir2kx2L2SC3fIHB2sNuK+exmGVJttHu4at7VKzLUauGP7xixGAqgcj2NVNY0mTVoRah8NN96Tb9xe5rctlXYfLUDuxPA+tWYXCxl1Gd46/8A1vSvJpxfNzdj0HKyseYXmgR2F3CrKZrUOUJkf5s56/hWjZRy21w0Ic4Tpz296v65FeSXjLFHaCPIEbncz4PXii3tZwH+0yQu0r5O1CAB24pYitzLVl06aXQ1rCPJ5DbjySTxV54icZABPQ+lQ2hEcJBwMDGMdPSrkAJjVScd+mPzrzZO70NtirNbbgRwzjB4qKSESQZ27cDHXmtgxrjacZxk4qrLEUZX/hIwQegoC5zFxEEfae/Aya5/ULfEydGO70rt7+0By+Dhscg8celc3cwKZpN3zAc4ataNWzKaujEEGJYxtZgwwdo7Hqa1tJttjqQoOSQx9cUsUSiTLHcCuMY4Az2rStEVGQIhBLHJ4x+FaVat42CMbamvYxGRsY+oNajwNFFgKGZiMFuMUWMZRS2QuelWUQyOGdRn+H3rz4q6uOTGxxjaTjDDgYpk8KAZG3fznHf61oIpUckZHJIHaopFBYEAZPfHWtGrIzUrs5rW4IzamY4Dwckselc3pJtY9Se4t4L+4kcbf3UbbSCQQecdK9DeA7tzDIPykY4qB7eKOJ/MfYkYOW6bB6/Sr9o4q1tytGadqEuIR5q84zz1FTi1JRljldR9M4rA1CW/slsP7NRrgzShdijJ8sDJI6dqnn1fU4YJZjYoLeKYxyuHLGMdA5GOg7+ld9GLqJNo5Kml7MuapHbWti8l/KDEgyVBwWPp/wDWqn4KDm4jn0/S1srViSyBv3lzIe7HpgD3qvbTXlxqkbvJC8/RA0PnQrn+NSp9PWu40+BV2GeV7jYMAbNiD/dHr719Ll+H5FdLc8XG1rvlua9osjx/vojG+f7wOfyNOA8qbahyepOOtLCGmP7vIPpmpY4sP8xA7H616yVjzGWIU2EkKAG6+/tUFyBIwJUKP7oGTVkqiRk7vbk9ahQ5jKpyfU0W7hczZ9PjnbMuFHZeoNUrvRBIrKoAB7bcVuqFWUbyMqeBUdzve480scZzkdKl04y6FKpKPU486RcQkiLtzknpVO4kvLaMnEZA7Fs5rqryXzbSZrTDOhyYyOtWIrO2kgjMkEalwCflrkq5bTlqkdNPHTjozghqU0rR7Y7YBmAb5jnH0rWIVtrF2+UnAB+U5Hcd63bjRbchniABH94cCsm70a4ji3wFizcDB6e4FebVyqS1gzthj4S0ZTnjV48Mu5ARweMVSe2tixJijyT/AHsVZks72KMK4O0HJd26/hVA3kxJw8q+wjXA/SvOnha8NGmdUatOezOC0O7ksb+KUADGOAele4aLqRu7NJmA8wjHr2rwjG04A5+ua7/4fatvzbSNllwR9K+nw1TXU8fEwuro9LR2IDMFDH0PWnqqSSBuc+hFMUh9vyHOO1EMh8wI/wB3sa9E84W6UI2WK7T27VC2HG1eB1q1eBWfy1OVxx71EygMVRflAwTQBXV0yfKPzEYo3uAVABY9iakkjCoEVCue/WqdxE7H5HK+jY6UASGMNt6ButMukDgIqrIrcMrAEE/SqgmeRguCpBw4A6GnRS20Tvtdd/TaG6fhU7lI5rW9Clgjun0vSNLuIp8NPBcKoRyO4wNwb9K4uLWXs5mXVNMghgx+7aFw+z/ZPevVrjUreMKm5S/oW/8A1muJ8TvFqU4fT7u2tZgf3qx4fdjuVIHP0rjxVNVI2Z2YWo6crlZL+G5tS3+tjC+YdkZxt65x6Vhalr32qOb7BG8kUJXzyeCUPdfcCsvUnl0uK4SN7e5ubnK+crskpyMZKY4AHpVebWZ4bkrbWqxyz2ywJuPLkEgMBjoOeuK+drUOXS2p79Kqmro6EyxQTQrNIrTTj5HI4f059cdqmRS0yttGfpyK5rQrSSXTLtLxzJvlIjf02jAZfQV1elI4aLezbkG4yAZy1eJXhGEmk72O6EnJXL9qNwJbB5+UAHgf1qypCuNoXHc461Cr+XJFucK7thQT97jp+VTbA0e4FiM9jnFccrrU0WpbjkXC7uMDlqryyrzyQD2UZqrKrlmCSBnzyvpTEkZH/eKSfbqKPbdB8iCWUoNrhdp6Y71ganDgkovDdc9K6Nts8b8kZ7Y6Vn30H7mRGA56HqKlTalfoWkcvGCsvouNvv1rpNNjBkGT8qDAOK5obzeLGrEkdz612NhGUCfPg9885rbFOyS7glbQ0rdCwGQMe/SrQfHyrjOM+hFVVZxJhcFfT0qxDBvKs2fbPU1yQk9kRK27JS7BjuwFx60sXzEjAVs46VYjtt4yQanSDBbOCOMZHQiuiMZN6mDmkVTHjjbk+1VNRsmurYxKQN8ipJg9U3DI/LNbKgAFQcEdfagRHJAJyR64rqpwu0ZuoccJLi0vbedbgLH9tlgCsNwQMMLj8q3NI8NX97ezQ6pqlysTnzfLiQRiUH72cZ9On0rftNBtri2uBOvmRXP7zaRyjeq/iM1fsZZopEtLhC08Ywk6j5Zh6+zeor6nBZeoJSkePisa5e7Eh0zw5Z6OGj077Rbg/eRZMq359PwxWiIwqhQgz396trIQCHBJ4w3SqzyOZxgYQnGT3r2Yo8qUixZ/KCi4DZPHenMHjQnsTzk0pjWOVJNytkcDPSlknyxG0cHvWiIY8HfFtYds1CrMmTGnyA4z6ijzQUIf7xPUGpoJmIAkGF/nRYRXWSI/KFO89c09od6quAB6YqzIqsR8oH0FL8oB+UnA4ApgVlt4octjknkmnM8fmAkA4OM1XmilLHCYQjp6VR0eOSKKQSI/3jjd6U7CbNuUwyY2gYYYIOKjdcho9oyfu9sU2IYzuAXGPm61LI5cgjDL3x2FFguJC1tsxIN5AxVJrOyLE+XjJ6CrgijAIVRtJz7inFQSTgUOKC7PmjAz3PbFS6TfNp+pxyg8Z5+lR5zhufyqnqBKpuXtXj0Z2Z6tSN0fQHh3U11CyR48dMitOIyPuLqvXrXj3gLXzbOltOTtJ4I/lXrtrcrIPMRhsI55z2r1qU+ZHm1YOLJixB3dGHbFKJVdeVPPJ7VW+1oJnHknHGGOMN647j8aiadkk2gMQecVtYxuWxc43EJ3GKrlgp+cde1LHJuYbhhfpUGpXMcUZdtxVepUE49+KT7D8yveh1b7RCOFH7weq+v1FYGoT2N/OsX2xEbqMhSX/wC+utbt9Ii20c+BIAQyANwfc4rkr6704ym0uowhkLYjmwyt7K3T8Otc9asqceY3o0vaSsQiSaGdoozvtdmOGKFT1B2nJ/IkewqhejzBkrH8rcExjKn/AOvVliIreKOEkY4/eO0mR9Tz/SqctwwG4A8epxXz9fGyvoz3aOFilqjm9R0hQZHtpJI5MbvlXPJ9M9BWLbsguiNSYtKx2mctkEeg9K6W8uI4kJOADzwT/Mc1yg0xtUubuSKQNbJhiEIIYnjrXJ7R1b8z0OtQULcqOjHlROkKTCVCMABhkDt+FdBYDaoK7QAccLn61554XkkimMMnReQPT15rubOYGLBOecnIwSfavKxUOSVrnXTfNFM14XyrfJgA/KGzVmFFihaMRqGYbmUHv35qpZszlCrMBzwO1XTgR/e6nk4wAa4HJ2NB+9GYZHJ44HX3NIIVkGeOv/fNHlJt+fADHPLdaSaN9p8vcRjnacfrUpt7oCrNb7GPOSOTzWbdkvG6yMCD93AP5VqzOY1Cqc9flbk/XNZeoSYg7Lj0qWkmrFxZxkMr/wBvSKwyQOg7n6V3GnyHywqnDDqfrXnFvdEeI2fk8ba9D0x22JwBu6ev1rrx8OVR9Cacr3Ny1iwVKkc9dxxWtEsaYxjd6+tZlt8xPzcD8K0IyiKpbJA4yBmuSh8OxlW3LSEsRhcZ5PPf6VKoy3OMg9OwpqMqAgjgn2pQSzEjOOoPtXZGTRxskZASMZBOfTNM2jK7sfTpSMd5+VioHPUc0ySTaQAFGOOvNbwkr3Ek9jW0mVPs5Q5XYSAS2Sato+4sS2Qa5UXv2d5WDIVLZJPGOPWq2ga3qOszXAtovKtF4DE4cj2r6vCY2Lios8rEYOV3JbHb52ldxIGOB3//AFUblPHbtisi4t7VWiQXsyz7AXVpcn8qtQmVQNsyyrkYz1P416cZpnnODRqIMTDHzDtTXGZS2QRnGBTYZgrEyfhUMsgVgzNyTgZ4rVGbL8ccDDe7N6BQen1qRxCYtpJ3duKoweVsb5iCelJhmI2kKADye9MRZO5kYjoMY561NG+9SUcblIzmq/8AqlwuWz1704xllOw4Q45A7UDLDy5U/MAmeSccVCVLYCMNuODipoIo2wr8gY71XuGKTZVcjoF/rVIQ+GE4IyH55zVq0ZYZSHjBGM/SmRZkiHl5VvekiDRNuZgSO9Ai8yRvG8mQAeOOhrPMqZP7q4/ACrSTeZZsACSTxgVU8onruz3pjvY+WzN5MjRTH94uRk9vwqMzBl5INdN8R9BNjeSXEcZ2knJx3rz1L7LmMZ3D0rzZ4dpux6Mal0bAuDG4dGI2969I8B+JmkSOzuWyeADkDNeSMJHxzViwuJrOVXhYqwOQR2rWk1Ezqw5j6YeRSY3VlEfuf85p0bKCzAkKemcc/SuM8JeI7XVoYUuUTz48FcjocYyPwrtQDNhsjAGBgcV2qaktDhlBxepHOT0U/Lj1qsX/ANISJWT7wIJ5Deq/71XpMcDbyDVS+YSQGJxhAPvA4I+lDegJa2MbVEktQ4tHVFf78TruQ+4HY1zlxdXsjGO5h2Ach42G0+mM8g1Z1i7YSbLV0kYLklzjdiseS4YgtKAHxjaWyK8LG1uZs9nCUuVIk835Ubducdfm5FZ9xJjcX+XHyglsg/lSS3JztZhz1A7VWndUj+XIGBjFeHOV2etBWMLW7oRgRiWOPeMZL43ex9a1/CVlbrp1zdR20cEj/uty/wB0c844rmNXEVzMiSRrIC+cuOhrfRR4et5tKs1hklmAaFlXB3Hqj4/Q1q4WgktyFN8/kc6kh/4SFp5Z7SCFdwUJJ9/68121nl0G0Hae9YdsLC2H2e5tBBdwgF0eDcDk9QQOR71u27KcshwPReBiuDGJu2ljqotdzYtiMJkkHqCepq7LMmAzD5xwCKyo3JClQCOnBqUSlBsViTn7ucZry3No3SJ5NQ2krlTJ2UmnG++X5QuQMdao7f3pJxkdMnp65qR22Rs4EhxksFHJx6CsrvoOyJXvg4OAQfXqfzrOvbjdG247WbnOKZY3Ms1nvuYBbvn/AFe/fxnqTjr7dqoajIWjfBCnGceo9K2hF83K+g01a6ORMLJqxcr8vmnpXommyho0C9xwMDrXCxW7bSdwILbvl7d667TpEKK6g4bB5rrx3vxXkZ01a508TScKTxjHHFW43kwDvYc54OKoWzcAZOfUrxWjGAyYUAjvzmvGje9kXOxNCztyTnPqasqwULnbgVBsGPkYADgmnxknKEjI6nFdUJOOjOaSuT+afvKMoRjA/nVeeWJQSHAI6nODSSSngjgYPPTFUbudsZcgbem498d61VXUI07syddvhDpx3eYUYkliCSfQAVkaFb6ujzMbu6trefG23RwCAPfsfYVovMjzxq0i+aVzgjqB/wDrFJq22S3jtjeNbNeSrCXjQuzDqQMfdz612YfGST5V1LqUlYtM0NrKoiYS3ajdI33iq+5Jzn/OKp2niF7673R31zaxbinlKwQ8Hk9K6a20/T7S3XybO3VIuUGzJz6knvWPDocC38102Wu7lt7HPH0Ga9GOOdPrqcvsITT5joLP7aiK9pqZuQOTDdDnPsw710FhqCX4VZ43t5+yMOD9DWBBlVCLEdo4ZhtAH5cn8sVdjZlAeNd2D0/rXsYfMk7cx5FbBWvY3nLNjC7SOgx1qzbMgVo5vTgg9T3GKzIdR3FQkbFsHkc/pVlJFIBVg0ntwRXswqRmrxZ5soOLs0W1aSTckSggDODxipS/k5BJ3MMlfvY9qismManfkZpIXQSvJLjju3H41ZBN5rBTgBVbnkc0wXKQqCRnJxnNQ28zPcSEurKOmB2qzbYbOV4Bz0qxF23lRiVCldw49qjbZ9oZM5O3dVeVhGe6sRxzSxh2ZMEjBJIByD9aYi0ksSISO3bOKlGoWuOc5+g/xqmUxIduRxyKq74/4tu7vgcUNXE20YXiLTIb2xkF2hbK98HP1r558TaPFp2sSCIYjJ4B7V9O3NqqxlWYnjADGvJviF4beQm4gQ7/AOJRyM0TV00janOz1PMEIC59OlKB8w4I/pTPLeMssow4J6Dp+fel3gjGCK8ucHFnfGakjQ0+8kspllgfa49+teveDPE0epRCGeURy9PmPevETkDJ6e9SWupS2colhcqwOaqlUaehNWmpI+hru8kT5C20H+Ic/jWPqd/JDaMrXXnFx0AArmvD3ja0vrDyb1j5g4wK4/XNTvLW/cqS1uTkD0HpXZUleNluclOPLK7N26nilmEoZklHaqj3PzgKcHuR1rnodXaZ8g8Y55q3Hcq4+9znORXz+JhK9mexRkmro0zNu6nIPfHNUb/UIbeLMzhew3HFMaZVXLn5e+KztWEEiDzI1cpyMjqa5KdDmlqdLqWWhBbq95dSSWsiIQp2mT5QDj1Hf0rbtLnTbeRfs6ySyXNtskXGW80EbST65zVHSrVJLdGkBBf0OCfap0sjDdh7WPljnAOSuPSu1xi37PqcqlK3P0Lvhq11XVNVMkwXbJE8xQMeMHaVx7EZroRbk8OCgJ+4eq103g/RDaaXE+N128e1if4csWI/UVU1qxFrcFWCjflhtzg56g96WPy+Kpe0gGDxkpVHCRjJH5Ib7qEfd5J4+lSTL5IRtp2j5sAcE/j9akaMpGAq7SvVVwQfYVFLI7P5QCjK8Nnr7etfK1Ycr2PbjK4yFXiwXuS7Bi2MfKM1ZdwQy7gBnquf8aY2AAuBnj8R71Wc4OclWIyOO/8AWuN+8zZDpn2oMBcdMg1jX5SRWC5x0rQmkD5OBuxVGYK7Bew5wPX0rekrO4ygsWxDg4GcZI71paWDG5XqxwSeeagEaF/mAC/rmrgUrtIHK9gK1qSurCUToLOZSgzyw6qOo+taUbKGGG6Vz1rMWGV7cnPetG3mVkwNuD6npXl1IWdx2voayMMHPO4frUqkFgRgHucckelUVPG1XyCOmf5UsKmGJIixKgYyxz/OnTk07mbgXZSI1BL5yOeawdYuBtSFRknktxgACrt5cqqfKQGAypIyDWPfWsiotxLFujm+6Yzkge/pXq4fCzr3UFsYyqwpWc2cvFd/aNYunAH+jfu2jzjMbDqP611HhB7Z4MW0krwIcL5h3YxxgE9q4HU7We21OWeFi8UwI3KO2OVI9asaLqMmh3ErSqfskjEHyjypGOmfX/Gu6WCdlbpbQz+sx1uerTXYDLGzdefrUIlkec7GQhR90jkE1yNxrbHUbdjE0UEwykrqQhHsa0rS8WcqAck5yM4znjmuGrSq05c01Y1i4yXuu51ltL9pwcoZEwQ3JDDvwKWzk1IXH+lfYWtudrwlgwPYMD/ME1haCgtbWS2XKotw7w7G5CE5I/A/zrfVi2LhDhinPH5ZqlW5HoZShc0AWwpACyAcFTx+Bq7ZagRLtuthxxuPUf41l28q5G0YB9Bwc96kZBNwzueem7af0xivUwmYSpvR6HDXwynudIJcMFjHmA85z+n1ptwA6OkwBT0B5rAtrn7OyswW4TJyEbDL/wAC71sWLRTJ5iSswPVZAAQfT3r6jDYqFZeZ41ahKmy3p4SQ/u1PlnjpirxCRL8uCPSq8dwyOBCgZfQHO36Ut1vKITuGOdtdlzmHvt/1snTPAI6VLaxswAQ7QT3PSqjyRmMeYvz9MZzUeyfdlNwTFVYk0b0YZjCwyVxuFc3/AGXIeftL8+4rTmY7N0uMryM9qy21WyDEG4Oc+lWm1sKye5t3EaS3KMx+TocVmapbRTOVKggjgnvWqXHlKhQIg7nuaZLGiRBY0Uj3OMUDPEPHfhgwMbqFCNxOQOmc9a88cMpIYMGHGDX07fWf2t5Yp0jNuYxtkJyS3cEenTBrx7xv4SmsJGngjLR5OdvOPesalPmN6dRo4Hft4OMkcCq9xynrU1wjD73GfWq7Ejqa5PZ8rOrnuiku+GTfESprXi1ndF5N2QR0+aqrBCOeRWTqFuzgiM4wexrSK53aRnLRaFmK8iW9kWJvlJrZiuCsZYDkcY9a5HT7SRZi57cV0MUhQAEVliqCctDTDVZcvvGlbXZmiJJ2nPQ1LYRi8nw53BDyKzreKW5nEUEbSSMQAqjrXRaZYXOn3sthKF3MAzOBz06CsFRVNOTNnVcmoonsYjCJSAWRSZFUds9q6Twrpy3Gq7kJkUAEE8fpXPqDbSSKXMryHaiivRPAOntaRGadfnl5GaywlN1Kjm0PFTVOHIdRHEU2oTg44yayfElukkLOqhZR919mWPtWtdymPL5+WuO8QeISsywpbSLEQS0j8ZHbFenX5VTaltY4aHM5qxk+aGXdHng7hkBTj8aree6kgp5mSMkHBNV5J7fyxJE5ljd8kAHIz6nt9KSWYyrnIOOBhsYFfD4mnyyZ9XSd0ixcSMWeON9uRwe4/Cq00m5ADxgAYOOfeojMpVfmJJ5II4NVGk/elhkAe/WuBQOlaE8kpCALnfz1pPlSJdpJPBx3+lRdGyM/NzzQyuQcMM9OaqwxxB3A5Uewq5bufLx1Yjp6Vkl5Ek8vfgk9hV6KNtnJ56ZxROOmo07l6GTymGfutyM1a81xNDtQks2GZTjYPXnrWcEddvOefyqaOQno+3HU461zyinqDRupcyRptjzIQPvNgE083HDHBz0GD1rHF4sbY3YH5nmh7p5h5SlPm4xnjH6YrGNJvQB91qkMU6m4ZgoYFto5I+ldpHcW9/Yx/ZnV1JBynYe4rzLUYHiBdVR35HI6+xrV0fVZLRUKQuj7QHDYwSOmK+qyurDDw5JPc8nH0ZVGnEu+KNNEd0S0SiNuuBjPvWHJpMU1wQAVhbG49QWHTiu//tDTdbtmtrxjFN7g5Bx2rjdRs7vTbsRLKGs2PJI5xXTiqV/3lJ6HNQn9iotRNNgeFWshOUs25EMq74wfUA/dP0qxd+G7y3jc2qrcLt3nZ1+h7n8KZJAZEGDk4zGfWt3wpqkyTvBMcHoOeKdB068fZ1RVVOi+emcx4euZn1TUEaUoqSKIY84wdvPX+VdZb3G2X92uT3wMEj0+tTah4UF/9uvrR1jvZJi6heQ6YAOMd+tc7FcGCd7a8jKsgC7GHPv19u9ePmOXyw8uZaxO7C4mNeNup1SsV2shc9AF7/8A6x+NVY7zUleXytNSa0U/JKt0pJ7nIfvVe2nwAmfkA4Qk529iD9Kub5EY+WF3Fg3flf8AGvOhLkepvKFzSSRZowsrqCwyys4GOOgA/pTdjRNv2hmPOPugD29Kri4cgq/BwfmfsRxnuKsKckqfLdSRngcn6Z5rvw+LdNppnLUoqW5r6fqsQKlLgoR8rJPzz7N6Vvi4csrMVZe2On51xCtJBIZYOWwAAAAfxBrX06/s5yULLb3fAIjOA3/ARxX1WDx8aySlueLiMI4ax2N5WEz42KR1PU1NEVkQKpDMo655qlAfIO4sXJ44GP8A61XoyhQyDCkjHIwR/jXqpnBYzbuJ5XdZPlQjA9KzjpViTkpz361uTq7wgM3ftSiGLA+ZT9a0TM2gDKNqSyKpYk/OccDqQO+OKmmAxtQgtjrVfZCdks0aPLErCJm6pu4bH1qwpAiw30GOapjRlzTBXJGCVOGA5waq6lBFcw/MeGrQvmMcR+UM2flAqGKISLmQZb9KLCueJ+NfCckNw01mmVPUDmuAuYjCSrjaRX089hFOCJQAx4ArgPG3w+mv9zWACOenHFDhGTsy1UaVzxbIcgdPxpZlGAE59TXap8M9ZR8OYdvc56VbsPhxqE1xslUJEOr+tRKlFPRlqq7Hn6RhRjHNX9F0XUNYuhFZwl0/vY4H1New6Z8N7CzdWucTvn7rdMV2Wl2FtYQrHbwIpx0A4FQ4RQe0l3POvD3hq28O2Ul5cyLJe42k9lrMmjMl5Ldrgu4IHqRXW+MZQXMKFFZmydtc3KEEZyoBXrgcV5mPnryI9LBQ055FbSrNLvUk2jG3v616hbxiO2SMLhQM/SuS8IWaOTOwIOflJra13VksbcLlQx43N0rfDxVKnzM5q7dWpZDdd1VLW2ZA48084xmvN9Y8+/eCRmlPltuxnHOOK6BbqzcPPcOzYXLMytgVnXVw140UsDwWekxEmS4n/wBZKMdEA6D3rzcXjZSvy7HoYbDRhZsyjbvGgaDMLlhv5zkVUE/k3DRMpyeQpHB/GrX222NrJcLmGASbVebILD1ANQl4buJijiRDnDg9D/8AWrwKjd/eR7VO1tBhkkbIjHzAHAbHB/wqS2MmF+0KN+BnAwCfaqcc8iOY50yqclvUdqnTzcrJlvnIzjovtWbpt6GnMkaMeEXPQYzz2qZGjdMk4B9QBWWkTOohkZsnJPbPt+dXoIpAE5OR98kd/THXmsZYeVropTQ4rGJAenpk9aso8bqMMAenWo3sZbny/lwUbcuR0qB9NldE+Q9eW75+lL6vJrUfOi35sa4G8H2xUbsiuQHCt9envVNNMWPdvd2XPzKAAR/k1LJYFrYSWzq231PQ9+aX1ez0Yc4lzKsMJdNxI6FvWpo4ysIkKhmXBAHH5VSiExlXz0Jx+PPrV1pRACzyhUUZ57VMouOnUdyeNxdgyj5kI5GMkY7VPG1zDdNGdIuHgwD9ohZCfptJzWOiz3sc09vFmJx80YJV5V9fZvQ1q6HkWQksNTmnhX5WivcMUx1UnqDWkI8t5NmU23oieW7hRcQwzPOefJdSjL+f9DTdN8QQXTyafqxIOcAgcoM8HNVW1k3Qksb5EF7ESygfddM8On4daz9L026i1Oa/hlYsRgiUZEg9MV6WGxHspWkcdah7SOh0UkC2zqhmEsBPyunQfjUlwAkQeFhjoxI5q5ptoLtC8ULQMRlonOfxx6VVliltp9kqgnpg111aXJ+9hscsJ83uS3Oj8K6xvAj3ZYDBycGtvxHoEeqWxaNVN4y4V+h9Rz7V59IDE3n2xZHQ8oOMCu38Pa0Lq1TcWDDC7m/QV6WGrxrx5JnDWpOjLngcGwm0+7mtbyPbIrYZSmQ3PGPoKtQ6hHb3KxEhFmP7tAcsSOp5ruPEOmW+tQEzbVuguI5F6g9q8teCew8UK9/Dse2hES7l+8WP3gT7DqK8PMMq9k3OGx6uExqrJRe51wkUpksoXGS+cBiPf1FT/aQpTDmWMjnGPzPtWJDegpvPK/fMe3kfSrizEAFJEYEZ3KMjjtnrzXiRTvqdsom3HIjMGXDfLy2MjFNeNT88SCNtw5A9uvH9azVllEe5izkg7VI7dhx/Pg1Rs5fE8jSbU0iJUPyrM8pcr26cCu6jV5XvY5p07q52mna1Jviju4VZ8cN6jtz/APWrqLeTzIckDZjIHTH415zG00kBN3HEJuywuSoPqc4IrS07Wby0YQXHlSx9mw3H1x/9evpcDmSl7tRnj4rBNe9BHYTzlcLIhGRjAO7H496rKiBQBcTnA7vzSQXIuER1weM53bgfx/8ArVYyvtXuqStdHkyiyeOxEwfzmXPYg1J5MtvsQEFQDkk8+2KS3kL/AHoXQEnAPOBjv6H2qe4xJ+9JPA5XtWouhUFvIyqqsA7nORT2he3BBjBcHsaBJuycbGBwvOeKEYLgsSVx+NBJG1sFYnac/WoSQxO5iuOgqR55DKAoBTv2oYrtPPPQGkMz9QMsEefLEgPp1pqOWtdxG30FXJ0LKF35J7iqQdCWhGSw6nvQIiRnlZWCEe5qtql2lsrbuoGcirgYoy7jjcdo3HGT/jWB4zl8iERjlmHDAdamclFXZVOLbsjlZ5FvpXLuQUyVyM559aznDTTLbq2N55x6VYhVBbhGciRmJ4Par/hq2V7sswUjdhSTXgx/fVrnuSfsaVjctmTTLKNAu+cruWNeOP7x9BXnfjVtSuLq3lQp5md7QKPujPGa9I1VPK0+dwP3szbA3X5c9PpXKw2iMk8iqXmznOcMTXZi63sopHLhKfPJyKdrdzXdtCs626KuCFALbj7881amkYjzJlSZRyAFGAao6qzafaW7Ja3d1K+ESNFycnux7Y9arw3bpa75zFBwWMavuwB1Y5xXy9ZT3ue7TcdiW9kgulkjCpHIRgA9On8/euS02RgJI3Dl8YkZeAT7nsatx3zXoku95ht2z5EY4Zx/fPf6Cs/Tp3urm58sOuwKjnHHXr70qdKVpJ9CnUSs+5rw26RFVZGklODsY9R6ZzWtaWKXFqquDjbwSCD9PpVXSbVJrlHeVmliOPKJzxzya6q3VQwyME4HAxj2py0Gn1Kn9nw7VldR5YYEnHI4qylgqtjy23MB8owM4471pBMxuilW3Nyc9e/NWFg814nUdDw3QnPWqT0J5tTP+xBFkbupB54/X8qfJZkFCEUHAk9CDnoD+da7W4dXV8hTwCp6e9NMYbaCpdl3HJHXNDkK5gXenAx3CruKkDpxk5yelZIt30+/fkCBugPP4fWu3lVeD3I4xWbqFkHiZV544DdM/SuaUbmsZnPvGjSxt5YLMwUoOKoeLdIXT7XzIiXtnJKFiSVP901spYCR4I1ARS24kDoe9buqWaapoM1jOCZkU7HK5yV5/OvSwOEjiIS5t+hyYvFOjONjgdEmCWEZ+be3OTyevFZuu3T2N0dQs4jIr/LcQr911/vHHQ57+9Uws2lXk0dzL8qkA9fl9Ca0hIikOHilyu4PGFKt7D1PtXn1cPKhUbaujthVVaKsyTSjZasbe+MA+1xPtSNicoSMkFT7Amuosn/dTEjnOWy+7/P4VzEMF0uuRz28atb3MIFyFbByp+VtvXOOPxrpLZl+zbAvylsAMuB+AOMVzVGk00/1t5FJNqzNDQ7n7Hc7jGAsoKlSTW/rGmx3lrvEIDgA7s81zJR1CA7guOj9zXaaHe+darC+1pYxzs5BHv719BltRSTpS2Z5GOg4tVInn7JJFvEqkzKTjjqPSpNLu54HEh3JEXLCI84966HxNp00J86OMsgOSmeRWJbyxvDuzvK/LjuM0VaUsPO8RwqRrQszvNE1CK8tFMagyDrUmuaDBr1s6SkrIFwkgbBU49a4ewvn065i2D90zYr0PTboTxiTzFHAwOn516lCtGvC0jzq1N0Z3ieR6hY3mjXUcFyGDjdtJJ2txjOf6Ultf7YDIrlQuSxYYG4dRjt+Fes+INIt9WgaK8j3oRwVH3T6ivJvFnhmXTIWt7lnFvL/AKuYcgexrxsdlST54bHq4XHqouWe5oxOLgl4WHGJCR1YY6Z7jHf1q3FciK3B/eRLnIXcD/wLBrl9BnX+x4oST5lriJk3YBIPGDW3HcAOd6kOP40XIx75618/Ug6cmux6StJXRtrciUFJDgkHB5BXPvmlZkK4mVgPuqzH7341khlUlSZF4wXDHGP5fpmpYp3Rmw5ywz93gD6UQquLM5UzWstVuNMGWZXtv4k3h+Pb3rbHii0IB2zc/wCwK5CKctiJdzMufnAHr044P5UwgZOY5SfXyx/hXuYXOJUo2ep5lfAxm7nrczOmzbj6VI5kOCRgD0qmkqAJLlydtWopUkRSM7SOpGOfSvtD50rNLhwQc7m6UxtjzcO24cFR0FLtCSOeBnpShMdUCt60CI5FbZJ15OBjrVaO3aNfnYsc8ZqZDLHdAyn5M/nUrzGWb5CMjtRcVr6kUgIjUYx6VCoCwksAXJ4xViSVnIEqgY/lUE8ieYgjBIUUihsRUBjKxVSPyrz/AMT3IutVZUYlYvXtXT65efZ7Z3XBBHFcG6ieOaZz98YGK4MbWUIcvc78DS55X7Ed08Qt1YZBQfiSe1dL4VtGjthcOoRgMqpNczpFot1qUcbliikEgjOTXptvbpHbKI1AwOBisMDSsuZmuOqXfIjI1S9E9sEOAEOOtYcGxZ2iXO1u571f11o4SFYEFu/Y+grGQSQuGfC5YEYz/M1x5nK8mkdGAjaCZUfFnHc7/PiUtkyO67ffGTwBXFancN4hBFoZpbGKQ+dODthlAPbOWb8AK7u42fbJuNxdMkZ42jOSRjHf1rKvYI4rTZYxxQxnHloRtDADOR6fjXiqpyy5ra9P67nqct1a+hyd0hhlCR+R5ZAG0Ajdx0ra8G6Mk9jcSFnZXZwhK4BIxyD3rA3rrOpxW9uF8ln2M6HiQ56L7e9erTxR6ZpqqFCPtCBVHAYjt9BmvVwdLljKU+2pwYqo5TjGBhaJbrapNKxOWPJxn8/at2Nd0m8qmANwVR9046g1WtFxIAu4ADrxg/5/rVuINtBLnbzn5BjHvXkSkuh6Jbj6jZGzs5PKnlfrn61chDERgdiSy/hVMPljHjBCgEkdc1pBcAEPk4xgHGfanFkMcBkL0yD34xToWHl/Md5DEZU9eaIguRgAE8n3/wAaANpJbGM9hyOKpoi5EsbBwuMheN2Ogz/Oo5VJMhI5HXb3/OrjFSwI4JAzTGU+YRhtw6YHt0rNqxaZjLEkM4HQP0HYGty1toQGuVwHdsEKTjcP5Gsu+hyrL2HK1a8P3pKyQTOwZRnHUMPWvTyuuoTcH1OPH0nOCmuhQuvDaXz3kChQzN5wOM5OOn0rya+tLrRruZLaVYjuJNq4JVjnop7V786sZ45IyVK/Ln1+teZ+PLEw6ulwXIDqSdw5DDqB/nvXbjqK5OdGOBqty5GY+iag19DK8lvJGd2GLrggjnJ9Rx+dbdsy7YDCoTJJA3Z49z1rMsXMsakooOBuY+g78HrV+DcRH8oGckMoIB9wP1618nUS5rpWPe6F+aVGCpJIEZui5QbffJPOa1vCFz5OpiIiNTICFbP8XoQOlc3LY2Ekv2i5soJbgYXzSo3Ae3J5rTspxbXEMkcbSKrDIz0Ht/SvSwU+WcWcWJhzQcT0R1aeOSOfb83auQ1rTDATJGoYg5IHVq7S3Pmxh4WLRsMqSKjvrPz48SAbj6CvqqtJVY2PnqVR0pXPP47RJrbK7ixzkdSKs6ReS2riFuVZflz1H1p97ZS6denC/u25JBptxbmWNXjBEo+YYPArw1z4apZnqtRrwudppF99ptU8w7iDzitW+jtNRsPsk9sskZ+8GGa4TwbfeW5t7pgJlbIPPI9a7aLO4SI4VfUda92lONSN0eTUg6crHkd14LlsYLjUdLDP5c0scsPP3A3ysPcAVkrdgZaQY5JG7kD1r222hkjkuirApJKXXHTkDP6iuX8XeCDeRm800ol0cEx9FYf4152Ny2Nb347noYXH8nuT2OGtrjgqm5mABOV4bPPB/wAOKsLNwfJIkCg8OM/UVhTpPbSiCTfHIp+ZCMcg9s0+C7OdpLJiQ7tx5U/4Gvl8Rg5Qex7cKkZLQ1mnXYiu42khQpO0fQUv2pBwLdsf73/1qzPtRZiJCqPk7cj7w9x0qLP+1/49XGuaJbime/qAp2H7vuB/SnMVXiMfKaYj+WzCVRu9TTgwljkRhtcjhv61+qHwg6S1BtzIrgg5XDHJ6VUMccCbEXOOcVNbLOIQJYiyZ5J4yPWo5NocnOe3TtQBCxO0FiCx746CoGjVHLK3XqatpDJOCEUMfSqt2GjXyipDdOe9FxCRyk7mZ9/bpVK7llUDyFxk9SalZSqbE6nsKqaqpW3AZsY6ih2QK72OU8SXLTTiDgsOuO9ZU7RwbEbgEcL6mq5uPN1R0Vssp9c4qS7zKyR7QSz8E9fwr5/FydWtyn0GGiqVHmZu+FIPLkMxX5c8V19xueDcjbQO1ZeiWohskRxzgZNXCxBaNcE45NevShyQSR49WpzTbZz2tZkuEIPybDnJxn+v5Vjk7imAw43AlcAD6k9ferfiMn7YiKQQnQE459azRIuXGArMAzBowC3PGTya8DMn78j2sF8ERb/EywtIFIJ+4RkE/wAOeRj1rB8RWF1qsaJb3XkW8mGuMcecv8xWrdKTaSbQTIGGWUjgnuCeBxVW5nCQyIeDIA3Dg5OMKOnoO1eNGTi+Zbo9K11ZlHwfCD4ssYmiC+TxtIAxgcdOPxxXZ+KpxPrUUUS/LAg3AH+I9a5fwJKo8WfvMlhE/U7u1bAk+06hc3Bx87k9fyrunW5MLy9ZM5o0+bEc3ZFmDKrhgxwe/pV1E4C4xxg8+9Q2uHlwQSAowOvNW0ULGF6nuWHPFeZzanWyWNGW5AQgkLyx4PsMVYDFI+uTnILdcZwahiyZXwqnaAMk89KYZHAKYz8obPUCtU0mZ2Lcch2PzgjO057VZimBYKxJPfPSsiNj5pBCsDkY24x7+9TxT/uzyQFJxznPeqdRC5TUVxlSecU1XKptzgDqSarJISisuFyQxDc4GelWYmHmkscY5qHK7Faw28hCx5U7iPU9qxZCbe5Eg6qcn6d8VuzYeMKVGCDzWXeRBmUsOvBqZTcXdFQ1Vma9tPwrIcxsMjFcX8U4IzZxzMiSeW24Kzkcn0GeQfeuh0p/KiaNgNqnA9cfSs74kQC48OeZjmKQHIPX0H0r2sLiHWoyi9TgqUlTrRaPNdH1OKWWG3WC4SVckoUAUr7Y4rq4irQoQW8s5Cgn9Ae1cxYXA3mGTJAHBHG0d+a07O4LZC+X8nLHHbsfr3rxqy5pXirHqxfu2bNmGRQo4yvAODgfTFOYlZVlDsDsxtz8vXg1SilVQX3Ng/MWAzuxwatWzbkIJ3AjPQHePy5+tXh7pkVNj03Qb1302OZl2vjaUPPP/wBetH7R5uBgKffNZXhN0n0uNlBGPlIPOMdK2WgVCSV6dK+xou8Uz5iqrSaM68sY9Qhbfj0+prkmVrSdrZsDshJ6V6CmAgUgBT1+tZev6X58TSKVXbyMdc1ji8OqsdNzXDV/Zuz2OMv45IVW5jOZF67ea6bwzqv2q38uQguffrWdpWnNOlys0qxNEN3zHhx+dZcQawvA1udqj5wP7y9683D1J4eSU9jurQjWi+Xc9Gg8st1wx7f/AKqluZNlqDEhDZ4rI0PUI7k7cncAPmHf8K3WeN4ipxuzx7170JKSujx5RcXZnM+INGttctX82IR3gHyygfofWvM9f8MajpYd54fNhwAJgCOK9xRFYlM/PkY4zUV3FlPKdVaMfM28BgfbBrGthYVt9zehi50fQ+a5ZpLZhuP7orjgZIx3qqb4AndEWPc5616p4s8BWMN7/aFl5kFvOdkoBJELH7rj2zwRXHTeBtbjldBZSsFYjK4wfcc9K8arlVpaHs0cwhJXbse9jDcqMuOeRT3gaVQx+VvpSJHwORGM54702efBB6jscZr6hHzBPLchIyjbQPXuf8KoMoALcEHpU0ccjKx2mRuoUj+XqapznbOVkG1QdnXqaBMdbzMgcq5z0HGKgnZ2ctKcgDgmpjGxcF8gD9aqSzAO25v3Y5+lMQ+MCSQEYyB3HSud8Yy/ZYDsIyeuD05rZjk8re+8ccgZ4rivEN+b7USqjn68VzYmp7ODZ04Wn7SaRj2NrElwzkCN9pyx9ataNA11qnmNjZHxuqlGs6+ebldwJyFFdl4ThjSzM7KArDI5FePg4OpV5metjZ+zp8qNaXCgIpKqy8kVXWT9/gdR0x6VauV86LCctnr1qlKnlvk/ex2r3tkeFZtnOeImZLuRlOG27ly2BnuDXN2VqbQb2Ktd3K/vXZySWPpngACug1xSbzzGJYtwqgc8fWue1S5uEaCKxhae4lbYiucDGOS57AfrXzmPi3OUT3sI0oRY6JoyohTC/KygDhig9B0qE3k/lYkZQSGKoB2A4JJ4HHvTolJdElkGN21g3ygAL+ozVC6FzLa7LZmiuD8sTSAEMRwCcdvavEcba7HppkOiztFq9vJbPvQoynfnjI//AFV12mxAHAC9hwO9ef6fPdQ6mi6iio8MgDNF90g+/wCPQ16VZqPNUo2RjIweCKismmkwhJNM0YY8s5O07cH0H/16bCZTNGQgaIod2Tg+wFW4YyAzAjBwOnHTrSkbwDtLKOMg+lZyj1KTK6n5TywBJ5PtTZOYt/OQeMcVJ5RVTggg8+hA70kcO5+QxXORmslJ31KK86/uhJIWXBByGK5x6Yp7sXidiSm8gDHp6mrEcYnTB/1Y6AjGT70CJ1AVWxkkn/ClOTBWLMADJhuR6VZcZABZgQAQVOKpxZEh+XCgdfWrcRf93uxz6VcJ6GU0KgJmYYwM8fSop4MkEjIBwTjgGrUEYLE7sEc80Socon8JOSOxNXa61IUrMyoYzFICcnOQST6mjxGgn8M38OCvybiwXpj/APVWg0OdwK4B9e1MeETwzQ4+ZkKOcdMj9a7MFNwnbvoRXSlG/Y8BNxNJcAWlu8iIfmYnGP8AGt61uFZlTzHOMZYqPyrLugbeSeEHaFY7gOpANL4fgW3tnmaZgZHJKN1PpWlWlzJvaxUZtNLudFHcbQh4z6Zzn0NSG6trWIfaGUoe2fmJ9APSqDPiMgSPzyDtzye1Safpdpa3K3UrvPMe7DIQdgKMPCN7tlVJO1ken/DqZpdNkjKlVR8qCMFR6EV2MO95sMeOxPeuG+Hs6NNOipgDjrnBrvc5Rsdh1r6fDfw0fPYr+Ix6xFWcN09/6U0QuB853If4c8AUwzAKxbcfekilMkeVUk+9dFjnuc34p08xqZ4QoI7L3rDe3TUEillOPKOeM5z716H5XmrtmQd+ew+tcjrmlvbP9o0+bChsuo7j6V5mNwvN78dz0sHiLe5IpRSnT7xZlVhG3YHFdlpt3HePEygleMYbqfcVy0kCXEYz8ykcZ7H3pmk3EmnXKxyHjPGKywWJ5H7OReKoKa5onocds0d4u5vlPB56U/UyqyFy2cjbtHGKp2twksalWAx2FTyTM7LGFDYGdzD+te3F3PJloU5GR4Hi2ZgYbWRjkYrMFtqiAJHf4ReFDJk47ZNa7QxXLI6yFecEAEc/jQyRbjxKeeu2qcUyOZrYghdnt1KnKseM85qtLITOE2uXxjC/XrVhXUquCcnpRGkg3Zwozgcd60MyMMQpR5CueAVPOaRI0JjDMXGQeRnpViaJVUpJ8wI6kcj8aqoQrHy8gDrxQMdcXILbRnC9M1UYpKH3gc+vANOuLrc6qR35I6UkhRUXH3+3vQLcyNXxBZOwb5h0HvXHwRq8bTBv3oPze1b/AIrmwoiC4ZuPXP8AhWHEnl26pgq56k142Z1tqZ7OXUdHMrGLzLiKPDP6npk/Su00TT4LC2eGK3SCOQ+a6qOC2B+VYOhwK05dcmUtgA9APWuzizGoD8kjBrbL6XLTv3OfH1OaduxG1zHEAsSFmPTHanG2DAuQ7OMdBnFOtbUK5fClT09qnkmeGGbbyOvy8mu5nGtDhvFhRLqIfOWZTlV4II6D8655lKv8oJbPzdseg963vEzRXJNyYmSQMEJYcEAHpXNoh2DcHwzZzvJJA+vSvBzFXm2e1gnaCKTyEkljkbuAMDcP/wBdQgkPtjJkfI2AYx75Hqe1Sks0pL4C9Cy8nbVKbzZE3W4YylcA5xzngH1rw5R1PSUivIHmvFLESsZdvzDacdwccGvRLK2FraqEwY0+4O4Hp+deYqbmGbZexLBICCChyrYPr2Neu2yB4IQ4+QpluhzwO9RUi0rDjJMt2jAhWIOWBBUnuKs+UFU4UspJAwOR3AqrHEVmikyT82Dk9M9xWlEgONpOW5xnipgr6MUnYptGSUkGSMcgjk+opyxLuGOpz+FXXQEt8rZzn1x601oTuOfvfnmonASqFQR/NkbiT1xQyfOvBZRzgVYdA2CM44PHrUhUBlOAPl6Vi4hzlJUYA4AwvC455q7bxgbcFiFGPx705ITtXu2cknnNWrNcKyZVSj8jHb3rWnS1M51NBkcZVSMHg4PemMpEw5HAJ5q+qZjKnJBOSajKH5Wxn1HrW0oW0Rip6leVMsSP/wBdVWXypcgfKO1XgjbFymCeuDxUF7vigZkTe4Hyr6n606bcZJlp3VjxPx3arZeJrmJfl3kSBB6EVjwPutiuScN9411/xF00WLWs8haW5uGZppG/iOOK4yKTaxXGBXqzgnqiITdjQidjy44x179avwNmMheSretZULZVh3FW4AGHXaT/AJ61zxhyuxtz3O7+HlwY9cEcvy+ajANnjI5Ar09eGwAeT+deNeF7r7PrFs25iGOwkHqDXsIdmAUsAMZyOor6DBu8LHjYxWnctJhmYMMDFJCu2I7CQfalh3qkjcOSOP8AapGkIiwyjJPOO1dhxj4Lh2yp6dCapX1hFKrLI21scYGMVoxLtGWGMjOe4psqhsmRRx2qXZ7lJ21OCZ7rT9QkinRTA3RwelSXsSyLvZiMchh2rqrzTkntGRl3Yzhjy30zXJGCSOYwzswC8qM/lXi43DOnLnjsethq/tFyy3NHQNUMbGGZcN2JPX3rsrMxPHl2yM9BnPNecaoEjUTl/LbIGSeM/wCNbeh6sxjXzmLFW2t6fjXXgsXzrlkc+Kw1veidbIiyOMbgB93HWmtZksTu6mm4DShgRt65z/KpfPuBwCcD2r1TzGVLa2Me3zBgYyPWrslyHiWKNMEc7h2qg13O3zSIOmMDsaZG8kMbSOflbnbnmtLE3sQyShDIzK3HGD3qtNOWhLQ/KG9qnld2bdtXDdT7fSqtzJhNqAAE+mKaRLYy1ikdBk4XOevNR3EEjTb2YbV5wfSrgkIjCsADjpWL4huzBbDkbm7ZqZSsrlQjzWRi63It7ejA/dpgYB6Vm38ksFqxhywHTAzTojI8bnPLtjFOlgDzxxxMct1Ar5erP2+IPpIR9jRNvwXEIYvOuzliPl9hXSrJ5pVctIefmC4GM8Vl6Jp7WeZbhiV6BT2rTBjjYSxx89FPoK+kp01CKij5+c3KTkyRVlO5MZwcZpYiPM2sDmknlwwyTtxx71EyMx3cc+/WnYm5znjNNlhkL1kGSBmvP9XvY7WJTPyM+WoGeSemBXpPjGULoFwNo4Ix9c15m8QN2J3ZW8uIiNfvEE9Tj6V5OOS5rvsepg2+TQrSNmdcIcLjC9qoaj9pVWe1KO68+W3sOcelaBAV+BhRg5xUG9VlDBSctwe3414jhyu7R6d76XM83P2yCOQqrKSDtZcEH3/xr1rTV/0C1JOTswMc9RXjgjEHnAjbFuLAf0r2DQw0mkWjpkDywc9s+1ctey22NINta7mpbR5BXgHgjjv7VdiDDBbIycc9xUFsCV6gjHX0NXkh8xCc9BxWULsmcrbgRlsn8qMbc8/N2PqKAnI3AZppBOcduK0fmZCGMeYSMYOD/wDXqRoxgDqcZ/CmJJsY5XBJwDVuPGwBgvI46Uo00xSbQkCAIhJwSM9eKc0ed7oSDjGAPf8A+vSFh5QZeeMZx1qUYLEnkmtFbYybe4iLKpRQEIB680rB0G4EAdTxnnoasqSF3AAkcgZxmkfO8Fup5IqpLS5HNqUY4zv+d8r2HoPWnSxEk4AAweD61YRcbjjGcUrqwBIPuO9RFFc+p5x8VLbzNEicKN6TdceoryKVSjgqMk9TX0D4tsWvtHulQYZRvX6ivBL1WwRnO0817EFzRixX3RNC3zEE5NWoWXAHcHkVlwN8oI4OatJJtYetS4WZalodHp8qxywyqMBXB6e9e26aFuI4mbcdyg4rwW0m4znIPtmvcPC00Fx4fgNyjSKVAI65r0cG7XRx4vZM2UPlsFfhAfl5qdEhIYSEkdRn1qu2xm3A5QHGT71JOqPGvlE7/wDaFd9rnAPRBG7KpHzHgn1oKBCFQE7uM4xTGSTydzFFxwMnpTnWRo1ZjtxyTQkK5BcSfZQzSZVVGScVzupWw1CzN5ZksOuCOa6VnNzmJgGJyMnsKYkKwwCHZ82cnbwCaU6cakXFlQqOEuZHF2s5fkttYAA+uah1KOSNVeHPQkhT0rZ1zTGhn+0QgAdWU1SO11DjofvDtXz1alLCy0Pbp1FWjc2fCOqNdaeqzFd68EMM1vG45P3/AM685kuDZ3Ylt23JGAXC4wCfUda6aLWo2jQmVQSASMV6uFxkakddzzsRhXGWhrPL5aMY9pHT73Q/SoIIi53zHhucY7U2F1QMADnPTFWIsNmQgABcYPevW2PMKk84OVQEKox0qu0gdMtjd1x6VZaUsThFA9ulVbq1KyCUsFGOaZINFMYy8SiR+OGbaCPrg/yrjfF1xnU0tsFOK7VJhApdnIQc/WuGuR/aOtSTSL8oIK8dv61w46t7Ok2zvwNLnqIhikeOZFCkIByx6Ve0aA3V28iod2cBjUN4wWM7SSc9MVveFbd47ck8E8knpXjZbS9pU530PUzCryQ5V1Ny2hufI/0lVYhRkDpT7VPLkOzLHHftVyMsqbAwPFQE/Zm7EmvojwbW1K90VL7iCDUluY2YHb04xmopHJbJ70wFw4RRnPf0ptaCT1MjxlCx0m5ZADGcbR2z7159BGVTj73TIGPrXp3iWELokuCeuTXmd5KI4iMqeOhB5rzMYk3c9HCtpWMq9kAdtpYr2J5rNdx5m8k4J6Nz9akvLgvIQCwA4CmsW7knhaGaMgpuw3tmvHqx9pKyPRUuWN2Wpws4YbkVSevTFeo+DzIthbW9w+JYo8qB0dT3H0ryvePKLbf4scdRXsvhhFm0SwkIBdIwobHIFefWVtDqi76mzbcsRjv6YxWhCCFyOd3+eKqxKMg+1WYQB6tgnB9KypmVR3HFSR8hBO7P9ahkBCkL8pzwM9asso3E4yBhqc6BVwd3XvziqkmZKVjObIZd43E9Ap5NQQv5RMG24gRD8rNj5ievPNaqQnzlcrkY6+9TvGnluGGQRURbQ3URQj+cEDkEZzVmJdp3NuJznr09qWOLbISgABwMGrMaDaOe/SiHM3cicyUYCHnAx/8AqpHUMQPTHNSKAcALx1NIy5OT05Jrqa0OdMYe/QEcnPrQRjsMEU4YMh70suMcHketJK+o7mfJGsgnjKkhkI5r538Q2v2TUruEDG1yQPavovaTP8mORya8P+ItuYPEExbguMj3r2MNFuimJytNo4gMwbj73WrqOSgzycfrVdCqSPj9adGwOQT07VvKN+gRdtC0ss8bI43eUGBO3qfrXtPw01JLjTjFyQDnHYe1eM2U204zkY6dq7/4YMY9Ql2NhSOFJ4rWi0nqjOsm46Hr74K7QwIY9Kiii8hQgI2AlgC24kk5PWiIskQZ/mZu/pUqxOydM5ORuGa9A4LiJM81xsK8NxkcfnU7IYxt3jJ5K04QkLuXG76UxYRsJKsZewPFGgtSKZxEQ8jhf9oYxVhjvQkgH+6c5/P0piQoyYdct/dNTwqPuI2c/wB7mmIpyhZUCHoFwwNcvqNqtnJI4lRY+OW6V1hjkjVhNgnuRxVa8tY5rU7tpHbjNc+Iw6rQ5Wb0K7pSv0OSjt1USK77gx+UHjH0rOa0kDHCcZ4xmtadHtZvKYAgHgnuKhMhz1f8q+VqKdCTie9GSqLmR0Ms7ouVjw/qeBUsLSOoUk4bqAP0pLn7Q0CrGPvd8dqtR2zqqkPztyTX3Leh8mk7j1hC2+z5dwHJ6VlSEyFgScDjk9KsXPmB9pkVjxnjGR9aiWE+Y3IAz3HU0titzG125WGyZU/irMgjaOC33DLLFg49ep/nUviN1kvfIDfd4PvSh/kwOAAAfwr57Na3M+RHu5dS5YqZU2Ge7jjUfLn5q7eAxxxxpFGFVRyQOtctoMRku5JgOBXXKgZDn5R1xXZltL2dO76nJj6nPUsugi3IdgABtxwcikQpIWViAc8fX1qIx/u22kZPOc5qGJJC/AJP516lkebcdPb+aPm4Cc5qS0VJFyTgjpzVhVY4IyBjkZpFYLIUVOBzxUtjS1MzXA50y5i5IK9ff1ryHUXY5HmHPTPAxXs3iCQ/2ROyZAC559K8W1IgbtoG3uDxmvNxvQ9HCdTDmOJB0PXHvVR/3tu0WSMnI3cnNWpM5JPPX8KqK4CcZ4rynHqj0L9CSBWEBBIVs5z7e1ey+FVxodpuOBsycivHoQDCBlgT6V7J4az/AGLZrxnYOO9cNePVnRB9jdiJJCk/MvoPyqeLcGOcbdvaoYiAWHIJGfxqcISQc/MRz6/hXKtNiJEjtujIUKQuNwPU/SrUkYJbkmqfkhWIOeQBg96tbg4ycZ45x0rSLvuYS8hxYbRjgt3xxTJsFWBxgYOAM1KyjHpk5GKjZVJOOu4ZocUSmPjUScsGxyAf6+tTJwi4HA/GoxjaC3r+VSkZbCjAAxVpENiEkOeQSecdqfEMylTk4OT6c0iIQVJ44x9KlkwpGB2xke1O3VkN9CJxhgcHOOcVHJIM/hSPJ5h5wPpUTnbyO9JavQ0iu5GjDzuc9OcV5D8Srdru5kvwD5SHYMn3r1ly0dpLKFydpGK5HxPYRz+GZgR86rvOO59K+kw9LlopHLKa9q2eGXBIlyO5pMlTk8ZFOvMCTA6ios5GT1q+Uu5NHNtbOT1rsfA2oLb6xC7SAA8c9SK4RnwST0q1peoiG9iLEhQ2cg4P1rSNK+qIlUtoz6osGAi3oQ5blauMzB1OeehGOlc34NvUvdKjMT7sKOh9q6GFWcggnZ6V0I5HoWmL9GVvpmmyiQrtZfm9Qan2tsDgZ25yMc1E0hduSckZzTRLIkhk2s5fD9gR096YFk3fKSWHYGpVDeaGDHPTng1KwTZmNgQWJ61QiKVUaMI2A7H5STz+FRMgw25SRxVmT5IsqcDvUIBjXIJOeue4poDK1WyWW3dWyGHIrlmku0YpsjO04613qN5yOkhwMYXFZL2al2wjYzXBi8DHENM66GLdJWLkatErOz5Hb0FJLKwjWZnYANkbeM+x9aWI7kdSDszxkVDKC0bKWQRr9055PrXpnCU7v95IsrZJY9MdqmkcCCR9wUKM5NLDGjBVYBR25rH8VyGKFokYgvU1JqMbvoVSg5yS7mCx+1ahJODkFgDzjv1zVi7wkOFDEk4GeKr2CgRxu+fMAIH44zUrPvuUV/m56dq+Tb9vWufS/wAKn6G7okP2ewTGTv5rWJkaP5hgH0qPTnTykWOMk9MkdKvSclYy3BFfUU48kVE+bqS5pNlYxARDaxx196WOXaxjiXaercVMysUAjHyjuaJthjEZkyTjGK0uRaxKwDL8jHPem+WwUqcHNLbJGzBckHFWo3jiV02b3J4f0qWUjA1wbdNuBIwOEOcDj8q8W1JzufbnCmvbPFLLHotycjOOTXg+rXoW6EbqNzDIGeg964sTDnaR24aXKmZUz4L4OR1+tVgoVCqnBbPHapZnGWIFVGm3Eqv3sZ/CuBUzr59UXogzRIFYrIeAa9o8N86Jb7dwkjULIrcFTXieXFurR/eUgj86+gNDSG+0a0ulbLNEokA6ZpQwyqpphUrezaZOj/KpU9BgmrCtsdepPA/CqwAjk2scelTRtkbiQOa8SrScJNM6+ZSV0X1kXIzjA5Bx0ogVo1kU8AvkZ54NVwQVPPHB+nNWFb5RjOeDUmMlYsgHGAc+3vT44wQcg5piEHuamVslcdzg8VqkmYO43yQE+4PoaXIPyt7ZIp7P0GSagkmQEdeTgCnpEFdk6kA8H3NQvIUYBjgkfnSbzjHOc45psjFlcFT8o4Pak9RpajJBjdjsaqzyndsGefxpZJVAIXqOaW0jWRjJJ26V04Sh7WdiqkvZxux8rAKqBSQ3UVn61H51hNGEG1lI6VfmdQzKCaZDGTuSdvldSM+lfUcvu2PJU3e58yazH5V/LH0IYiqiBVXLHGe1bfj2EWniG6XGBuyKx9PRGkBmOB2FZzp2VzphO7K0ytg4Q49ayIQ7XYQ5xnH0rqL/AGk4jIAPaseWFUOR1zkVpQrRWgq9ByV2exfDC9n0dYoLuT/RpeUbsPavYLO6wVwco3OSMA18v6Frk6Qi3kYkL93J6V7B4R8bWUtqkWpO0UycAkHBok7PUy5W1oeizyyeYY0GD6iiKJVjOSWPTHSqNneyXkImjAjhONpJ5YetXd+5AR1B69qEyGmmS2kOCxchT70SE7gOoJ5OaAhcgq+Nw5B4pVPO0/ezjAqkKxJIRgxk4HSoZFAiHzc022vI71ZtinZHIYt56OR1x7A8U2VzkqRlR2600xMlSeLcMx5wM5xx+dQmZCSRAfyqstyouIoHBEsu5kA9F6k/mB+NJ9occYTjj71MLX3Ikj3ynC/vNuM9yPT86ourNMxjfAU4dWXBzWjbbhJI28FSOBioryJpDsXoe9a3MraFNLgKw3EMq87q5bWrk3mpFSw2L057VpeICtjZMzSbGB5965AXCrG8kbeZvOAf8K8vNKzjT5V1PVy2jzT5n0N22ZXLyKeOnWtDQrQzXLOQGx2rAglSG2KEZz7+tdNocLR2qOxdMjhRXnZZScqjk+h15jU5YWN+FvKTaiKCfarIbcAMZPc+lU7ePcy7mYZq1AqLKSp57nrX0TR4KJXIC7VOCaiitgmW2k8damCM8gyu4HrT53+RQvA7jNICkZQ4OAAfu8g4NXYUyF5y5qnCjw7jb4YM2WQnjPqPStuGyLlWfCdCfaiWg4q5zfjO1KaFcyHpj6V893IBlmmbG5vlHFe/fEIlNGuIlkDLzz714DehYkAyDiuSvqdlAzZNqqQeDmqTMRcgdyMZqxOcnI6Goiqkoc/NWMY2Nm7vQ2NOG6aLPc4r3XwfbfZdPe0bB24ZQOwNeFWL7Jonb7oIHSvftIHlRW8ytndGAR68U6ELSuTiJe6PvYSz8HkdDVRHZBsfOf8AarWB8y5G5SB9Kj1Gz8wfLkHt71GNwSqrmjuThsTye7LYrJIrYXPzEY9qsxSHzCuQAOmKx8+Q5WVcNjrjOPpU9vMMIEB67ck18/OhKDsz07qS0NyGQhsHjB61LG4WPjICnOc9frWbFMrNleg75qVZfMDBSduMe2aSujNwLnmhpNuw4IJ3DoPQf59KYZFBLH72PrUL48vG4BsVCXEaKhYZ9aOV2EoItPISG7nqKge4O7GeCKpXF0FywYZ65zUI3zlSQcFh83tWtLDzqOyQ24wV5EyB7qYqhIHXjtWnFGEiKrk022gW3QlO/c1OoL/dwx9q+iwuGVGNup5dev7WXkVxF5syiVdo6ZzVhVKmSHYSFGRiobiWKIF2bnOMH1qwlwRGjqBk8Y64/Guuzsc6Z4f8XPDs82rJd26EK4wwx0NeeRQSwNtlGGXrX0/renR38OZV+bI249a4Lxj4Dma3M8ETLIByB0NEpcy5WaUvcfMjyDORx1qGQBx6VoXdpJbTNHMpVwcEEVTkjIAK1zuny7HbGrzFVVKSZH610Gm3R2jzAGHoayzDvUEDHtT4C0Zxg4rKdS6LjDXQ7vRfEt/prBYpt8YACrJkgCuzh8dyRoqzQxkHnKHr+NeSwSZdVJJH1q4s3lqWl6L37Vi6zgX9XjNnrcPjbTh5kn2doXcgs2RhvrjvUepePrRbGdbeOQXBQosjEBUJ4DH8680t7hJP9WwKHgj1/CrCxr5xG0FlOMIOBWbxzQ/qKex6hY+MdJ0zTraHBYxoI0RWz+JY9yeajufHtomSEeaXBGBwM+n0Hc156bdMNkEr/EAaPsoCbmCMRkGMc/L6Y/xqP7SK/s9GrP4vuZr69niVBI6LEjgkrCvU4z6nn8qp/wDCU6iONu7Hdgcn681TMW2LaItgxglRyPbPYe9R+Zbp8huNpXgghOKxnmUr6G0MBFHtItpYXCwjIxlvT86Ip0jkl89TgdCKjmmkVNwOGPauf1HUZBBPIJVVlH+rx1r6Z7anzsVd6GJ491KK7mWCI5C/ewR0965ywEjTRorL5UR+7WRqV5Ld30rNnk+nvRY3ckMpY5weMntXhY1Sqt2PosEo04anTWgln1XGd8akYQdDXo9l5iW8e/B/2R2rzXwXJnVZElC+Z97Oexr1G2GCWXDMTyT6V34Kj7OFnueVjqvtJ6FrLtcxsgQRBTuUqS2eMEHPAq5GIyrEyFWJ+6BVSLO0iQ4cdcDFIokUkvnGc112OK5cVZlcnHSpMYiLPgseMVWgvCIz1z0yVpbaUZILFn657UWC6J4lMZO0Nyc8jpViaWXKIGxnjrxTYXYsc9qiw8kpBfC5/Kp3KOY+JFxHa6FMoAEjcDnP418/6jOGbg9/pXq/xm1GO0tEg3qSSec9q8Na/E05BPJNTKk5LmNoVFH3S4W3AAYx0NKqgFGweopowU9ePzpRwR3xWHKdCepr6fH588UWQAxGD75r3nwpFIbCJJT++QY5P8q8F0OQf2jbBuDvXt719EaOCyiVgFyvAHU1VKLTM67TSL8Ss2DJ06DA709lGFJxITxlacQSoYsAR2AqEMyljIufQmt7HI2QahHG6ZkAVSMEjtWTcWhifEZwAMgVr+W6nOSzHoBUUtvJE264GM9BnmsqmHhU+JGkK86ezMc7xsEcT+/HX3pUuHj2goSpJ6DpV/DIxwOvFSRQgScgE+9cssspvZnQsdLqjO/fybgqsNvQmopVucBijscHoQB9M9q3z5QRi5CheT6VHLKI1XygG9vWqhl1PrqTLGz6Fe10yMxmRiM8d+tad1cK1skJRVde4HasqG5likYk5UgfL39qklR5gDKRkjjFdkKEaeiRyzrynqywYzLHjOFI6ioIIpbMuYm3E9iOlWLRSIGXd86jioIZUmK5kVypPPYH8a0sRcVIvNKJJH975mJ6VaiixKSjDYPeo42DcbuQDT7NSob5iz9eD0pMaNGwiWSWQS4+XoAaW7EZyGywHHHNQpITlgvOetSXQLdDg5HA61DRomcfr/gay1gPMiqkrenGa8j1nwrd6fdyR+Q7KM/w9K+jo5FRRGCWPfIqC+0+HUUImjH4DrSaKjI+XJLYxvnnjt6UgRTwRg/SvcNb8DWsx+RBuzwQMGuFv/At/wDbXgtwGO3cMelYToqR1Qr8pxEAxIS67cHAGc9/Wr/liVdjqRxkg9DWvN4Zv9LcPqFnIkPTeRxQbRfkKbip4GO9clei7qx2UasbGfDbIjL8mB2IGKvQ7UZQNygnPHenmBhIQGG7ghW7/hUsKyS/N8skQzljxg1wzw82dUasCSJ18oMFAbAyzndn8KuW5Rkz8hGM5wMY+lV2aSLKSRqUxuAA5+tP+0Awny44ixIBLqflHf25rleEqN2sb+3hbcmnztxAxOOfl9fxqibgA4wBjsWGR+tTzpeO/k29jJcFTubYwBA9s9aeLXUcDOkal+Fqf8auOXVWrpE/XKadrnrZKC1ndl+YDKvuz/8AqrxzXr6W41F1SbAjbtnmvaLuPzLeSFhgMMAg14tqekXdhqF1vizCCXDYyTX1Fe7g7Hz2F5edcxVj2JlhneepIqs3L8KzYIHPGfekjvldhbpu+bqSmAKtFdqHa2ceg614klKLuz3U4yVolGB5ra/S5h3hiMFScYr0bSPFObDM330HPfNcJcIEVXPyg9iMioETAHJx0BHQ/XtXXSxDSOCthk2eyJr1qRbT+fG1vIAjnoY2PRj7dq2G3ggjDhuVPr+NeCeZIIzFuLpjlSduOfTvWtB4i1K0AK3QIYhthGVX6eldca6Zwzw7R68kxg1I21ww2XKGS3PXDLw6f1/Or0BCyLsT5fX1rxu88V6hcwWpmLiW2mWeIqQMdQevqCRitpfHd4jIWjDoM4LcNg9AQDg1ftVYj2TPUy7I7k4IbpxwKpnUYhO8Vwxtzn+MYDe4PSuC/wCFgytCQ1uhkxjcpx+YNYmueOLvUNPls9sPluCGBjGV+hFCmnsDg1uZPxEuYdV1a7EjM0VuCo9zXknlf6ZgZC5rrNVn8u3wrks3Jz1NYECEybiOvPFdEJ8sWZey5pI1LeBHQBSwPSie3lg6MDTIyeMMRg9jipm3OrAOSevPNYLVnXaw3Tr3y9QhxgEOp6e9fUOiQPcaNDJERkoD6182aJ4aub1xcsp8kOASfrX1Jo0YtNKgSMrjy1wPStZqKa5Tl5pSvzEcMTxffGcdSKZK7ZCkYwSRg8GrkxYId+4lucVkXNyBJtQbnTggc4oSuRJ2LPmFcfMM9iaZPdRiBmndSw5GegpiQmaTzWB3kdMdKp3qecpScYRuCelNIXMLBFJdubjfmHsfWrrPGiqY8Z/nU0C2thYJHACsYUAYOariQbC20hs5HfNLcNitOzN9zlW61RL3KI6LlWJ4bGa0Jp/tDIkOInHPAqQ732blw69ferTsZtX6kVtZtJGPPP7zqealkgKxhUbYQCMnnb70+ac5GEYEHHT9fpTI1EoYkkEHmjXcemwyKBZbkhZCOxJGM8fp+FXYtKWSRliBJHSqqoRI5QZbGDj9Ku2DzwrkyEOeuD0qW2UkiBIIkcsVww4qRoRETJGBhz+dTrGu45BBzn61PDEXYBXXZ3B7UikiGImNicAJ0PsKe5A3N83qOc0s6FZDkgrxnFMEaNIpRwDjk4pDHwtvOfLIx60RSlWO8c+g5FPiLbWVcYHTAqVGKwjKjeex60hkE02VJcY9AKhls4pmhnVSJEXBPqKuOUDKCgO79KjfK4A4J/KlYdyNtPhlj23OJI24IIzmqk/h3S4tyC2Qq/OzHT6VqMWjCnG4Z60SK0rhsj8am2pXNoc3DpGnXcvlvYpiNsHehBB6/j+tJH4Wsf7Tu5TbRtbukflrk4DAENx2HSunEG0spOWYbt2MU2NSh8uTkEYYg1VkCkzB/wCEb0gBg1qrA87WbhfpVaPQtKWbZ9gjAQ5BGef1rqTFHNclUGMcAmqz2rCVycHaeB3ppITkypHZQxwER26RoPQenSod3rEQfQkH+tX5PMKAcr1yuBz6U8W6kAlBk9eBQ0K9zHdlkUJuLPjueKzNVsY721dCuXAxkd6KK1aWxmm1qec6toUlnKS0RIBznGapW0BcttIAAOQDzRRXnYmlFM9XDVpOOpHJblHePHOCRkdKoTGKPefPiZ8Z2+ZyPXgdaKK5IwVzqnJiQMqRKYxgnnG0gZ9elPAwu4K3zH5sdCffFFFVazIewIpZgc/NnjjBpxbqPmftuC9Pp6UUUyLEUzHZhTjPUkYx+NUmkEZwQSPWiiuikc1QydRCySEkYyPWqkEKIu4Yz7GiiunoZrctQxFicCtvQdHn1O6SGKJjk9cYoorS1kRKTue26X4XjtLC2hiGUXl9w7+tdVACiEbWKKMACiiixlvqK7qQTg7x2qvNCzo07KQuef8Aa96KKexL1BMxwGQA9s4PSsPWZJCcooZic4JwPoTRRWlPcyqOyGyyMwVIWzgZYZz+FaFqC0LkqQV79vzoopz2JjuNO3IkUgsBg7eOakSMmIuoAZjntRRUvQrqMiZoZP3o3t6deKVXR7kuPxC0UU/MV7E8MYimLZP7w5C9eKIbpWvmjIYFeme9FFTa5otCe4lZGJC1ejiWS0KyHy3ccAHBNFFSxrcQyF9sQ+ZAuCSc0y6BCsEQDHIx3oopDEim2ouVIb+7U5AILlWO7oc0UUMEMYkuWjx9DTYAzysNmRnnvxRRQAtzcNLJtRcRIMZHBP1FXYootiOJATjO3oRRRSeg46j8xtkgtkDGP8KfbhPJ3n7zdjRRSGVZI2ZgegHVVplwWMZSNCCOhb1ooq0IhjKiPjkk8DpUP2lxxtb8MUUU7Eydkf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Spider appears larger than actual size. Kukulcania males are approximately 6 to 9 mm long (body length, not including legs) and females are 12 to 20 mm long.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard S Vetter, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41525=[""].join("\n");
var outline_f40_35_41525=null;
var title_f40_35_41526="Thiothixene: Drug information";
var content_f40_35_41526=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Thiothixene: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/31/10741?source=see_link\">",
"    see \"Thiothixene: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/38/27237?source=see_link\">",
"    see \"Thiothixene: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6697664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F227250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Navane&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F227271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antipsychotic Agent, Typical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F227253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Mild-to-moderate psychosis:",
"     </b>",
"     Oral: 2 mg 3 times/day, up to 20-30 mg/day; more severe psychosis: Initial: 5 mg 2 times/day, may increase gradually, if necessary; maximum: 60 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rapid tranquilization of the agitated patient (administered every 30-60 minutes):",
"     </b>",
"     Oral: 5-10 mg; average total dose for tranquilization: 15-30 mg",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F227263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/38/27237?source=see_link\">",
"      see \"Thiothixene: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Children &lt;12 years (unlabeled use):",
"     </i>",
"     Oral: 0.25 mg/kg/24 hours in divided doses (dose not well established; use not recommended)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Children &gt;12 years (unlabeled use):",
"     </i>",
"     Mild-to-moderate psychosis: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F227254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nonpsychotic patient, dementia behavior (unlabeled use): Initial: 1-2 mg 1-2 times/day; increase dose at 4- to 7-day intervals by 1-2 mg/day. Increase dosing intervals (bid, tid, etc) as necessary to control response or side effects; maximum daily dose: 30 mg. Gradual increases in dose may prevent some side effects or decrease their severity.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F227255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not dialyzable (0% to 5%)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F227232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 1 mg, 2 mg, 5 mg, 10 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F227217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F227235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of schizophrenia",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F227268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Psychotic disorders (children); rapid tranquilization of the agitated patient (children); nonpsychotic patient, dementia behavior (elderly); psychosis/agitation related to Alzheimer's dementia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F227280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Thiothixene may be confused with FLUoxetine, thioridazine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Navane&reg; may be confused with Norvasc&reg;, Nubain",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F227269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension, nonspecific ECG changes, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, dizziness, drowsiness, extrapyramidal symptoms (akathisia, dystonias, lightheadedness, pseudoparkinsonism, tardive dyskinesia), insomnia restlessness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Discoloration of skin (blue-gray), photosensitivity, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, breast pain, libido (changes in), changes in menstrual cycle, galactorrhea, gynecomastia, hyper-/hypoglycemia, hyperprolactinemia, lactation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, nausea, salivation increased, stomach pain, vomiting, weight gain, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Difficulty in urination, ejaculatory disturbances, impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Leukocytes, leukopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremors",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, pigmentary retinopathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F227239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to thiothixene or any component of the formulation; severe CNS depression; circulatory collapse; blood dyscrasias; coma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F227221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered cardiac conduction: May alter cardiac conduction; life-threatening arrhythmias have occurred with therapeutic doses of antipsychotics. Avoid use in patients with underlying QT prolongation, in those taking medicines that prolong the QT interval, or cause polymorphic ventricular tachycardia; monitor ECG closely for dose-related QT effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems. Relative to other neuroleptics, thiothixene has a low potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Blood dyscrasias: Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko-/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Antipsychotic use has been associated with esophageal dysmotility and aspiration; use with caution in patients at risk of pneumonia (ie, Alzheimer's disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms: May cause extrapyramidal symptoms (EPS), including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia. Risk of dystonia (and possibly other EPS) may be greater with increased doses, use of conventional antispychotics, males, and younger patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperprolactinemia: Use is associated with increased prolactin levels; clinical significance of hyperprolactinemia in patients with breast cancer or other prolactin-dependent tumors is unknown.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): Use may be associated with NMS; monitor for mental status changes, fever, muscle rigidity, and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: May rarely cause pigmentary retinopathy and lenticular pigmentation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May be sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with severe cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo.",
"     </b>",
"     Most deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Thiothixene is not approved for the treatment of dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with narrow-angle glaucoma; condition may be exacerbated by cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis; condition may be exacerbated by cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parkinson's disease: Use with caution in patients with Parkinson's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antiemetic effects: May mask toxicity of other drugs or conditions (eg, intestinal obstruction, Reye's syndrome, brain tumor) due to antiemetic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use in patients with dementia is associated with an increased risk of mortality and cerebrovascular accidents; avoid antipsychotic use for behavioral problems associated with dementia unless alternative nonpharmacologic therapies have failed and patient may harm self or others. In addition, use may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults May also be inappropriate in older adults depending on comorbidities (eg, dementia, delirium) due to its potent anticholinergic effects (Beers Criteria). Increased risk for developing tardive dyskinesia, particularly elderly women.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F227266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F227226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F227246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid kava kava, valerian, St John's wort, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12585965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F227241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Thiothixene Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg (100): $23.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg (100): $31.31",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $47.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $66.95",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F227230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs; lipid profile, fasting blood glucose/Hgb A",
"     <sub>",
"      1c",
"     </sub>",
"     ; BMI; mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Navane (AU, BR, NL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F227220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thiothixene is a thioxanthene antipsychotic which elicits antipsychotic activity by postsynaptic blockade of CNS dopamine receptors resulting in inhibition of dopamine-mediated effects; also has alpha-adrenergic blocking activity",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F227238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: &gt;24 hours with chronic use",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill SS, Bronskill SE, Normand SL, et al, &ldquo;Antipsychotic Drug Use and Mortality in Older Adults With Dementia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 146(11):775-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/17548409/pubmed\" id=\"17548409\" target=\"_blank\">",
"        17548409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore TA, &ldquo;Schizophrenia Treatment Guidelines in the United States,&rdquo;",
"      <i>",
"       Clin Schizophr Relat Psychoses",
"      </i>",
"      , 2011, 5(1):40-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/21459738/pubmed\" id=\"21459738\" target=\"_blank\">",
"        21459738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Peabody CA, Warner MD, Whiteford HA, et al, &ldquo;Neuroleptics and the Elderly,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1987, 35(3):233-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/2880887/pubmed\" id=\"2880887\" target=\"_blank\">",
"        2880887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.  Available at file://psychiatryonline.org/guidelines.aspx",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Risse SC and Barnes R, &ldquo;Pharmacologic Treatment of Agitation Associated With Dementia,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1986, 34(5):368-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/2870097/pubmed\" id=\"2870097\" target=\"_blank\">",
"        2870097",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Saltz BL, Woerner MG, Kane JM, et al, &ldquo;Prospective Study of Tardive Dyskinesia Incidence in the Elderly,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 266(17):2402-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/1681122/pubmed\" id=\"1681122\" target=\"_blank\">",
"        1681122",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneeweiss S, Setoguchi S, Brookhart A, et al, &ldquo;Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 2007, 176(5): 627-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/17325327/pubmed\" id=\"17325327\" target=\"_blank\">",
"        17325327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneider SM, &ldquo;Neuroleptic Malignant Syndrome: Controversies in Treatment,&rdquo;",
"      <i>",
"       Am J Emerg Med",
"      </i>",
"      , 1991, 9(4):360-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/2054008/pubmed\" id=\"2054008\" target=\"_blank\">",
"        2054008",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seifert RD, &ldquo;Therapeutic Drug Monitoring: Psychotropic Drugs,&rdquo;",
"      <i>",
"       J Pharm Pract",
"      </i>",
"      , 1984, 6:403-16.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wiener JM, &ldquo;Psychopharmacology in Childhood Disorders,&rdquo;",
"      <i>",
"       Psychiatr Clin North Am",
"      </i>",
"      , 1984, 7(4):831-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41526/abstract-text/6151651/pubmed\" id=\"6151651\" target=\"_blank\">",
"        6151651",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9993 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-2BB6473422-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41526=[""].join("\n");
var outline_f40_35_41526=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6697664\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227250\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227271\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227253\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227263\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227254\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227255\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227232\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227217\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227235\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227268\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227280\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227269\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227239\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227221\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227266\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227226\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227246\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12585965\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227241\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227230\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038842\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227220\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227238\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9993\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9993|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?10/31/10741?source=related_link\">",
"      Thiothixene: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/38/27237?source=related_link\">",
"      Thiothixene: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_35_41527="Sumatriptan and naproxen: Drug information";
var content_f40_35_41527=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sumatriptan and naproxen: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/20/37189?source=see_link\">",
"    see \"Sumatriptan and naproxen: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6103466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6103470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Treximet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F6103474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antimigraine Agent;",
"     </li>",
"     <li>",
"      Nonsteroidal Anti-inflammatory Drug (NSAID), Oral;",
"     </li>",
"     <li>",
"      Serotonin 5-HT",
"      <sub>",
"       1B, 1D",
"      </sub>",
"      Receptor Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F6104156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Migraine:",
"     </b>",
"     Oral: 1 tablet (sumatriptan 85 mg and naproxen 500 mg). If a satisfactory response has not been obtained at 2 hours, a second dose may be administered (maximum: 2 tablets/24 hours).",
"     <b>",
"      Note:",
"     </b>",
"     The safety of treating an average of &gt;5 migraine headaches in a 30-day period has not been established.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F6104157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F6104158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute Dosage adjustment not necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: Use not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F6104159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mild-to-severe impairment: Use is contraindicated by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F6104165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Treximet&reg; 85/500: Sumatriptan 85 mg and naproxen sodium 500 mg [contains sodium 61.2 mg/tablet (~2.7 mEq/tablet)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F6103472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089804.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089804.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6104161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food. Swallow tablet whole; tablet should not be divided, crushed, or chewed.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F6103476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute treatment of migraine with or without aura",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6103467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Naproxen may be confused with Natacyn&reg;, Nebcin, neomycin, niacin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       SUMAtriptan may be confused with somatropin, ZOLMitriptan",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Treximet&reg; may be confused with Trexall&trade;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6104126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Chest pain/discomfort (3%), palpitation (&gt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness (4%), somnolence (3%), fatigue (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (3%), dyspepsia (2%), xerostomia (2%), abdominal pain (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Neck, throat, and jaw pain/tightness/pressure (3%), paresthesia (2%), weakness (&ge;1%), muscle tightness (&gt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Feeling hot (&gt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &le;1% (Limited to important or life-threatening): Abdominal distention, acute coronary syndrome, ambulation difficulties, anemia, anxiety, aphasia, arthralgia, asthma, attention disturbances, back pain, biliary colic, bruising, burning, cardiac flutter, cataract, CHF, colitis, conjunctival hemorrhage, conjunctivitis, constipation, cough, depression, diabetes mellitus, diarrhea, disorientation, diverticulitis, dysgeusia, dysphagia, dyspnea, ear pain, epistaxis, facial edema, facial palsy, fever, flatulence, flushing, gastric ulcer, gastritis, gastroesophageal reflux, goiter, heaviness sensation, hyperhidrosis, hypertension, hypoglycemia, hypothyroidism, infection (various), insomnia, irritability, irritable bowel syndrome, jittery, lethargy, leukopenia, lymphadenopathy, malaise, mental impairment, motion sickness, myalgia, nephrolithiasis, nervousness, oral mucosal blistering, oropharyngeal edema, panic attacks, peripheral coldness, peripheral edema, pleurisy, pruritus, psychomotor impairment, rash, renal insufficiency, right ventricular failure, sedation, systemic lupus erythematosus, tachycardia, temperature intolerance, thirst, tinnitus, tongue edema, tremor, urticaria, ventricular extrasystoles, vertigo, viral myocarditis, visual disturbance, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6103482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sumatriptan, naproxen, aspirin, other NSAIDs, or any component of the formulation; patients with a history of ischemic heart disease or signs or symptoms of ischemic heart disease (including Prinzmetal's angina, angina pectoris, myocardial infarction, silent myocardial ischemia); patients with a history of or signs/symptoms of cerebrovascular syndromes (including strokes, transient ischemic attacks); patients with a history of or signs/symptoms of peripheral vascular syndromes (including ischemic bowel disease); patients who have had coronary artery bypass (CABG) surgery; uncontrolled hypertension; use within 24 hours of ergotamine derivatives; use within 24 hours of another 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist; concurrent administration or within 2 weeks of discontinuing an MAO inhibitor, specifically MAO type A inhibitors; management of hemiplegic or basilar migraine; prophylactic treatment of migraine; hepatic impairment",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6103491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid reactions: Even in patients without prior exposure anaphylactoid reactions may occur; patients with \"aspirin triad\" (bronchial asthma, aspirin intolerance, rhinitis) may be at increased risk. Do not use in patients who experience bronchospasm, asthma, rhinitis, or urticaria with NSAID or aspirin therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular events:",
"     <b>",
"      [U.S. Boxed Warning]: Associated with an increased risk of adverse cardiovascular thrombotic events, including MI and stroke.",
"     </b>",
"     Risk may be increased with duration of use or pre-existing cardiovascular risk factors or disease. Avoid use in heart failure. Should not be given to patients with documented CAD, history of CABG (contraindicated), or who have risk factors for CAD (eg, hypertension, hypercholesterolemia, smoker, obesity, diabetes, strong family history of CAD, menopause, male &gt;40 years of age) without adequate cardiac evaluation. Patients with suspected CAD should have cardiovascular evaluation to rule out CAD before considering use; if cardiovascular evaluation is &ldquo;satisfactory,&rdquo; first dose should be given in the healthcare provider's office (consider ECG monitoring). Periodic evaluation of cardiovascular status should be done in all patients. Coronary artery vasospasm, transient ischemia, myocardial infarction, ventricular tachycardia/fibrillation, cardiac arrest, and death have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist administration. Patients who experience sensations of chest pain/pressure/tightness or symptoms suggestive of angina following dosing should be evaluated for coronary artery disease or Prinzmetal's angina before receiving additional additional doses; if dosing is resumed and similar symptoms recur, monitor with ECG.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cerebrovascular events: Cerebral/subarachnoid hemorrhage and stroke have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May cause drowsiness, dizziness, blurred vision, and other neurologic effects which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Discontinue use with blurred or diminished vision and perform ophthalmologic exam. Periodically evaluate vision in all patients receiving long term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elevated blood pressure: Significant elevation in blood pressure, including hypertensive crisis, has also been reported on rare occasions in patients with and without a history of hypertension; contraindicated in patients with uncontrolled hypertension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal events:",
"     <b>",
"      [U.S. Boxed Warning]: NSAIDs may increase risk of gastrointestinal irritation, inflammation, ulceration, bleeding, and perforation.",
"     </b>",
"     These events may occur at any time during therapy and without warning. Use caution with a history of GI disease (bleeding or ulcers), concurrent therapy with aspirin, anticoagulants and/or corticosteroids, smoking, use of alcohol, the elderly or debilitated patients. Use the lowest effective dose for the shortest duration of time, consistent with individual patient goals, to reduce risk of GI adverse events; alternate therapies should be considered for patients at high risk. When used concomitantly with &le;325 mg of aspirin, a substantial increase in the risk of gastrointestinal complications (eg, ulcer) occurs; concomitant gastroprotective therapy (eg, proton pump inhibitors) is recommended (Bhatt, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: Platelet adhesion and aggregation may be decreased; may prolong bleeding time; patients with coagulation disorders or who are receiving anticoagulants should be monitored closely. Anemia may occur; patients on long-term NSAID therapy should be monitored for anemia. Rarely, NSAID use has been associated with potentially severe blood dyscrasias (eg, agranulocytosis, thrombocytopenia, aplastic anemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Severe hepatic reactions (eg, fulminant hepatitis, liver failure) have occurred with NSAID use, rarely; use is contraindicated in patients with existing hepatic impairment. Closely monitor patients with any abnormal LFT; discontinue if signs or symptoms of liver disease develop, or if systemic manifestations occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperkalemia: NSAID use may increase the risk of hyperkalemia, particularly in the elderly, diabetics, renal disease, and with concomitant use of other agents capable of inducing hyperkalemia (eg, ACE-inhibitors). Monitor potassium closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin reactions: NSAIDs may cause serious skin adverse events including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN); discontinue use at first sign of skin rash or hypersensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vasospasm-related events: Peripheral vascular ischemia and colonic ischemia have been reported with 5-HT",
"     <sub>",
"      1",
"     </sub>",
"     agonist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Do not administer to patients with aspirin-sensitive asthma; severe bronchospasm may occur. Use caution in patients with other forms of asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure/edema: Use with caution in patients with heart failure or fluid retention; edema has occurred in patients receiving NSAIDs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: NSAID use may compromise existing renal function; dose-dependent decreases in prostaglandin synthesis may result from NSAID use, reducing renal blood flow which may cause renal decompensation. Patients with impaired renal function, dehydration, heart failure, liver dysfunction, those taking diuretics, and ACE inhibitors, and the elderly are at greater risk of renal toxicity. Rehydrate patient before starting therapy; monitor renal function closely. Not recommended for use in patients with advanced renal disease (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute). Long-term NSAID use may result in renal papillary necrosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with history of seizure disorder or in patients with a lowered seizure threshold; seizures have been reported in patients receiving sumatriptan.",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Serotonin syndrome: Symptoms of agitation, confusion, hallucinations, hyper-reflexia, myoclonus, shivering, and tachycardia may occur with concomitant proserotonergic drugs (ie, SSRIs/SNRIs or triptans) or agents which reduce sumatriptan's metabolism. Concurrent use of serotonin precursors (eg, tryptophan) is not recommended.  If concomitant administration with SSRIs is warranted, monitor closely, especially at initiation and with dose increases.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Only indicated for treatment of acute migraine; if a patient does not respond to the first dose, the diagnosis of migraine should be reconsidered.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6104143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of other Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Agents with Antiplatelet Properties. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Agents with Antiplatelet Properties. This interaction is likely specific to aspirin, and not to other antiplatelet agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Aliskiren. Nonsteroidal Anti-Inflammatory Agents may enhance the nephrotoxic effect of Aliskiren.  Management: Monitor renal function periodically in patients receiving aliskiren and any nonsteroidal anti-inflammatory agent.  Patients at elevated risk of renal dysfunction include those who are elderly, are volume depleted, or have pre-existing renal dysfunction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Nonsteroidal Anti-Inflammatory Agents may decrease the excretion of Aminoglycosides. Data only in premature infants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Angiotensin II Receptor Blockers. The combination of these two agents may also significantly decrease glomerular filtration and renal function.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Nonsteroidal Anti-Inflammatory Agents may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Tricyclic, Tertiary Amine): May enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Nonsteroidal Anti-Inflammatory Agents may enhance the nephrotoxic effect of CycloSPORINE (Systemic). Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of CycloSPORINE (Systemic). CycloSPORINE (Systemic) may increase the serum concentration of Nonsteroidal Anti-Inflammatory Agents. Specifically, elevated diclofenac concentrations have been reported.  Management: Consider alternatives to nonsteroidal anti-inflammatory agents (NSAIDs).  Monitor for evidence of nephrotoxicity, as well as increased serum cyclosporine concentrations and systemic effects (e.g., hypertension) during concomitant therapy with NSAIDs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Digoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: When possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Eplerenone. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the vasoconstricting effect of Serotonin 5-HT1D Receptor Agonists. Serotonin 5-HT1D Receptor Agonists may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Bleeding may occur. Management: Concomitant treatment with these agents should generally be avoided. If used concomitantly, increased diligence in monitoring for adverse effects (eg, bleeding, bruising, altered mental status due to CNS bleeds) must be employed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrALAZINE: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of HydrALAZINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the diuretic effect of Loop Diuretics.  Management: Monitor for decreased therapeutic effects of loop diuretics with concurrent use of an NSAID. Consider avoiding concomitant use of these agents in CHF or cirrhosis with ascites. Concomitant use of bumetanide with indomethacin is  not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May decrease the metabolism of Serotonin 5-HT1D Receptor Agonists. Management: If MAO inhibitor therapy is required, naratriptan, eletriptan or frovatriptan may be a suitable 5-HT1D agonist to employ.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Agents with Antiplatelet Properties. This interaction is likely specific to aspirin, and not to other antiplatelet agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of other Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of nonsteroidal antiinflammatory drugs (NSAIDs) with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PEMEtrexed: NSAID (Nonselective) may increase the serum concentration of PEMEtrexed.  Management: Patients with mild-to-moderate renal insufficiency (estimated creatinine clearance 45-79 mL/min) should avoid NSAIDs for 2-5 days prior to, the day of, and 2 days after pemetrexed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Potassium-Sparing Diuretics. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of PRALAtrexate. More specifically, NSAIDS may decrease the renal excretion of pralatrexate.  Management: Closely monitor for increased pralatrexate serum levels and/or toxicity if used concomitantly with an NSAID. Monitor for decreased pralatrexate serum levels with NSAID discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Nonsteroidal Anti-Inflammatory Agents may enhance the neuroexcitatory and/or seizure-potentiating effect of Quinolone Antibiotics. Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Quinolone Antibiotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: NSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Choline Magnesium Trisalicylate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the antiplatelet effect of NSAID (Nonselective). NSAID (Nonselective) may diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors. Management: Consider using alternative analgesics, when appropriate, and/or addition of an gastroprotective agent.  Monitor patients closely for signs/symptoms of bleeding, and for evidence of diminished SSRI effectiveness with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: May enhance the nephrotoxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with NSAIDs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vancomycin: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Vancomycin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): NSAID (Nonselective) may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F6103477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6103478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal studies. There are no well-controlled studies in pregnant women. Women exposed to this combination during pregnant are encouraged to contact the Treximet&reg; Pregnancy Registry (800-336-2176). Also refer to individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6103480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6103481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sumatriptan and naproxen are excreted in breast milk. Breast-feeding is not recommended. Also refer to individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F6104160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food. Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Treximet Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     85-500 mg (9): $275.47",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6104163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Occult blood loss; periodic liver function test, CBC, BUN, serum creatinine; urine output; blood pressure; periodic cardiovascular evaluation (long-term use)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6104150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sumatriptan: Selective agonist for serotonin (5-HT",
"     <sub>",
"      1B",
"     </sub>",
"     and 5-HT",
"     <sub>",
"      1D",
"     </sub>",
"     receptors) in cranial arteries; causes vasoconstriction and reduces sterile inflammation associated with antidromic neuronal transmission correlating with relief of migraine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Naproxen: Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which result in decreased formation of prostaglandin precursors; has antipyretic, analgesic, and anti-inflammatory properties",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6104152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bhatt DL, Scheiman J, Abraham NS, et al, &ldquo;ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risk of Antiplatelet Therapy and NSAID Use. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2008, 52(18):1502-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/19017521/pubmed\" id=\"19017521\" target=\"_blank\">",
"        19017521",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boyd IW and Rohan AP, &ldquo;Sumatriptan - Induced Chest Pain,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1994, 344(8939):1704-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/7996981/pubmed\" id=\"7996981\" target=\"_blank\">",
"        7996981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boyer EW and Shannon M, &ldquo;The Serotonin Syndrome,&rdquo;",
"      <i>",
"       New Engl J Med",
"      </i>",
"      , 2005, 352:1112-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/15784664/pubmed\" id=\"15784664\" target=\"_blank\">",
"        15784664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clive DM and Stoff JS, &ldquo;Renal Syndromes Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1984, 310(9):563-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/6363936/pubmed\" id=\"6363936\" target=\"_blank\">",
"        6363936",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Diamond S, &ldquo;The Use of Sumatriptan in Patients on Monoamine Oxidase Inhibitors,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 1995, 45(6):1039-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/7783861/pubmed\" id=\"7783861\" target=\"_blank\">",
"        7783861",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heerdink ER, Leufkens HG, Herings RM, et al, &ldquo;NSAIDs Associated With Increased Risk of Congestive Heart Failure in Elderly Patients Taking Diuretics,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1998, 158(10):1108-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/9605782/pubmed\" id=\"9605782\" target=\"_blank\">",
"        9605782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ottervanger JP, et al, &ldquo;Characteristics of Sumatriptan-Induced Chest Pain,&rdquo;",
"      <i>",
"       Pharm World Sci",
"      </i>",
"      , 1995, 17:3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ottervanger JP, et al, &ldquo;Determinants of Sumatriptan-Induced Chest Pain,&rdquo;",
"      <i>",
"       Pharm World Sci",
"      </i>",
"      , 1995, 17:7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Page J and Henry D, &ldquo;Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2000, 160(6):777-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/35/41527/abstract-text/10737277/pubmed\" id=\"10737277\" target=\"_blank\">",
"        10737277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stricker BH, &ldquo;Coronary Vasospasm and Sumatriptan,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 1992, 305(6845):118.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9494 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-E03BC582ED-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41527=[""].join("\n");
var outline_f40_35_41527=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103466\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103470\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103474\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104156\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104157\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104158\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104159\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104165\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103472\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874992\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104161\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103476\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103467\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104126\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103482\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103491\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300102\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104143\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103477\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103478\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103480\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6103481\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104160\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570422\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104163\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104150\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6104152\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9494\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9494|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?36/20/37189?source=related_link\">",
"      Sumatriptan and naproxen: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_35_41528="Porokeratosis ptychotropica";
var content_f40_35_41528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53110%7EDERM%2F61803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53110%7EDERM%2F61803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Porokeratosis ptychotropica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scaly plaques are present in the gluteal fold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Porokeratosis ptychotropica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scaly plaques are present in the gluteal fold. Cornoid lamellae are visible in some areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41528=[""].join("\n");
var outline_f40_35_41528=null;
var title_f40_35_41529="Gastrointestinal manifestations of systemic sclerosis (scleroderma)";
var content_f40_35_41529=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gastrointestinal manifestations of systemic sclerosis (scleroderma)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Stephanie A Kaye-Barrett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Christopher P Denton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     John S Axford, DSc, MD, FRCP, FRCPCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/35/41529/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/35/41529/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly 90 percent of patients with systemic sclerosis (scleroderma) have some degree of gastrointestinal (GI) involvement, with approximately one-half being symptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These problems contribute significantly to patient morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Severe GI problems, including malabsorption and intestinal pseudoobstruction, are much less common, affecting less than 10 percent of patients during the first nine years of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/5\">",
"     5",
"    </a>",
"    ]. The earliest visceral manifestation to be described was esophageal disease, which remains the most common source of GI symptoms in scleroderma. It has since been demonstrated that any part of the gastrointestinal tract (from mouth to anus) may be involved (",
"    <a class=\"graphic graphic_table graphicRef55280 \" href=\"mobipreview.htm?2/35/2621\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The issues relating to the pathogenesis, clinical manifestations, and diagnosis of gastrointestinal disease in systemic sclerosis (SSc) will be reviewed here. Treatment of these problems is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11415?source=see_link\">",
"     \"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSc is associated with alterations of the microvasculature, the autonomic nervous system, and the immune system, leading to fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/63/19450?source=see_link\">",
"     \"Pathogenesis of systemic sclerosis (scleroderma)\"",
"    </a>",
"    .) These same mechanisms may play important and interconnected roles in the pathogenesis of GI involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alterations in small vessel function may arise due to variations in neurohumoral mediators such as acetylcholine, norepinephrine, bradykinin, arachidonic acid metabolites, nitric oxide, and the endothelins. Physical agents such as cold temperature and trauma also affect vessel tone and diameter.",
"     </li>",
"     <li>",
"      Cytokines mediate inflammation and may contribute to connective tissue deposition and remodeling interacting with multiple cell types.",
"     </li>",
"     <li>",
"      Endothelial and mast cells and fibroblasts are the cells largely responsible for fibrotic and vascular changes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal pathological abnormalities of the GI tract consist of smooth muscle atrophy and gut wall fibrosis. Such abnormalities are generally similar throughout the entire system.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Villous architecture is generally normal, although there have been individual case reports of partial villous flattening in association with pseudo-obstruction or concurrent celiac disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. Epithelial cell morphology is also normal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/10,13\">",
"       10,13",
"      </a>",
"      ]. However, there is frequently a mild infiltration of the lamina propria with chronic inflammatory cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Collagenous encapsulation of Brunner's glands, periglandular sclerosis, and fibrous replacement of the muscularis may be found in the submucosa (",
"      <a class=\"graphic graphic_picture graphicRef62854 \" href=\"mobipreview.htm?0/34/548\">",
"       picture 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/15\">",
"       15",
"      </a>",
"      ]. Atrophic changes and fibrosis are more marked in the circular than in the longitudinal layers, and muscle atrophy appears to exceed fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although it has been previously reported that autonomic nerves appear normal by electron and light microscopy, electron microscopy studies have shown axonal degeneration and neuronal collagen cuffing (",
"      <a class=\"graphic graphic_picture graphicRef54076 \" href=\"mobipreview.htm?12/6/12388\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Vascular abnormalities include myointimal proliferation, luminal narrowing and obliteration, disruption of the internal elastic lamina, and capillary basement membrane thickening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sj&ouml;gren advanced the theory that SSc affects the gastrointestinal tract by an orderly series of steps that result in progressive dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/9\">",
"     9",
"    </a>",
"    ]. According to this hypothesis, the disease begins with an initial neural disorder, progresses to muscle dysfunction, and ends with fibrosis. Immunohistologic examination of surgically or endoscopically obtained gastric biopsies from 14 patients with SSc found expression of profibrotic cytokines in the gastric wall of those patients with SSc and gut disease. This series of biopsy and post mortem specimens, together with surgical samples, confirmed the presence of inflammatory cell infiltrates and highlighted the microvascular and neuronal alterations. The presence of fibrosis and replacement of smooth muscle cell layers with scar tissue suggest a multifaceted pathogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first stage begins with early neural dysfunction, which may be a consequence of vascular derangement or collagen deposits. The first possibility is supported by a study of the esophagus, which showed reversal of hypomotility and Raynaud phenomenon with an intraarterial injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/35/16950?source=see_link\">",
"     reserpine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, another report showed intimal proliferation and occlusion of the small arteries and arterioles of the esophagus in 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/20\">",
"     20",
"    </a>",
"    ]. The same process may affect the vasa nervorum.",
"   </p>",
"   <p>",
"    Compression of nerve fibers by collagen deposits has been offered as an alternative explanation for neural dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/21\">",
"     21",
"    </a>",
"    ]. An ultrastructural study has demonstrated perineuronal collagen cuffing in the small intestine (",
"    <a class=\"graphic graphic_picture graphicRef54076 \" href=\"mobipreview.htm?12/6/12388\">",
"     picture 2",
"    </a>",
"    ). This initial neuronal abnormality may then result in dysfunction of smooth muscle. At this stage, the muscle may still respond to prokinetic agents since it is not primarily weak. After prolonged ineffective neuronal stimulation, however, the muscle may become progressively weaker. Such functional abnormalities may remain asymptomatic for long periods of time.",
"   </p>",
"   <p>",
"    A third possibility is autoimmune-mediated injury. In one study, high titer antibodies directed against myenteric neurons were detected in 19 of 41 patients with SSc but not in normal controls of patients with idiopathic gastrointestinal dysmotility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/22\">",
"     22",
"    </a>",
"    ]. The presence of CD4+ lymphocytes in the gastric mucosa and fibrosis have also been noted, emphasizing a complex pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The second stage of small bowel disease occurs with smooth muscle atrophy. Most patients present with symptoms at this stage. This is followed by the final stage of muscle fibrosis. At this point, the muscle is incapable of responding to stimuli.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of the gut occurs with equal frequency among patients with the diffuse (dcSSc) and limited subtypes of SSc (lcSSc) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/24\">",
"     24",
"    </a>",
"    ]. It is rare in localized scleroderma syndromes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/3/44087?source=see_link\">",
"     \"Classification of scleroderma disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of malabsorption and esophageal dysfunction among patients with SSc is associated with an unfavorable prognosis. Among 264 patients with dcSSc, for example, 5 percent died from GI complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/26\">",
"     26",
"    </a>",
"    ]. It is, therefore, important to recognize such involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OROPHARYNGEAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSc may affect the oral and perioral tissues. This can lead to rigidity of the facial skin and tongue and can result in impaired mastication and deglutition. These functions can be further compromised when sicca syndrome and SSc coexist, since saliva production is severely reduced with sicca syndrome.",
"   </p>",
"   <p>",
"    Oropharyngeal dysphagia and incoordination occur in up to 25 percent of patients with SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. This may lead to oral leakage, retention, and aspiration and may result in a sense of food sticking in the throat, nasal regurgitation, and coughing after swallowing.",
"   </p>",
"   <p>",
"    Patients develop narrowing of the oral aperture, as well as rigidity and thinning of the soft palate, larynx, and oral mucosa (which may also become tender). Extrinsic pressure from skin changes may cause resorption of alveolar bone and malalignment of teeth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ESOPHAGEAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal dysfunction as detected by motility testing has been found in as many as 90 percent of patients of SSc. However, many of these patients are asymptomatic. When present, symptoms may be produced by gastroesophageal reflux, stricture formation, and abnormal motility. The upper skeletal muscle portion of the esophagus is rarely involved, although thickening of the pharyngoesophageal muscles with collagenous tissue has been reported to cause dysphagia of the upper esophagus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal manometric findings include a reduction in, or absence of, peristaltic waves in the lower two-thirds of the esophagus and a significant decrease in lower esophageal sphincter tone. These abnormalities were previously thought to result from infiltration and replacement of smooth muscle fibers by collagen. However, postmortem examination of patients with suspected esophageal involvement has failed to reveal excessive collagen deposition but frequently shows smooth muscle atrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations suggest that the esophageal muscle dysfunction may be secondary to a neuronal abnormality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients with SSc and",
"    <strong>",
"     normal",
"    </strong>",
"    peristalsis were found to have elevated lower esophageal sphincter pressure, which increased further after administration of either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    (a cholinergic agonist) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35156?source=see_link\">",
"     edrophonium",
"    </a>",
"    (a cholinesterase inhibitor). However, the administration of gastrin I, which releases acetylcholine, produced a smaller rise in lower esophageal pressure, suggesting latent cholinergic nerve dysfunction. Similar findings were found in patients with primary Raynaud phenomenon; as a result, there may be a common neurogenic abnormality in both disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By comparison, patients with",
"    <strong>",
"     abnormal",
"    </strong>",
"    peristalsis and low sphincter tone eventually failed to respond to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35156?source=see_link\">",
"     edrophonium",
"    </a>",
"    and later became unresponsive to direct stimulation by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/29\">",
"     29",
"    </a>",
"    ]. These pharmacologic responses correlated well with disease duration, suggesting a progression from latent neurogenic dysfunction to muscle atrophy.",
"   </p>",
"   <p>",
"    Some patients have prolonged cold-induced vasospasm in the vessels of the esophagus (esophageal Raynaud phenomenon) concurrently with Raynaud phenomenon of the hands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/30\">",
"     30",
"    </a>",
"    ]. A role for abnormal neural function was suggested by the finding that reversal of this vasospasm by intraarterial injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/35/16950?source=see_link\">",
"     reserpine",
"    </a>",
"    relieved both Raynaud phenomenon and abnormal esophageal motility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;At postmortem examination, the muscle of the lower esophagus may be partly replaced by fibrous tissue. The lamina propria and submucosa often contain increased quantities of collagen, and the mucosa frequently shows the inflammatory changes of esophagitis. In severe esophagitis, leukoplakia or Barrett's esophagus may be present (with or without fibrous stricture formation). Since patients with Barrett's esophagus have an increased risk of adenocarcinoma of the esophagus, such an association would be expected in SSc. However, esophageal adenocarcinoma appears to be rare in SSc, as a review of the English literature in 1985 revealed only 13 reported cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current advice is for repeat endoscopy and biopsy at two yearly intervals in cases of SSc that have demonstrated Barrett's esophagus, but the risk of progression to malignant disease is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incompetent lower esophageal sphincter leads to gastroesophageal reflux. In turn, acid reflux may result in:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe inflammation of the lower esophagus (reflux esophagitis) and subsequent stricture formation",
"     </li>",
"     <li>",
"      Diffuse esophageal spasm",
"     </li>",
"     <li>",
"      Hypertonic upper esophageal sphincter",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients may complain of heartburn (acid reflux) and food \"sticking\" (dysphagia). Patients with advanced dysphagia may regurgitate food and fluids.",
"   </p>",
"   <p>",
"    Dysphagia may result from reduced peristalsis and stricture formation, particularly when the luminal diameter is less than 13 mm. Stricture formation markedly decreases gastroesophageal reflux and the symptoms of heartburn. During or immediately after stricture dilatation, marked reflux returns, and patients are at risk of aspiration into the bronchial tree. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/38/13928?source=see_link\">",
"     \"Pathophysiology of reflux esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with established SSc, the onset of upper gastrointestinal symptoms (such as dysphagia or heartburn) indicates the presence of esophageal disease. Classic manometric findings consist of an incompetent lower esophageal sphincter, low amplitude contractions in the distal smooth muscle portion of the esophagus, and (in advanced disease) diminished peristalsis in the upper skeletal muscle portion. Importantly, motility studies have shown that up to 40 percent of patients with abnormal motor activity of the esophagus are asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In view of the high proportion of asymptomatic patients, various methods are required to establish esophageal involvement in this disorder.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Manometry and radiographic examinations &ndash; Conventional radiology (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      swallow) is less sensitive than manometry in detecting abnormal motility in SSc. Studies that compared both techniques demonstrated abnormalities in 85 to 90 percent of cases using manometry versus 60 to 70 percent with radiographic methods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/33\">",
"       33",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Diagnostic accuracy may be substantially improved by cin&eacute; radiography, and radionuclide transit measurements have been reported to be as accurate as esophageal manometry when the transit of a bolus of 99-Tc sulphur colloid in water is used [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/34\">",
"       34",
"      </a>",
"      ]. Further refinements have included the use of a semi-solid radioactive meal 99-Tc-tin colloid and a simplified method of grading abnormalities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/35\">",
"       35",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Since manometric abnormalities are present in over 80 percent of cases of SSc, such measurements remain the most accurate method for evaluating esophageal function in this disorder. The procedure, however, is time consuming and may have low patient acceptance. By comparison, scintigraphy is noninvasive, is easy to perform, and has high patient acceptance. For these reasons, scintigraphy (if available) may be used for disease detection in asymptomatic disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/35\">",
"       35",
"      </a>",
"      ]. The use of specific tests for screening is probably of value only when the underlying diagnosis of SSc is uncertain. In such a situation, manometry and scintigraphy are both sensitive tools. Scintigraphy has an especially good tolerability. The value of repeat scintigraphic assessment is uncertain, but this technique is substantially less invasive than manometry. Studies have failed to demonstrate improvement in scintigraphy even with adequate control of reflux symptoms using proton pump inhibitor drugs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/36\">",
"       36",
"      </a>",
"      ]. If scintigraphy is not available, we advise manometry or barium swallow when confirmation of the diagnosis is needed. If there is concern about stricture or if food bolus obstruction is a feature of the history, then barium swallow should be performed.",
"     </li>",
"     <li>",
"      Esophagoscopy &ndash; Although esophagoscopy provides little information on smooth muscle function, it enables accurate diagnosis of mucosal abnormalities such as reflux esophagitis, candidiasis, Barrett's esophagus, and esophageal stricture. In addition, the technique allows dilatation of strictures or mucosal rings by Maloney or Savery dilators. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11415?source=see_link\">",
"       \"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Esophagoscopy is indicated in patients if they have persistent and progressive symptoms of heartburn or dysphagia that are refractory to proton pump inhibitor (PPI) or if there is suspicion of candidal esophagitis or odynophagia. It may be appropriate if",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      swallow suggests stricture formation or raises concern about possible malignancy. The prevalence of Barrett's metaplasia in PPI-treated SSc patients (13 percent in one study) is similar to that in other patients with gastroesophageal reflux [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/37\">",
"       37",
"      </a>",
"      ]. If any metaplasia is seen on biopsy, then repeat studies are essential. The frequency of screening esophagoscopy and the appropriate response to dysplasia, if present, are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link\">",
"       \"Management of Barrett's esophagus\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GASTRIC INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histological abnormalities of the stomach consist of submucosal collagen deposition and replacement of smooth muscle with fibrous tissue. These pathologic changes are less marked than those of the esophagus or small intestine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stomach is not usually the primary source of symptoms in gastrointestinal SSc, but it may contribute to esophageal symptoms when emptying is delayed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/38\">",
"     38",
"    </a>",
"    ]. Rarely, severe involvement of the stomach results in gastroparesis with intractable vomiting, which may cause weight loss and nutritional deficiencies. The symptoms are intermittent, with remissions lasting several months.",
"   </p>",
"   <p>",
"    Massive upper gastrointestinal bleeding secondary to mucosal telangiectasia (as part of the CREST syndrome) can also occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/39\">",
"     39",
"    </a>",
"    ]. Gastric antral venous ectasia (GAVE) is an increasingly recognized complication of SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/40\">",
"     40",
"    </a>",
"    ]. It is best diagnosed by gastroscopy. Clinical suspicion should be high, particularly in patients with unexplained iron deficiency anemia. Treatment is successful using laser photocoagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/41\">",
"     41",
"    </a>",
"    ] or Argon plasma coagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/42\">",
"     42",
"    </a>",
"    ], although treatments may have to be repeated. There is increasing recognition of this complication in both major subsets of SSc, and in dcSSc improvement can occur in association with stabilization or resolution of skin sclerosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41865?source=see_link\">",
"     \"Uncommon causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most sensitive method of detecting gastric involvement is via radionuclide gastric emptying [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    meal may reveal a dilated atonic stomach, and endoscopy may show a lack of peristalsis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/12/43209?source=see_link\">",
"     \"Etiology and diagnosis of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SMALL INTESTINAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal small bowel function has been reported in 20 to 60 percent of patients with SSc, and more than one-half have a histologic abnormality at post-mortem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of studies on the small intestine point toward an underlying neuromuscular disorder similar to that in the esophagus:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recordings of duodenal myoelectric activity in patients with SSc have revealed normal basal slow wave and spike potential activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/43\">",
"       43",
"      </a>",
"      ]. However, the response to mechanical and humoral stimuli in this study was abnormal. The majority of patients showed an abnormally low spike response to distension, while a smaller group exhibited a diminished response to exogenous pentagastrin and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/49/28435?source=see_link\">",
"       secretin",
"      </a>",
"      . These results suggest a defect in the intrinsic cholinergic pathway that mediates the spike response to distension. The group that failed to respond to humoral stimuli had longer disease duration and probably more severe disease. These findings were supported by another study, which found abnormal motor activity as measured by intraluminal pressure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another report found that proximal small bowel postcibal motility was usually reduced in symptomatic patients and that a minority of patients had uncoordinated fasting or postcibal hypermotility suggestive of a neuropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/45\">",
"       45",
"      </a>",
"      ]. These results support the hypothesis that both neuropathic and myopathic stages occur in the small bowel of patients with SSc.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light microscopy reveals few clues to the evolution of the pathology of small intestinal involvement in SSc. Villous structure is normal, but there may be collagen deposition around Brunner's glands, leading to periglandular sclerosis. This feature is said to be pathognomonic of intestinal SSc and may occur in the absence of radiologic changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/15\">",
"     15",
"    </a>",
"    ]. Unfortunately, this finding is of limited clinical value since small intestinal biopsies rarely include the submucosal layer. Full thickness biopsies may reveal a marked increase in submucosal and serosal collagen and elastin as well as atrophy of the smooth muscle layers.",
"   </p>",
"   <p>",
"    Electron microscopy has shown reduced numbers of smooth muscle cells in the external muscle layers and a marked paucity of junctional complexes between muscle cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/46\">",
"     46",
"    </a>",
"    ]. In addition, we have found evidence of perineuronal collagen cuffing, neuronal degeneration in the absence of collagen cuffing, and perivascular fibrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 to 30 percent of patients with SSc have evidence of malabsorption. Intestinal stasis with overgrowth of bacteria is considered to be the major cause of this complication. One study, for example, performed jejunal aspirates in 20 unselected patients with SSc; bacterial overgrowth, defined as &gt;10",
"    <sup>",
"     6",
"    </sup>",
"    <span class=\"nowrap\">",
"     organisms/mL,",
"    </span>",
"    was present in one-third [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/47\">",
"     47",
"    </a>",
"    ]. The majority of patients with bacterial overgrowth had small bowel involvement and steatorrhea; by comparison, patients with normal bacterial counts had normal intestinal function.",
"   </p>",
"   <p>",
"    How bacteria impair nutrient digestion or cellular transport in patients with malabsorption is still poorly understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. One proposed mechanism is that bacteria deconjugate and dehydroxylate conjugated bile salts, thereby reducing fat emulsification and micelle formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/32,50\">",
"     32,50",
"    </a>",
"    ]. Additional possibilities include vasculopathy, lymphatic obstruction, wall fibrosis, impaired motility, and pancreatic dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. However, apart from minimal inflammatory cell infiltrates, villous morphology appears normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/52,54\">",
"     52,54",
"    </a>",
"    ]. Furthermore, no defect in intestinal permeability was found in one report as estimated by the oral administration of cellobiose (a disaccharide) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    (a polyhydric alcohol) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major manifestations of small intestinal involvement are due to reduced peristalsis with resulting stasis and intestinal dilatation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/55\">",
"     55",
"    </a>",
"    ]. This results in abdominal distension and pain arising from dilated bowel loops. Bacterial overgrowth subsequently emerges due to intestinal stasis and pooling. As fat malabsorption ensues, the patient's symptoms may change from distension, pain, bloating, and constipation to diarrhea, steatorrhea, and weight loss.",
"   </p>",
"   <p>",
"    A rare complication is intestinal pseudo-obstruction, resulting in recurrent obstructive symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/46,56\">",
"     46,56",
"    </a>",
"    ]. Affected patients typically complain of an alteration in bowel habit with diarrhea, constipation, or both (intermittently). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/26/2474?source=see_link\">",
"     \"Chronic intestinal pseudo-obstruction\"",
"    </a>",
"    .) In comparison, persistent diarrhea and steatorrhea are most likely due to fat malabsorption. Other rare complications are small bowel perforation, pneumatosis cystoides intestinalis, and small bowel volvulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11415?source=see_link\">",
"     \"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Detection of bacterial overgrowth",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for the detection of bacterial overgrowth is small bowel aspiration. It is not ideal, however, since it is invasive and may need to be repeated due to bacteria regrowth. By comparison, the glucose hydrogen breath test is a noninvasive examination, although false negative results may occur when the predominant organisms produce CO",
"    <sub>",
"     2",
"    </sub>",
"    . A study compared a per-endoscopic method of small bowel aspiration using a sterile double-lumen tube with the glucose hydrogen breath test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/54\">",
"     54",
"    </a>",
"    ]. Of the 21 patients studied, only one had a false negative glucose hydrogen breath test for bacterial overgrowth. There were no false positives.",
"   </p>",
"   <p>",
"    We recommend initial screening with a glucose hydrogen breath test. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11990?source=see_link\">",
"     \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We perform aspiration in patients who have developed resistance to rotating antibiotics, as manifested by diarrhea that is difficult to control with empirical antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11415?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)\", section on 'Malabsorption'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiological examination using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    remains the most sensitive and specific technique available for the diagnosis of small bowel disease in SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/61\">",
"     61",
"    </a>",
"    ]. Superior visualization of jejunal and ileal loops plus evaluation of small bowel transit time can be achieved using small bowel follow through with intubation of the duodenum and instillation of contrast directly into the small intestine. Alternatively, a small bowel enema may be performed. Unfortunately, collagen deposition can occur before radiographic abnormalities become apparent.",
"   </p>",
"   <p>",
"    Dilatation of intestinal loops is the most prominent radiographic feature when absence of peristalsis affects the duodenum and proximal jejunum. A characteristic sign of small bowel SSc is a &ldquo;hide-bound&rdquo; or &ldquo;wire-spring&rdquo; appearance produced by closely packed valvulae in a dilated bowel (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51096 \" href=\"mobipreview.htm?31/51/32575\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/62\">",
"     62",
"    </a>",
"    ]. This finding is due to neuromuscular abnormalities and excessive collagen deposition. In the later stages of the disease, pseudo-obstruction occurs, and duodenal and jejunal loops become markedly dilated with arrest of contrast within the bowel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In practice, we do not often perform",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    follow through or small bowel enema. These tests are cumbersome and time-consuming and may give a false negative result. They may be a useful confirmatory test, but, if persistent diarrhea is present with a positive breath test, we assume that bacterial overgrowth is present. Barium studies with small bowel biopsy are performed if an alternate diagnosis, such as inflammatory bowel disease or celiac disease, is considered.",
"   </p>",
"   <p>",
"    MRI has also been used to assess scleroderma bowel involvement and is likely to be increasingly used for assessment of disease and exclusion of other pathologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COLON AND ANORECTAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colonic disease occurs in 10 to 50 percent of patients with SSc, with the anorectum as the most frequently affected area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/65\">",
"     65",
"    </a>",
"    ]. One study, for example, found that the colon is almost as frequently involved as the esophagus; in addition, patients with abnormal esophageal manometry almost always had abnormal anorectal motility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSc involvement of the large intestine is similar pathologically to that of the small intestine. Collagen is deposited in the mucosa and submucosa, while the muscularis externa undergoes atrophy. Thinning of the muscular wall leads to the development of wide-mouthed diverticuli on the antimesenteric border that can be detected on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81427 \" href=\"mobipreview.htm?19/33/19999\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physiologic studies show that the gastrocolic reflex, in which ingested food leads to significant spike and contractile activity in the colon, is absent early in the course of SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/58\">",
"     58",
"    </a>",
"    ]. Administration of the anticholinesterase,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/41/10901?source=see_link\">",
"     neostigmine",
"    </a>",
"    , restores the postprandial motility response in patients with early SSc but not in those with longstanding disease (see below).",
"   </p>",
"   <p>",
"    Disordered anorectal function is also an early finding in SSc and is a major factor in the development of fecal incontinence. Magnetic resonance imaging abnormalities in such patients include forward buckling of the anterior rectal wall, air in the upper portion of the anal sphincter, and atrophy of fibrotic appearing sphincteric muscle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/67\">",
"     67",
"    </a>",
"    ]. The most common manometric abnormality is an absent or diminished rectoanal inhibitory reflex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/66\">",
"     66",
"    </a>",
"    ]. The response of the internal anal sphincter is diminished or absent, and the response of the external sphincter is either normal or increased. These changes correlate with the reduction in the amplitude of relaxation of the lower esophageal sphincter. These findings are similar to those seen in Hirschsprung's disease and are consistent with a neuronal abnormality in the myenteric plexus.",
"   </p>",
"   <p>",
"    The later stages of the disease are characterized by reductions in resting pressures of the internal and external sphincters, in the length of the anal canal, and in compliance due to collagen deposition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/66,68\">",
"     66,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation (less than two spontaneous stools per week) and fecal incontinence are common problems in SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/32,69\">",
"     32,69",
"    </a>",
"    ]. Other, less frequent symptoms of colonic disease include rectal prolapse, spontaneous perforation, and colonic infarction. Diarrhea is usually a symptom of small bowel bacterial overgrowth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     LIVER AND BILIARY TREE INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic disease is rare in SSc; the most common association is with primary biliary cirrhosis (PBC), a chronic cholestatic liver disease characterized by inflammatory infiltrates within the portal tracts and the development of fibrosis. Two observational studies of patients with systemic scleroderma showed a much higher prevalence of PBC in patients with SSc (approximately 2 percent) than in the general population (0.04 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/42/41641?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and natural history of primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients with both SSc and PBC have limited cutaneous SSc or scleroderma overlap syndromes; diffuse skin involvement is much less common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. Anticentromere B autoantibodies (CENP-B) are strongly associated with PBC in SSc, while antitopoisomerase I and anti-RNA polymerase III (RNAP) antibodies are not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a strong association of PBC with antimitochondrial antibodies (AMA), which are also present in PBC patients with SSc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. A registry-based study of 817 patients with SSc, 16 of whom had confirmed PBC, showed the following regarding PBC-associated antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/71\">",
"     71",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The sensitivity and specificity of AMA testing by an enzyme linked immunoassay were 81 and 95 percent, respectively, while AMA testing by indirect immunofluorescence had a sensitivity of only 44 percent.",
"     </li>",
"     <li>",
"      Antibodies to the sp100 nuclear protein, which produce a characteristic \"multiple nuclear dots\" pattern by indirect immunofluorescence, had a sensitivity and specificity of 31 and 97 percent for PBC.",
"     </li>",
"     <li>",
"      The combined use of both the AMA by ELISA and sp100 testing by indirect immunofluorescence increased sensitivity of testing to 100 percent, while decreasing specificity to 93 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, in AMA-negative patients with SSc and clinical findings suggestive of PBC, testing for antibodies to sp100 may aid in making the diagnosis of PBC.",
"   </p>",
"   <p>",
"    Patients with lcSSc tend to have slower progression of hepatic disease compared with patients with PBC but without SSc. This was illustrated in a study of 580 patients with PBC, 43 of whom had SSc (40 with lcSSc) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/73\">",
"     73",
"    </a>",
"    ]. There was a significantly slower increase in bilirubin and a lower rate of liver transplantation in those with SSc associated PBC versus PBC alone. Overall mortality rates were similar in those with and without SSc. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5737?source=see_link\">",
"     \"Pathogenesis of primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, cirrhosis is very rare, as is nodular regenerative hyperplasia of the liver and idiopathic portal hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PANCREATIC INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic disease is uncommon in SSc. When present, it can contribute to malabsorption, and, in these cases, treatment with pancreatic enzyme supplements can be very effective. In one study of 20 unselected patients with SSc, three had evidence of severe pancreatic insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/35/41529/abstract/53\">",
"     53",
"    </a>",
"    ]. There did not appear to be a correlation between the severity of SSc and the degree of pancreatic insufficiency. Histologic studies show a fibrotic process; hemorrhagic pancreatitis has rarely been described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4587364\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nearly 90 percent of patients with systemic sclerosis (SSc, scleroderma), including both diffuse and limited forms, have gastrointestinal (GI) involvement; about half are symptomatic. Any part of the gastrointestinal tract (from mouth to anus) may be involved (",
"      <a class=\"graphic graphic_table graphicRef55280 \" href=\"mobipreview.htm?2/35/2621\">",
"       table 1",
"      </a>",
"      ). Alterations of the microvasculature, the autonomic nervous system, and the immune system, leading to fibrosis, appear important in the pathogenesis of SSc in general and in GI involvement. The principal pathological abnormalities throughout the GI tract are of smooth muscle atrophy and gut wall fibrosis, which may result from an initial neural disorder. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'General pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SSc of the oral and perioral tissues can lead to rigidity of the facial skin and tongue and can result in impaired mastication and deglutition. Oropharyngeal dysphagia and incoordination occur in up to 25 percent of patients with SSc. Patients develop narrowing of the oral aperture as well as rigidity and thinning of the soft palate, larynx, and oral mucosa (which may also become tender). Extrinsic pressure from skin changes may cause resorption of alveolar bone and malalignment of teeth. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Oropharyngeal involvement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Esophageal dysfunction is present in about 90 percent of patients of SSc, although many patients are asymptomatic. Symptoms result from gastroesophageal reflux, stricture formation, and abnormal motility. Typically, manometry shows an incompetent lower esophageal sphincter, low amplitude contractions in the distal smooth muscle portion of the esophagus, and (in advanced disease) diminished peristalsis in the upper skeletal muscle portion. Up to 40 percent of patients with abnormal motor activity of the esophagus are asymptomatic.",
"      <br/>",
"      <br/>",
"      Asymptomatic cases may be screened by manometry or scintigraphy, or, if these tests are not available,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      swallow may be used, although this is less sensitive. In definite cases of SSc, routine screening is unnecessary, given the use and effectiveness of proton pump inhibitors (PPI) in treating gastroesophageal reflux. Esophagoscopy should be performed if complications are suspected. Esophagoscopy is indicated in patients with persistent and progressive symptoms of heartburn or dysphagia that are refractory to treatment with PPIs. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Esophageal involvement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The stomach is not usually the primary source of symptoms in gastrointestinal SSc, but it may contribute to esophageal symptoms when gastric emptying is delayed. Histological abnormalities, which are less marked than in the esophagus or small bowel, consist of submucosal collagen deposition and replacement of smooth muscle with fibrous tissue. Gastroparesis may occur but is rare. Upper GI bleeding may result from mucosal telangiectasia (as part of the CREST syndrome) or from gastric antral venous ectasia. The latter syndrome should be suspected in patients with unexplained iron deficiency anemia and can be diagnosed by gastroscopy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Gastric involvement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Symptoms and signs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormal small bowel function is present in 20 to 60 percent of patients with SSc. The major clinical manifestations are due to reduced peristalsis with resulting stasis and intestinal dilatation, causing abdominal distension and pain arising from dilated bowel loops. Bacterial overgrowth occurs due to the intestinal stasis and pooling, resulting in malabsorption (in approximately 10 to 30 percent of patients with SSc) and the development of diarrhea, steatorrhea, and weight loss. Intestinal pseudo-obstruction, small bowel perforation, pneumatosis cystoides intestinalis, and small bowel volvulus each occur rarely.",
"      <br/>",
"      <br/>",
"      We screen initially for bacterial overgrowth with a glucose hydrogen breath test. We perform small bowel aspiration in patients who have developed resistance to rotating antibiotics, as manifested by diarrhea that is difficult to control with empirical antibiotics.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       Barium",
"      </a>",
"      studies with small bowel biopsy are performed if an alternate diagnosis to bacterial overgrowth is considered, such as inflammatory bowel disease or celiac disease. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Small intestinal involvement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Malabsorption'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Detection of bacterial overgrowth'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Radiographic findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colonic disease occurs in 10 to 50 percent of patients with SSc, with the anorectum as the most frequently affected area. Thinning of the muscular wall may lead to the development of wide-mouthed diverticuli on the antimesenteric border that can be detected on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      enema. The gastrocolic reflex is absent early in the course of SSc. Disordered anorectal function is typically seen early as well and can be associated with the development of fecal incontinence. Constipation (less than two spontaneous stools per week) and fecal incontinence are common problems in SSc; less frequent symptoms of colonic disease include rectal prolapse, spontaneous perforation, and colonic infarction. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Colon and anorectal involvement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hepatic or pancreatic involvement is rare in SSc, although primary biliary cirrhosis is more common in patients with SSc, particularly the limited cutaneous form, than in the general population. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Liver and biliary tree involvement'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28\">",
"       'Pancreatic involvement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/1\">",
"      Turner R, Lipshutz W, Miller W, et al. Esophageal dysfunction in collagen disease. Am J Med Sci 1973; 265:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/2\">",
"      Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 1989; 28:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/3\">",
"      Khanna D, Hays RD, Maranian P, et al. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009; 61:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/4\">",
"      Thoua NM, Bunce C, Brough G, et al. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology (Oxford) 2010; 49:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/5\">",
"      Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43:2437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/6\">",
"      Russell ML, Friesen D, Henderson RD, Hanna WM. Ultrastructure of the esophagus in scleroderma. Arthritis Rheum 1982; 25:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/7\">",
"      Dessein PH, Joffe BI, Metz RM, et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992; 93:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/8\">",
"      Silver RM. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 1991; 50 Suppl 4:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/9\">",
"      Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 37:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/10\">",
"      HORSWELL RR, HARGROVE MD Jr, PEETE WP, RUFFIN JM. Scleroderma presenting as the malabsorption syndrome. A case report. Gastroenterology 1961; 40:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/11\">",
"      Schuffler MD, Kaplan LR, Johnson L. Small-intestinal mucosa in pseudoobstruction syndromes. Am J Dig Dis 1978; 23:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/12\">",
"      Marguerie C, Kaye S, Vyse T, et al. Malabsorption caused by coeliac disease in patients who have scleroderma. Br J Rheumatol 1995; 34:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/13\">",
"      McBrien DJ, Mummery HE. Steatorrhoea in Progressive Systemic Sclerosis (Scleroderma). Br Med J 1962; 2:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/14\">",
"      Kahn IJ, Jeffries GH, Sleisenger MH. Malabsorption in intestinal scleroderma. Correction by antibiotics. N Engl J Med 1966; 274:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/15\">",
"      ROSSON RS, YESNER R. PERORAL DUODENAL BIOPSY IN PROGRESSIVE SYSTEMIC SCLEROSIS. N Engl J Med 1965; 272:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/16\">",
"      Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML. Advanced scleroderma bowel: complications and management. J Rheumatol 1988; 15:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/17\">",
"      D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/18\">",
"      Manetti M, Neumann E, Milia AF, et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 2007; 56:3442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/19\">",
"      Willerson JT, Thompson RH, Hookman P, et al. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. Ann Intern Med 1970; 72:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/20\">",
"      TREACY WL, BAGGENSTOSS AH, SLOCUMB CH, CODE CF. SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS. Ann Intern Med 1963; 59:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/21\">",
"      Di Trapani G, Pocchiari M, Masullo C, et al. Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. Ital J Neurol Sci 1982; 3:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/22\">",
"      Howe S, Eaker EY, Sallustio JE, et al. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994; 94:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/23\">",
"      Manetti M, Neumann E, M&uuml;ller A, et al. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis. Arthritis Rheum 2008; 58:2866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/24\">",
"      Furst DE, Clements PJ, Saab M, et al. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration. Ann Rheum Dis 1984; 43:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/25\">",
"      Zaninotto G, Peserico A, Costantini M, et al. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol 1989; 24:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/26\">",
"      Altman RD, Medsger TA Jr, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991; 34:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/27\">",
"      Rajapakse CN, Bancewicz J, Jones CJ, Jayson MI. Pharyngo-oesophageal dysphagia in systemic sclerosis. Ann Rheum Dis 1981; 40:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/28\">",
"      Montesi A, Pesaresi A, Cavalli ML, et al. Oropharyngeal and esophageal function in scleroderma. Dysphagia 1991; 6:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/29\">",
"      Cohen S, Fisher R, Lipshutz W, et al. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 1972; 51:2663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/30\">",
"      Belch JJ, Land D, Park RH, et al. Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol 1988; 27:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/31\">",
"      Segel MC, Campbell WL, Medsger TA Jr, Roumm AD. Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology 1985; 89:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/32\">",
"      Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980; 79:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/33\">",
"      Weihrauch TR, Korting GW. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease. Br J Dermatol 1982; 107:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/34\">",
"      Blackwell JN, Hannan WJ, Adam RD, Heading RC. Radionuclide transit studies in the detection of oesophageal dysmotility. Gut 1983; 24:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/35\">",
"      Kaye SA, Siraj QH, Agnew J, et al. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method. J Rheumatol 1996; 23:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/36\">",
"      Pakozdi A, Wilson H, Black CM, Denton CP. Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis? Clin Exp Rheumatol 2009; 27:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/37\">",
"      Wipff J, Allanore Y, Soussi F, et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005; 52:2882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/38\">",
"      Maddern GJ, Horowitz M, Jamieson GG, et al. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 1984; 87:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/39\">",
"      Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol 1998; 93:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/40\">",
"      Watson M, Hally RJ, McCue PA, et al. Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996; 39:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/41\">",
"      Calamia KT, Scolapio JS, Viggiano TR. Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol 2000; 18:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/42\">",
"      Klump B, Schneider GA, Fierlbeck G, et al. [Argon plasma coagulation in endoscopic therapy of CREST syndrome associated upper gastrointestinal hemorrhage]. Z Gastroenterol 1997; 35:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/43\">",
"      DiMarino AJ, Carlson G, Myers A, et al. Duodenal myoelectric activity in scleroderma. Abnormal responses to mechanical and hormonal stimuli. N Engl J Med 1973; 289:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/44\">",
"      Rees WD, Leigh RJ, Christofides ND, et al. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology 1982; 83:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/45\">",
"      Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989; 96:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/46\">",
"      Greenberger NJ, Dobbins WO 3rd, Ruppert RD, Jesseph JE. Intestinal atony in progressive systemic sclerosis (scleroderma). Am J Med 1968; 45:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/47\">",
"      Cobden I, Axon AT, Ghoneim AT, et al. Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 1980; 5:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/48\">",
"      Salen G, Goldstein F. Malabsorption in intestinal scleroderma: Relation to bacterial flora and treatment with antibiotics. Ann Intern Med 1966; 64:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/49\">",
"      Scudamore HH, Green PA, Hofman HN 2nd, et al. Scleroderma (progressive systemic sclerosis) of the small intestine with malabsorption. Evaluation of intestinal absorption and pancreatic function. Am J Gastroenterol 1968; 49:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/50\">",
"      Drasar BS, Hill MJ, Shiner M. The deconjugation of bile salts by human intestinal bacteria. Lancet 1966; 1:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/51\">",
"      Kaye SA, Seifalian AM, Lim SG, et al. Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud's phenomenon or chronic vasculopathy? QJM 1994; 87:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/52\">",
"      Cobden I, Rothwell J, Axon AT, et al. Small intestinal structure and passive permeability in systemic sclerosis. Gut 1980; 21:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/53\">",
"      Cobden I, Axon AT, Rowell NR. Pancreatic exocrine function in systemic sclerosis. Br J Dermatol 1981; 105:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/54\">",
"      Kaye SA, Lim SG, Taylor M, et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995; 34:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/55\">",
"      REINHARDT JF, BARRY WF Jr. Scleroderma of the small bowel. Am J Roentgenol Radium Ther Nucl Med 1962; 88:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/56\">",
"      TREACY WL, BUNTING WL, GAMBILL EE, CODE CF. Scleroderma presenting as obstruction of the small bowel. Proc Staff Meet Mayo Clin 1962; 37:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/57\">",
"      Jayson MI, Salmon PR, Gough J, et al. Spontaneous bowel perforation in intestinal scleroderma: first report of a non-fatal case. Postgrad Med J 1972; 48:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/58\">",
"      Battle WM, McLean GK, Brooks JJ, et al. Spontaneous perforation of the small intestine due to scleroderma. Dig Dis Sci 1979; 24:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/59\">",
"      Meihoff WE, Hirschfield JS, Kern F Jr. Small intestinal scleroderma with malabsorption and pneumatosis cystoides intestinalis. Report of three cases. JAMA 1968; 204:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/60\">",
"      Hendy MS, Torrance HB, Warnes TW. Small-bowel volvulus in association with progressive systemic sclerosis. Br Med J 1979; 1:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/61\">",
"      Olmsted WW, Madewell JE. The esophageal and small-bowel manifestations of progressive systemic sclerosis. A pathophysiologic explanation of the roentgenographic signs. Gastrointest Radiol 1976; 1:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/62\">",
"      Horowitz AL, Meyers MA. The \"hide-bound\" small bowel of scleroderma: characteristic mucosal fold pattern. Am J Roentgenol Radium Ther Nucl Med 1973; 119:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/63\">",
"      Miercort RD, Merrill FG. Pneumatosis and pseudo-obstruction in scleroderma. Radiology 1969; 92:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/64\">",
"      Madani G, Katz RD, Haddock JA, et al. The role of radiology in the management of systemic sclerosis. Clin Radiol 2008; 63:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/65\">",
"      MESZAROS WT. The colon in systemic sclerosis (scleroderma). Am J Roentgenol Radium Ther Nucl Med 1959; 82:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/66\">",
"      Hamel-Roy J, Devroede G, Arhan P, et al. Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 1985; 88:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/67\">",
"      deSouza NM, Williams AD, Wilson HJ, et al. Fecal incontinence in scleroderma: assessment of the anal sphincter with thin-section endoanal MR imaging. Radiology 1998; 208:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/68\">",
"      Chiou AW, Lin JK, Wang FM. Anorectal abnormalities in progressive systemic sclerosis. Dis Colon Rectum 1989; 32:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/69\">",
"      Leighton JA, Valdovinos MA, Pemberton JH, et al. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 1993; 36:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/70\">",
"      Jacobsen S, Halberg P, Ullman S, et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998; 37:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/71\">",
"      Assassi S, Fritzler MJ, Arnett FC, et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009; 36:2250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/72\">",
"      Reynolds TB, Denison EK, Frankl HD, et al. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med 1971; 50:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/35/41529/abstract/73\">",
"      Rigamonti C, Shand LM, Feudjo M, et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 2006; 55:388.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7548 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-62FEFCC119-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41529=[""].join("\n");
var outline_f40_35_41529=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4587364\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OROPHARYNGEAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ESOPHAGEAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GASTRIC INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SMALL INTESTINAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Detection of bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COLON AND ANORECTAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      LIVER AND BILIARY TREE INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PANCREATIC INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4587364\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7548\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7548|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/51/32575\" title=\"diagnostic image 1\">",
"      Dilated bowel in scleroderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/33/19999\" title=\"diagnostic image 2\">",
"      Colon diverticulae scleroderma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7548|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/34/548\" title=\"picture 1\">",
"      Duodenum in scleroderma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/6/12388\" title=\"picture 2\">",
"      Autonomic nerve scleroderma EM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7548|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/35/2621\" title=\"table 1\">",
"      GI symptoms in scleroderma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/26/2474?source=related_link\">",
"      Chronic intestinal pseudo-obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/3/44087?source=related_link\">",
"      Classification of scleroderma disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11990?source=related_link\">",
"      Clinical manifestations and diagnosis of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/42/41641?source=related_link\">",
"      Clinical manifestations, diagnosis, and natural history of primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=related_link\">",
"      Management of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5737?source=related_link\">",
"      Pathogenesis of primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/63/19450?source=related_link\">",
"      Pathogenesis of systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/38/13928?source=related_link\">",
"      Pathophysiology of reflux esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/9/11415?source=related_link\">",
"      Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/56/41865?source=related_link\">",
"      Uncommon causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_35_41530="Phosphorus foods 1 PI";
var content_f40_35_41530=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F79877%7EPI%2F56081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F79877%7EPI%2F56081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Table 20. Phosphorus content of protein-containing foods",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 694px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Table 20. Phosphorus content of protein-containing foods (cont'd)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 585px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A common way to determine a dietary phosphorus limit is to use an average of 10-12 mg/g of protein (multiply protein goal times 10-12 mg phosphorus). Thus, for a 70 kg individual requiring 84 g of protein, the phosphorus range is 840-1008 mg.",
"    <br/>",
"    Considering all common sources of protein, the average phosphorus content per gram of protein is 17.8. If all diary products, nuts, beans, and seeds are eliminated, but meats and tofu are considered, the average phosphorus content per gram of protein is 10.3.",
"    <div class=\"footnotes\">",
"     FF: fast food; Tb: tablespoon.",
"    </div>",
"    <div class=\"reference\">",
"     US Department of Agriculture, Agricultural Research Service. 2001. USDA Nutrient Database for Standard Reference, Release 14. Nutrient Data Laboratory Home Page, file://www.nalusda.gov/fnic/foodcomp.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41530=[""].join("\n");
var outline_f40_35_41530=null;
var title_f40_35_41531="Infant NVP dosing recommendations";
var content_f40_35_41531=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Extended simplified infant nevirapine dosing recommendations*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Infant age",
"       </td>",
"       <td class=\"subtitle1\">",
"        NVP daily dosing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Birth&bull; to 6 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Birth weight 2000-2499 g",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 mg twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Birth weight &gt;2500 g",
"       </td>",
"       <td class=\"sublist_other\">",
"        15 mg twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;6 weeks to 6 months",
"       </td>",
"       <td>",
"        20 mg once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;6 months to 9 months",
"       </td>",
"       <td>",
"        30 mg once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;9 months to end of breastfeeding",
"       </td>",
"       <td>",
"        40 mg once daily",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Based on the dosing required to sustain exposure in the infant of &gt;100 ng/ml with the least dose changes.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Low birth weight infants should receive mg/kg dosing; suggested starting dose is 2 mg/kg once daily. Therapeutic drug monitoring is recommended.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Mirochnick, M, et al. Nevirapine pharmacokinetics during the first year of life: a population analysis across studies in Pediatric Academic Society. 2006: San Francisco, USA. Reproduced with permission from: World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: Recommendations for a public health approach (2010 version). World Health Organization, Geneva 2010. Copyright &copy; 2010 WHO. Available at:",
"     <a href=\"file://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf\">",
"      file://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41531=[""].join("\n");
var outline_f40_35_41531=null;
var title_f40_35_41532="Drug therapy in acute pericarditis";
var content_f40_35_41532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drug therapy in acute pericarditis for adult patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of therapy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tapering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        For initial combination treatment of most patients:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ibuprofen",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        600 to 800 mg three times daily",
"       </td>",
"       <td>",
"        1 to 2 weeks",
"       </td>",
"       <td>",
"        Decrease the dose weekly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"4\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Indomethacin",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        50 mg three times daily",
"       </td>",
"       <td>",
"        1 to 2 weeks",
"       </td>",
"       <td>",
"        Decrease the dose weekly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"4\">",
"        <strong>",
"         PLUS",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Colchicine",
"        <sup>",
"         &Delta;&sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.5 to 0.6 mg two times daily",
"       </td>",
"       <td>",
"        3 months",
"       </td>",
"       <td>",
"        Usually not tapered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        For initial combination therapy of patients following myocardial infarction:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspirin",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        650 to 1000 mg three times daily",
"       </td>",
"       <td>",
"        1 to 2 weeks",
"       </td>",
"       <td>",
"        Decrease the dose weekly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"4\">",
"        <strong>",
"         PLUS",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Colchicine",
"        <sup>",
"         &Delta;&sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.5 to 0.6 mg two times daily",
"       </td>",
"       <td>",
"        3 months",
"       </td>",
"       <td>",
"        Usually not tapered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        For refractory cases or patients with a contraindication to NSAID therapy:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        0.25 to 0.5 mg/kg/day",
"       </td>",
"       <td>",
"        2 weeks",
"       </td>",
"       <td>",
"        Slow tapering, see \"Treatment of acute pericarditis\" section \"Glucocorticoids\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" colspan=\"4\">",
"        <strong>",
"         PLUS",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Colchicine",
"        <sup>",
"         &Delta;&sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.5 to 0.6 mg two times daily",
"       </td>",
"       <td>",
"        3 months",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        Usually not performed",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *&nbsp;All doses&nbsp;are for oral administration.",
"     <br>",
"      &bull;&nbsp;Proton pump inhibitor (eg, omeprazole)&nbsp;gastrointestinal protection may be indicated.",
"      <br>",
"       &Delta; 0.5 mg colchicine is not available in US. It is widely available elsewhere.",
"       <br>",
"        &sect; Colchicine dose should be reduced to 0.5 to 0.6 mg once daily in patients &lt;70 kg.",
"        <br>",
"         &yen; The duration of colchicine therapy for recurrent or refractory pericarditis is at least 6 months.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41532=[""].join("\n");
var outline_f40_35_41532=null;
var title_f40_35_41533="Metabolic syndrome age";
var content_f40_35_41533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Prevalence of NCEP ATP III metabolic syndrome among subjects in the NHANES III survey, by age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 299px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41533=[""].join("\n");
var outline_f40_35_41533=null;
var title_f40_35_41534="Intertriginous diaper derm";
var content_f40_35_41534=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pattern for intertriginous diaper dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_35_41534=[""].join("\n");
var outline_f40_35_41534=null;
var title_f40_35_41535="Contents: Breast cancer";
var content_f40_35_41535=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?3/43/3774\">",
"       Oncology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Breast cancer",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Breast cancer",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Carcinoma in situ",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/14/44265\">",
"           Atypia and lobular carcinoma in situ: High risk lesions of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/33/6680\">",
"           Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/43/37561\">",
"           Ductal carcinoma in situ: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/41/14998\">",
"           Microinvasive breast carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Evaluation and screening",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/59/24504\">",
"           Breast biopsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/35/39482\">",
"           Breast imaging: Mammography and ultrasonography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/63/44025\">",
"           Characteristics of hereditary breast and ovarian cancer syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/49/10009\">",
"           Clinical features, diagnosis, and staging of newly diagnosed breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/36/24138\">",
"           Diagnostic evaluation of women with suspected breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/60/5064\">",
"           Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32249\">",
"           Genetic testing for hereditary breast and ovarian cancer syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/0/17418\">",
"           Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/45/24278\">",
"           Tumor node metastasis (TNM) staging classification for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/51/17207\">",
"           Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/34/2602\">",
"           Breast cancer during pregnancy and lactation: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/10/20649\">",
"           Breast development and morphology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/21/34137\">",
"           Cardiotoxicity of radiation therapy for malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42232\">",
"           Cardiotoxicity of trastuzumab",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/17/28954\">",
"           Factors that modify breast cancer risk in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19194\">",
"           Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/55/10103\">",
"           Inflammatory breast cancer: Pathology and molecular pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/0/19464\">",
"           Management of brain metastases in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43465\">",
"           Measurement of prognostic factors in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/21/41302\">",
"           Molecular intrinsic subtypes of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19177\">",
"           Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/0/8202\">",
"           Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/22/6503\">",
"           Prognostic molecular profiles of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/52/20296\">",
"           Sentinel lymph node biopsy in breast cancer: Techniques",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hormones and hormonal replacement therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/40/20106\">",
"           Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19194\">",
"           Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/13/44246\">",
"           Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/55/21370\">",
"           Treatment approach to metastatic hormone receptor-positive breast cancer: Endocrine therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lymphedema",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1866\">",
"           Clinical manifestations and diagnosis of lymphedema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/1/33817\">",
"           Prevention and treatment of lymphedema",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Male breast cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26186\">",
"           Breast cancer in men",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pathology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19194\">",
"           Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/55/10103\">",
"           Inflammatory breast cancer: Pathology and molecular pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43465\">",
"           Measurement of prognostic factors in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/21/41302\">",
"           Molecular intrinsic subtypes of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/42/16040\">",
"           Pathology of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/22/6503\">",
"           Prognostic molecular profiles of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/52/20296\">",
"           Sentinel lymph node biopsy in breast cancer: Techniques",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/27/12728\">",
"           Accelerated partial breast irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/33/41496\">",
"           Acute side effects of adjuvant chemotherapy for early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/4/37961\">",
"           Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/40/20106\">",
"           Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/7/11384\">",
"           Adjuvant medical therapy for HER2-positive breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/0/34826\">",
"           Adjuvant systemic therapy for older women with early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/21/43352\">",
"           Axillary node metastases with occult primary breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/18/13608\">",
"           Bisphosphonates and denosumab in patients with metastatic cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26186\">",
"           Breast cancer in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/19/36150\">",
"           Breast lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/29/39386\">",
"           Breast reconstruction in women with breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/3/28729\">",
"           Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27689\">",
"           Breast sarcoma: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/21/34137\">",
"           Cardiotoxicity of radiation therapy for malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42232\">",
"           Cardiotoxicity of trastuzumab",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30359\">",
"           Complications of breast and chest wall irradiation for early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/40/34441\">",
"           Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/58/13226\">",
"           General principles on the treatment of early stage and locally advanced breast cancer in older women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/22/30058\">",
"           HER2 and predicting response to therapy in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/20/31048\">",
"           Inflammatory breast cancer: Clinical features and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/0/19464\">",
"           Management of brain metastases in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/53/34650\">",
"           Management of locoregional recurrence of breast cancer after breast conserving therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/45/30426\">",
"           Management of locoregional recurrence of breast cancer after mastectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/52/42825\">",
"           Management of the regional lymph nodes in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35831\">",
"           Metastatic breast cancer: Local treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/31/1529\">",
"           Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/40/35466\">",
"           Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/54/8042\">",
"           Osteoclast inhibition in the management of bone metastases from breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19177\">",
"           Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/35/33336\">",
"           Overview of the use of osteoclast inhibitors in early breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/0/14\">",
"           Paget disease of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/63/18424\">",
"           Phyllodes tumors of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/3/41017\">",
"           Postmastectomy chest wall irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/55/42873\">",
"           Radiation techniques for locally advanced breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/7/11385\">",
"           Role of radiation therapy in breast conservation therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/52/20296\">",
"           Sentinel lymph node biopsy in breast cancer: Techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/27/11705\">",
"           Systemic treatment for metastatic breast cancer: Combination chemotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/11/7354\">",
"           Systemic treatment for metastatic breast cancer: General principles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/43/22202\">",
"           Systemic treatment for metastatic breast cancer: Molecular targeted therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/20/32072\">",
"           Systemic treatment for metastatic breast cancer: Selection of chemotherapy regimen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/53/29528\">",
"           Systemic treatment for metastatic breast cancer: Single agent chemotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39657\">",
"           Techniques of breast and chest wall irradiation for early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/19/43321\">",
"           The roles of diet, physical activity, and body weight in cancer survivorship",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/55/21370\">",
"           Treatment approach to metastatic hormone receptor-positive breast cancer: Endocrine therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/60/40903\">",
"           Treatment of metastatic breast cancer in older women",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-F43DD23066-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_35_41535=[""].join("\n");
var outline_f40_35_41535=null;
